Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 4 contracts
Sources: Merger Agreement (Skullcandy, Inc.), Merger Agreement (Mill Road Capital II, L.P.), Merger Agreement (Mill Road Capital II, L.P.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdverse Effect on Financing 7.18(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(aBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Cash Offer Price Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8 Effect 1.1(u) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c) Event Notice Period 6.3(e)(i)(2) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Form S-4 2.1(e) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Lease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(iFractional Share Payout 3.7(d) Minimum Condition Section 2.1(a)(i) Merger Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)
Appears in 3 contracts
Sources: Agreement and Plan of Merger (Herc Holdings Inc), Agreement and Plan of Merger (Herc Holdings Inc), Agreement and Plan of Merger (H&E Equipment Services, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.11(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.19 Book-Entry Shares 3.9(c) Board Recommendation Section 2.2(bCapitalization Date 4.4(a) Cancelled Company Shares Section 3.7(a)(ii) Capitalization Representation Annex A Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Claims Annex A Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.17(a) Company Preamble Company Common Stock Recitals Board Recommendation 2.2(a)(iv) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Company License-In Agreements Section 4.16(gRegistered Intellectual Property 4.20(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 7.1(b) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Stockholders 2.1(f)(ii) Company Stockholders’ Meeting 7.3(a) Compensation Committee 4.3(c) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) Continuing Employees 7.11(a) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.16(a) Employment Agreement Recitals ESPP 3.8(c) eScription Transition Condition Annex A Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iFinal Exercise Date 3.8(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 4.16(k) Recitals Recitals Funded International Employee Plan 4.16(b) Government Conditions 7.5(f) Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 International Employee Plans 4.16(a) IP Contracts 4.20(h) Lazard 4.26 Leased Real Property 4.18(b) Leases 4.18(b) Material Contract Section 4.18(a4.11(a) Material Customer 4.23(a) Material Supplier 4.23(b) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 3 contracts
Sources: Merger Agreement (Nuance Communications, Inc.), Merger Agreement (Nuance Communications, Inc.), Merger Agreement (Transcend Services Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality A&R Partnership Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Recitals Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Financing Section 6.19(a) BAM Letter Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Recitals Cancelled Company Shares Section 3.7(a)(ii2.07(a)(ii) Capitalization Date Section 3.06(a) Cash Electing Share Section 2.03(d)(1) Cash Election Section 2.03(d)(1) Certificate of Merger Section 3.2 2.02 Certificates Section 3.8(c2.09(c) Changes Section 1.1 Charter Closing Section 3.3 2.03(a) Charter Closing Date Section 3.3 COBRA 2.03(a) Charter Effective Time Section 4.11(d2.03(a) Citigroup Section 3.25 Class B Exchange Recitals Class B Exchange Agreement Section 2.03(b) Class B Exchange Closing Section 2.03(b) Class B Exchange Effective Time Section 2.03(b) Collective Bargaining Agreement Section 3.19(a) Committed Financing Section 4.29 Company Preamble Company Common Stock Benefit Plans Section 3.18(a) Company Board Recitals Company Board Recommendation Section 3.02 Company Board Recommendation Change Section 5.03(c) Company Board Recommendation Notice Section 5.03(f) Company Budget Section 5.01(a) Company Charter Recitals Company Disclosure Letter Article IV III Company License-In Agreements Related Parties Section 4.16(g8.03(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.08 Company Securities Section 4.2(a3.06(c) Company Shares Special Distribution Section 5.01(a) Company Stockholder Meeting Section 3.02 Company Stockholders Recitals Competing Acquisition Transaction Section 8.03(b)(ii) Competing Proposal Section 5.03(b) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 9.04 Consent Section 7.8(c3.05 Continuing Employees Section 6.08(a) Customs Laws Converted Option Section 4.22(a2.07(d)(ii) Debt Financing Dispute Converted Restricted Stock Section 10.9(a2.07(e)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.07(c)(i) EAR Election Deadline Section 4.22(a2.08(b) Effective Time Election Form Section 3.2 2.08(a) Election Form Record Date Section 2.08(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.02 Escrow Account Section 4.15(b2.09(a) Escrow Agent Section 2.09(a) Escrow Agreement Section 2.09(a) Exchange Fund Section 3.8(b2.09(b) Expiration Time Expenses Section 2.1(d)(i8.03(a) Financial Statements Incipio Incipio Merger Agreement Fee Letter Section 4.7(b4.29 Final Offering Section 2.07(g) Recitals Recitals Financing Commitment Section 4.29 Financing Commitment Papers Section 4.29 Form F-4 Section 4.23 Form S-4 Section 3.28 Fraud and Bribery Laws Section 3.21(b) ▇▇▇▇▇▇▇ ▇▇▇▇▇ Section 3.25 Indemnified Persons Parties Section 7.8(a6.07(a) Inventions Mailing Date Section 1.1 2.08(a) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Merger Closing Section 2.03(e) Merger Closing Date. Section 2.03(e) Merger Consideration Section 3.7(a)(i2.07(a)(i) Minimum Condition Merger Effective Time Section 2.1(a)(i2.02 New Plans Section 6.08(b) Multiemployer Plan Non-Electing Shares Section 4.11(c2.08(b) Notice Period Section 5.03(g) Old Plans Section 6.08(b) Operating Partnership Recitals Owned Real Property Section 3.13(a) Parent Preamble Parent Capitalization Date Section 4.06 Parent Common Units Election Section 2.08(b) Parent Common Units Election Share Section 2.08(b) Parent Common Units Exchange Section 2.03(f) Parent Disclosure Letter Article IV Parent Material Contract Section 4.12(a) Parent Related Parties Section 8.03(d) Parent SEC Reports Section 4.08 Parent Securities Section 4.06(c) Parent Subsidiary Securities Section 4.07(c) Parent Unitholder Consent Section 4.04 Parent Unitholder Meeting Section 6.16 Partnership Agreement Amendment and Restatement Recitals Payment Agent Section 2.09(a) Per Restricted Share Cash Consideration Section 2.07(e)(i) Permits Section 3.20 Pre-Closing Dividend Section 2.03(d) Prorated Per Share Cash Dividend Section 2.03(d)(1) Prorated Per Share Stock Dividend Section 2.03(d)(2) Proxy Statement Section 3.28 PTP Qualifying Income Section 8.03(b)(iv)(1) Qualifying Income Section 8.03(c)(i) Qualifying Income Section 8.03(b)(iv)(3) REIT Affiliate Section 8.03(b)(iv)(3) REIT Subsidiary Section 3.17(f) Representatives Section 5.03(a) Requested Transactions Section 6.14 Requested Transactions Closing Section 2.03(c) Requested Transactions Effective Time Section 2.03(c) Requisite Stockholder Approval Section 3.03 Retention Program Section 6.08(d) Rev. Proc. 93-27 Section 3.06(b) Reverse Termination Fee Section 8.03(c) Rights Agreement Recitals Schedule 13E3 Section 4.23 Shelf Registration Statement(s) Section 7.03(e) Short Taxable Year Section 7.02(d) Special Committee Recitals Specified JV Agreements Section 6.19(c) Specified JV Consent Section 6.19(c) Specified JV Party Section 6.19(c) Stock Electing Share Section 2.03(d)(2) Stock Election Section 2.03(d)(2) Subsidiary Interests Section 6.14 Subsidiary Securities Section 3.07(c) Surviving Corporation Section 2.01 Surviving Debt Section 6.19(b) Surviving Debt Consent Section 6.19(b) Surviving Debt Party Section 6.19(b) Tail Period Section 8.03(b)(ii) Tail Policy Section 6.07(b) Tax Protection Agreement Section 3.17(j) Tax Sharing Agreement Section 3.17(j) Termination Date Section 8.01(a)(ii) Termination Fee Section 8.03(b)(i) Uncertificated Shares Section 2.09(c) Voting Agreement Recitals Voting Parties Recitals WARN Section 3.19(c)
Appears in 3 contracts
Sources: Merger Agreement (Brookfield Property Partners L.P.), Merger Agreement (Brookfield Asset Management Inc.), Merger Agreement (GGP Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.12(c)(i) Board Recommendation Section 2.2(bCFIUS Filing 6.2(c) Cancelled Company Shares Section 3.7(a)(iiChosen Courts 9.12(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.6 Closing Date Section 3.3 COBRA Section 4.11(d2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Benefit Plan Expiration Date 6.11(b) Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(g) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPlans 6.11(c) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(e) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSoftware 3.15(j) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stock-Based Award Consideration 2.11(a) Company D&O Insurance Section 7.8(cTrade Secrets 3.15(i) Customs Laws Section 4.22(aComparable Plans 6.11(c) Debt Financing Dispute Section 10.9(aContributor 3.15(h) DGCL Recitals Copyrights 1.1(eee) Dissenting Company Shares Section 3.7(c)(i2.10(c)(i) EAR Section 4.22(aDissenting Shareholder Statute 2.10(c)(i) Draft CFIUS Filing 6.2(c) DTC Payment 2.12(d) ▇▇▇▇▇ 3.8 Effect 1.1(x) Effective Time Section 2.5 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEvent Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.12(b) Excluded Benefits 6.11(c) Expiration Date 2.1(c) Expiration Time Section 2.1(d)(iAnnex I Extension Deadline 2.1(d)(ii) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Expiration Date 2.1(c) International Company Benefit Plans 3.18(a) Joinder 9.7 Lease 3.13(b) Leased Real Property 3.13(b) Marks 1.1(eee) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Sub Recitals Minimum Condition Section 2.1(a)(iAnnex I New Plans 6.11(d) Multiemployer Plan Section 4.11(cOffer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(f)(i) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i)
Appears in 3 contracts
Sources: Merger Agreement (True Wind Capital, L.P.), Merger Agreement (Zix Corp), Merger Agreement (Open Text Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approval Annex A Appointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.14 Assumed Option 3.7(e) Board Recommendation Section 2.2(bAssumed RSU 3.7(d) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.18(k) Company Disclosure Letter Article Art. IV Preamble Company License-In Intellectual Property Agreements Section 4.16(g4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.2(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 7.2(c) Confidentiality Agreement Section 10.4 Current Company 8.8 Consent 4.5 Continuing Directors 2.3(a) Conversion RSUs 3.7(d)(ii) Covered Securityholders 4.18(k) D&O Insurance Section 7.8(c7.1(c) Customs Laws Section 4.22(aDeemed Cashout Value 3.7(e)(ii) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) Employment Compensation Arrangements 4.18(k) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.1(a) Inventions Section 1.1 Material Contract Section International Employee Plans 4.18(a) Leased Real Property 4.13(b) Leases 4.13(b)
(a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNew Plans 7.2(d) Offer Recitals Offer Price Recitals Offer to Purchase 2.1(a) Offer Documents 2.1(g) Old Plans 7.2(d) Option Consideration 3.7(e) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Proxy Statement 4.28(c) Recommendation Change Notice 6.3(b) Representatives 6.2(b) Requisite Stockholder Approval 4.3 Schedule TO 2.1(g) Schedule 14D-9 2.2(b) Stockholders Recitals Subsidiary Securities 4.7(c) Superior Proposal Notice 10.1(e) Surviving Corporation 3.1
(a) Tax Returns 4.16
(a) Tender and Voting Agreement Recitals Termination Date 10.1(b) Top-Up Notice 2.4(a) Top-Up Option 2.4(a) Top-Up Option Shares 2.4(a) Uncertificated Shares 3.8(c)
Appears in 3 contracts
Sources: Merger Agreement (3PAR Inc.), Merger Agreement (Hewlett Packard Co), Merger Agreement (Hewlett Packard Co)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAmended Offer Documents 2.1(a)(i) Antiboycott Rules Section 4.22(aAnnual Meeting 7.6(b) Board Recommendation Section 2.2(bAssets 4.19 Assumed Option 3.8(a) Cancelled Company Assumed Restricted Stock Unit 3.8(b) Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d3.2 Collective Bargaining Agreements 4.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Products 4.20(a) Company Financial Advisor Section 4.10 Restricted Stock 3.8(c) Company SEC Reports Section 4.7(a4.6(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.6(a) Confidential Materials 7.9(a) Continuing Directors 2.4(b) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(vi) EAR Section 4.22(aEffect 1.1(pp) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b3.3(a)
(a) Exchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Foreign Employees 4.15(j) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 4.20(d) Recitals Recitals Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 Independent Directors 2.4(c) Leased Real Property 4.17 Leases 4.17 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.6(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A NetApp Merger Agreement Recitals Notes 7.9(a)
Appears in 3 contracts
Sources: Merger Agreement (Emc Corp), Merger Agreement (Data Domain, Inc.), Merger Agreement (Emc Corp)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this Jounce Lead Co-Co Agreement set forth opposite each of the capitalized terms indicated below: Adverse Study Effect 2.3.2(c)(4) Allocable Overhead Exhibit D Allowable Expenses Exhibit D Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Co-Co Candidates Recitals; 2.2.3; Exhibit B Co-Co Diagnostic Products 2.2(a) Co-Co Enforcement Proceeding 6.5.2(d) Co-Co Materials Receiving Party 2.7.1 Co-Co Products Recitals Co-Co Step-In Proceeding 6.5.2(d) Co-Co Target 2.1.2; Exhibit B Co-Co Transferring Party 2.7.1 Commercialization Report 3.1.3 Competitive Infringement 6.5.1 Cost of Goods Sold or COGS Exhibit D Cure Period 8.3.1 [***] [***] Development Cost Report 2.3.6(c) Development Cost Share 2.3.4 Distribution Costs Exhibit D Full Amount 8.7.2 Gross Profit Exhibit D ▇▇▇▇▇-▇▇▇▇▇▇ Act 6.5.2(a) CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Indemnification Claim 7.3 Indemnitee 7.3 Indemnitor 7.3 [***] [***] Information Request 3.1.5(d) JCC 4.3.1 Jounce Preamble Jounce Co-Co Additional Study 2.3.2(c) Jounce Co-Co Additional Study Approval 2.3.2(c)(3) Jounce Co-Co Material Transfer Agreement 2.7.1 Jounce Co-Co Material Transfer Agreement Effective Date Exhibit E Jounce Co-Co Materials 2.7.1 Jounce Co-Co Product Patents 6.5.2(a) Jounce Co-Co Program Exhibit A Jounce Co-Co Purpose 2.7.1 Jounce Co-Co Selling Party 1.11 Jounce Co-Co Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 8.1 Jounce Independent Product 2.9 Jounce Lead Co-Co Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseJounce Opt-Out Agreements Section 4.16(hNotice 4.4.1 Jounce Opt-Out Date 4.4.2 [***] [***] Jounce Lead Effective Date Preamble Jounce Reversion Products 8.7.1 Lump Sum 2.3.2(c)(3) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aManufacturing Costs Exhibit D Marketing Costs Exhibit D Master Collaboration Agreement Recitals MSKCC Patents 6.3.3 Non-Proposing Party 2.3.2(c)(1) Company Securities Section 4.2(aOperating Profits or Losses Exhibit D Other Actives 1.15 Other Operating Income/Expenses Exhibit D Party or Parties Preamble Payee Party 5.7.3 Paying Party 5.7.3 Pharmacovigilance Agreement 2.4.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cPharmacovigilance Expenses Exhibit D Product Recall Expenses Exhibit D Profit & Loss Share 5.6 Program Assets 2.9 Proposing Party 2.3.2(c) Customs Laws Section 4.22(aRecording Party Exhibit D Regulatory Expenses Exhibit D Report Exhibit D ROW Development Costs 2.3.4 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Safety and CMC Data 2.4.3(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety Reason 8.2.2 Sales Costs Exhibit D Sublicense Revenues Exhibit D U.S. Administration Liabilities 7.5 U.S. Commercialization Costs 3.1.6 U.S. Commercialization Report 3.2.3 Worldwide Development Costs 2.3.4
Appears in 2 contracts
Sources: Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.), Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.4 Additional Study Approval Section 3.4(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.9(a) Audit Rights Holder Section 9.9(e) Auditee Section 9.9(e) Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.1(b) Celgene Independent Product Master Agreement Challenge Section 14.2(d) Challenging Party Section 14.2(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.5 DEFINITION SECTION Combination Product Section 1.39 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGs Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.2(b)(i) Damages Master Agreement Deemed Buy-In Section 3.4(c) Develop/Development Master Agreement Development Budget Section 3.2(a)(i) Development Cost Share Section 9.1(a) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iv)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.10(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement DEFINITION SECTION Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.4(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.2(b)(i) Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.10(b)(i) Paying Party Section 9.10(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.6(a) Program Assets Section 12.4(a) Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.2(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.1(b) Regulatory Expenses Exhibit D Report Exhibit D Requesting Party Section 11.3(b)(iii) ROW Development Costs Section 9.1(a) DEFINITION SECTION Royalty Term Section Reference Acceptable Confidentiality 9.3(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.39 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.7(b) Acquisition Proposal Term Section 6.2(e)(i14.1(a) Acquisition Sub Third Party Contractors Section 8.2(a)(ii) Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) U.S. Commercialization Budget Section 6.2(c) U.S. Commercialization Costs Section 6.5(c) U.S. Commercialization Plan Section 6.2(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Vividion Opt-Out Notice Section 6.2(c)(ii2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA 2.3(b) Worldwide Development Costs Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c9.1(a)
Appears in 2 contracts
Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 7.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 4.21 Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.19(a) Company Preamble Company Common Stock Recitals Acquisition Transaction 9.4(b) Company Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Preamble Company License-In IP Agreements Section 4.16(g4.22(e) Company License-Out Agreements Section 4.16(hProducts 4.22(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRestricted Stock 3.7(e) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(c) Recitals Recitals Foreign Employees 4.18(l) Funded International Employee Plan 4.18(b) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Initial Termination Date 9.1(c) International Employee Plans 4.18(a) Leased Real Property 4.20(b) Leases 4.20(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNet Cash Position 4.7(h)
Appears in 2 contracts
Sources: Merger Agreement (Spectralink Corp), Merger Agreement (Polycom Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(b) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.12(f) Company Financial Advisor Section 4.10 Advisors 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholder Approval 3.5 Company Stockholders’ Meeting 6.12(b) Company Termination Fee 8.3(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aTail Policy 6.7(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.3 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.19(a)(xix) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(cNew Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Paying Agent 2.8(a) Proxy Statement 3.6 PSU Consideration 2.7(f) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) RSU Consideration 2.7(e) Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Uncertificated Shares 2.8(c)(ii)
Appears in 2 contracts
Sources: Merger Agreement (Intra-Cellular Therapies, Inc.), Merger Agreement (Intra-Cellular Therapies, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Balance Sheet Date 1.1 Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.2(b) Company Financial Advisor Section 4.10 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholders’ Meeting 6.12(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 9.4 Current Company D&O Insurance Section 7.8(c6.8(b) Customs Laws Section 4.22(aD&O Tail Insurance 6.8(b) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Effects 1.1 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FFDCA 1.1 GDPR 1.1 Indemnified Persons Section 7.8(a6.7(a) Internet Properties 1.1 Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a3.19(a)(xix) Maximum Annual Premium Section 7.8(cAmount 6.7(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(c)New Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Parent Disclosure Letter 1.1 Paying Agent 2.8(a) Predecessor Registrant 3.7(a) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) Reorganization Date 3.7(c) RSU Consideration 2.7(e) Specified Governmental Authority 7.2 Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Termination Fee 8.3(b) Trade Secret 1.1 Trademarks 1.1 Uncertificated Shares 2.8(c) Works of Authorship 1.1
Appears in 2 contracts
Sources: Merger Agreement (Ambrx Biopharma, Inc.), Merger Agreement (Ambrx Biopharma, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aASU 1.1(zz) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPrivacy Policy 3.16(h) Company License-Out Agreements Section 4.16(hPlans 6.11(b) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aComparable Plans 6.11(b) Converted Stock-Based Award 2.8(a)(ii) Copyrights 1.1(aaa) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDPA 4.13(a) DTC Payment 2.9(d) Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letters 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Lookback Date Article III Marks 1.1(aaa) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(c) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(e) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(aaa) Payment Agent 2.9(a) Payoff Letter 6.18 Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) SEC Reports Article III Reimbursement Obligations 6.6(f) Required Financing Information 6.6(a)(v) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tail Policy 6.10(c)
Appears in 2 contracts
Sources: Merger Agreement (Forescout Technologies, Inc), Merger Agreement (Forescout Technologies, Inc)
Additional Definitions. The For the purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto meaning specified in the respective sections of this Agreement Section set forth opposite each of the capitalized terms belowto such term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Aggregate Merger Consideration 3.1 Alternative Acquisition Agreement Section 6.2(c)(ii7.2(d)(i)(D) Antiboycott Rules Section 4.22(aCompany Agreement Amendment 2.4 Applicable Date 5.5(a) Board Recommendation Section 2.2(bBankruptcy and Equity Exception 5.3(a) Cancelled Company Shares Section 3.7(a)(ii) Book-Entry Share 3.2 Certificate 3.2 Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Change of Recommendation 7.2(d)(i)(D) Changes Section 1.1 Chosen Courts 10.4(b) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Approvals 5.4(a) Company Board Recitals Company Disclosure Letter Article IV ARTICLE V Company License-In Agreements Section 4.16(gMaterial Contracts 5.12(a) Company License-Out Agreements Section 4.16(hRecommendation Recitals Company Reports 5.5(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) DLLCA Recitals EECI Preamble Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Eligible Shares 3.1 Encumber 5.11 Encumbrance 5.11 Exchange Agent 4.1 Exchange Fund Section 3.8(b4.1 Exchange Ratio 4.1 Indemnified Parties 7.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cLetter of Transmittal 4.2(a) Merger Recitals Merger Consideration Section 3.7(a)(i3.1 Merger Sub Preamble Non-DTC Book-Entry Share 4.2(b) Minimum Condition Section 2.1(a)(iOriginal Date 7.4(b) Multiemployer Plan Section 4.11(cOutside Date 9.2(a) Parent Preamble Parent Approvals 6.4 Parent Board Recitals Parent Capital Stock 6.2(a) Parent Common Stock Recitals Parent Disclosure Letter ARTICLE VI Parent Material Contract 6.12(a) Parent Reports 6.5(a) Party/Parties Preamble Preference Shares 6.2(a) Proxy/Prospectus 7.3(a) Public Shareholders Recitals Registration Statement 7.3(a) Requisite Company Vote 5.3(a) Special Committee Recitals Surviving Entity 2.1 Tail Period 7.10(b) Transaction Litigation 7.13 Transactions Recitals Voting Shares 5.2(a)
Appears in 2 contracts
Sources: Merger Agreement (Enbridge Energy Management L L C), Merger Agreement (Enbridge Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Accel Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRecitals Accel Breakup Fee 1.1(ss) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(e)(ii) Antiboycott Rules Section 4.22(aAssets 3.14 Bylaws 2.5(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letter 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(c) Company License-Out Agreements Section 4.16(hProducts 3.16(b) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.16(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStock-Based Award Consideration 2.7(d) Company Shares Recitals Stockholder Meeting 6.4 Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuing Discussion Period 5.3(c) Dissenting Company Shares 2.7(c)(i) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a) 6.6 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aEffect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) ESPP 2.7(g) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinal Offering 2.7.(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 In-Licenses 3.16(c) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Lease 3.15(b) Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Newco Preamble Newco Expenses 8.3 Newco Representatives 5.3(f) No-Shop Period Start Date 5.3(a) Notice Period 5.3(f) Option Consideration Section 3.7(a)(i2.7(e) Minimum Condition Section 2.1(a)(iOther Required Company Filing or Other Required Company Filings 3.27(a) Multiemployer Plan Section 4.11(c)Other Required Newco Filing or Other Required Newco Filings 4.6(b) Out-Licenses 3.16(c) Owned Company Shares 2.7(a)(iii) Payment Agent 2.8(a) Proxy Statement 3.27(a) Recent SEC Reports Article III Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.15(c) Subsidiary Securities 3.8(c) Surviving Corporation 2.1
(a) Termination Date 8.1
Appears in 2 contracts
Sources: Merger Agreement (Sumtotal Systems Inc), Merger Agreement (Vista Equity Partners Fund III LP)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections Section of this Agreement set forth opposite each of the capitalized terms indicated below: Abandoned Patents Section 7.2(a) Agents Section 8.1 Commercialization Plan Section 4.2 Condition Precedent Section 2.1(a) Condition Precedent Satisfaction Date Section 2.1(a) Confidential Information Section 8.2 Courts Section 12.1 Demand Registration Section 6.2 Effective Date Preamble Elion Preamble Elion Excluded Affiliates Section 1.15 Elion Parties Section 10.1 Elion Pre-Existing Affiliates Section 1.15 Elion Sole Inventions Section 7.1(a) First Tranche Shares Section 6.1 Indemnified Party Section 10.3(a) Indemnifying Party Section 10.3(a) Infringement Claim Section 7.3(a) Joint Inventions Section 7.1(b) Joint Patent Rights Section 7.2(b) Late Payment Notice Section 6.15 Litigation Conditions Section 10.3(a) MRS Section 6.4 Offering Price Section 2.1(a) Paragraph IV Claim Section 7.8(a) Periodic Report Section 6.10 Product Liability Claim Section 10.1(b) Processa Preamble Processa Excluded Affiliates Section 1.42 Processa Parties Section 10.2 Processa Pre-Existing Affiliates Section 1.42 Processa Sole Inventions Section 7.1(a) Royalty Term Section Reference Acceptable Confidentiality Agreement 6.8(b) Second Tranche Shares Section 6.2(e)(iii6.1 Sole Inventions Section 7.1(a) Acquisition Proposal Sublicensee Intellectual Property Section 6.2(e)(i2.2(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Sublicense Materials Section 2.2(b) Cancelled Company Shares Taxes Section 3.7(a)(ii) Certificate of Merger 6.12 Term Section 3.2 Certificates 11.1 Third Party Claims Section 3.8(c) Changes 10.1 Third Party Patent Licenses Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c6.8(c)
Appears in 2 contracts
Sources: License Agreement (Processa Pharmaceuticals, Inc.), License Agreement (Processa Pharmaceuticals, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAcquisition Transaction 1.1(c) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Charter Amendment 6.20 Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.20(a) Company Preamble Company Common Stock 401(k) Plan 6.11(b) Company Board Recitals Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gPSU Consideration 2.8(b) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(ii) Company Financial Advisor Section 4.10 Restricted Stock Consideration 2.8(d) Company RSU Consideration 2.8(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aSpecial Committee Recitals Company Stockholder Meeting 6.4(a) Comparable Plans 6.11(c) Confidentiality Agreement 9.4 Consent 3.6 Continuation Period 6.11(c) Converted Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 2.7(a)(iv) Copyrights 1.1(oo) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) Effect 1.1(l) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Employee Plans 3.19(a) Exchange Fund Section 3.8(bEquity Commitment Letter 4.10(a) Expiration Time Section 2.1(d)(iEquity Financing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bERISA Affiliate 3.19(b) Recitals Recitals Fee Letter 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Investor 4.10(a) Lease 3.15 Leased Real Property 3.15 Legal Restraint 7.1(c) Marks 1.1(oo) Material Contract Section 4.18(a) Suppliers 3.14 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(i)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOwned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter 4.12 Parent Liability Cap 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(oo) Paying Agent 2.9(a) Payment Fund 2.9(b) Permits 3.21 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Amount 4.10(c) Requisite Stockholder Approval 3.4 Sublease 3.15 Surviving Corporation Article II Termination Date 8.1(c) Uncertificated Shares 2.9(c)
Appears in 2 contracts
Sources: Merger Agreement (Liberty Tax, Inc.), Merger Agreement (Vitamin Shoppe, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery/AML Laws 3.19(a) Antiboycott Rules Section 4.22(aBorrower 4.7(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Control Payment 3.15(a)(xii) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 6.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company ESPP Rights 2.7(e) Company Financial Advisor Section 4.10 Advisors 3.21 Company Financial Statements 3.5(b) Company Plans 6.9(c) Company Related Parties 8.4(c) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a3.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Company Termination Fee 8.4(a) Competing Acquisition Transaction 8.4(a)(i) Current Company D&O Insurance Section 7.8(c6.4(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.7(a) Debt Financing Dispute Section 10.9(a4.7(a) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.2 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(e) Recitals Recitals Financing Agreements 6.16(d) Financing Sources 8.5 In-bound License 3.14(b) In-the-money Option 2.7(c) Indemnified Persons Section 7.8(a6.4(a) Indemnified Proceeding 6.4(b) Inventions Section 1.1 Article X Know-How Article X Labor Agreements 3.15(a)(xvii) Labor Organizations 3.16(i) Material Contract Section 4.18(a3.15(a) Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Commencement Date 1.1(a) Offer Conditions Annex A Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Out-bound License 3.14(b) Parent Preamble Payment Agent 2.8(a) Payoff Amount 2.7(f) Payoff Letter 2.7(f) Plans 3.16(a) Principal Stockholders Recitals Real Property Leases 3.13(b) Representatives 5.3 Restraint 7.1(b) Regulatory Authorities 3.17(b) Regulatory Permits 3.17(b) Required Information 6.16(a)(iv) Restricted Benefits 3.19(b) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software Article X Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.4(a)(i) Trademarks Article X Uncertificated Shares 2.8(c) Works of Authorship Article X
Appears in 2 contracts
Sources: Merger Agreement (Horizon Pharma PLC), Merger Agreement (Raptor Pharmaceutical Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEffect on Financing 7.18 Advisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aE▇▇▇▇ 4.8 Effect 1.1(t) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c)6.3(e)(i) Event Notice Period 6.3(e)(i) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Go-Shop Period 6.3(a) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz)
(a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) No-Shop Period Start Date 6.3(a) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)
Appears in 2 contracts
Sources: Merger Agreement (United Rentals, Inc.), Merger Agreement (United Rentals North America Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBook-Entry Shares 2.8(c)(ii) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(a) Board Recommendation Section 2.2(bCanceled Shares 2.7(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation Notice 5.3(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.13(d) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.5 Company Board Recommendation Change 5.3(a) Company Disclosure Letter Article IV Company License-In Agreements III Term Section 4.16(g) Company License-Out Agreements Section 4.16(h) Reference Company Financial Advisor Section 4.10 3.12 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Termination Fee 8.3(c) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.4 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFDA Permits 3.22(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(f) Recitals Recitals Final Offering Periods 2.7(f) Foreign Antitrust Laws 3.7 Indemnified Persons Section 7.8(a6.8(a) Indemnified Proceeding 6.8(b) Intercompany Indebtedness 1.1 Inventions Section 1.1 Letter of Transmittal 2.8(c)(i) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 3.21 Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.9(c) Multiemployer Plan Section 4.11(cOld Plans 6.9(c) Option Consideration 2.7(d) Parent Preamble Parent Termination Fee 8.3(d) Paying Agent 2.8(a) Payor 2.8(e) Plans 3.13(a) Proxy Statement 6.1(a) Real Property Leases 3.20(b) RSU Consideration 2.7(e) Solvent 4.10 Stockholder Approval 3.6 Stockholders Meeting 6.1(c) Surviving Corporation 2.1 Termination Date 8.1(b)(i)
Appears in 2 contracts
Sources: Merger Agreement (Biogen Inc.), Merger Agreement (Reata Pharmaceuticals Inc)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.7(a) Audit Rights Holder Section 9.7(e) Auditee Section 9.7(e) DEFINITION SECTION Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.2 Celgene Independent Product Master Agreement Challenge Section 14.3(d) Challenging Party Section 14.3(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.4 Combination Product Section 1.41 Commercialization/Commercialize Master Agreement Commercialization Budget Section 6.2(c) Commercialization Costs Section 6.5(c) Commercialization Plan Section 6.2(a) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.3(b)(i) Damages Master Agreement Deemed Buy-In Section 3.3(c) Develop/Development Master Agreement Development Budget Section 3.1(a)(i) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iii)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 DEFINITION SECTION Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.8(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Initial Enforcement Party Section 10.3(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.3(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.3(b)(i) Non-Proposing Party Section 3.3 Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.8(b)(i) Paying Party Section 9.8(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.3(a) Program Assets Section 12.4(a) DEFINITION SECTION DEFINITION SECTION Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Proposing Party Section 3.3 Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Expenses Exhibit D Regulatory Interactions Section 5.1(b) Report Exhibit D Requesting Party Section 11.3(b)(iii) Royalty Rate Section 9.4(a) Royalty Term Section Reference Acceptable Confidentiality 9.4(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.41 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Step-In Enforcement Party Section 10.3(d) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.5(b) Acquisition Proposal Term Section 6.2(e)(i14.1 Third Party Contractors Section 8.2(a)(ii) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1 Vividion Opt-Out Notice Section 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.3(b)
Appears in 2 contracts
Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement Adjusted Option Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i3.2(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 2.2 Bank Merger Recitals Bank Merger Surviving Bank Section 3.8(c2.6 Burdensome Condition Section 6.3(c) Changes Cash Consideration Section 1.1 3.1(a)(1) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock 401(k) Plan Section 6.12(b)(1) Company Articles Section 2.5 Company Bank Sub Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.2(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.2(j)(1) Company Securities Indemnified Parties Section 4.2(a6.11(b) Company Shares Meeting Section 6.2(a) Term Section Company Restricted Stock Award Section 3.1(a)(1) Company Shareholder Matters Section 5.2(e) Company Stock Option Section 3.2(a) Company Voting Agreements Recitals Confidentiality Agreement Conversion Project Manager Section 10.4 Current Company D&O Insurance 6.13 Covered Employees Section 7.8(c6.12(b) Customs Laws Determination Date Section 4.22(a8.1(h) Debt Financing Dispute Disclosure Schedule Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 5.1 Effective Time Section 3.2 Enforceability Exceptions 2.2 Environmental Condition Section 4.4 6.15(a) Environmental Permits Survey Section 4.15(b6.15(a) Equity Award Exchange Ratio Section 3.2(a) Exchange Agent Section 3.3(a) Exchange Fund Section 3.8(b3.3(a) Expiration Time Exchange Ratio Section 2.1(d)(i3.1 FDICIA Reporting Requirements Section 5.2(j)(2) Financial Statements Incipio Incipio Merger Agreement Fee Section 4.7(b8.3(a) Fee Triggering Event Section 8.3(a) Final Parent Market Price Section 8.1(h) Final Index Price Section 8.1(h) Index Section 8.1(h) Index Ratio Section 8.1(h) Initial Index Price Section 8.1(h) Initial Parent Market Price Section 8.1(h) Intended Tax Treatment Recitals Recitals Indemnified Persons Interest Rate Instruments Section 7.8(a5.2(aa) Inventions Joint Proxy Statement Section 1.1 6.5(a) Loans Section 5.2(z)(1) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Section 7.8(c5.2(v)(1) Merger Recitals Merger Sub Preamble New Certificates Section 3.3(a) Old Certificates Section 3.3(a) OREO Section 6.14(a) Outside Date Section 8.1(e) Parent Preamble Parent 401(k) Plan Section 6.12(b)(3) Parent Audited Financial Statements Section 5.3(i)(1) Parent Bank Sub Recitals Parent Closing Price Section 3.2(a) Parent Common Stock Issuance Section 5.3(e) Parent Determination Stock Price Section 8.1(g) Parent Meeting Section 6.2(b) Term Section Parent Merger Recitals Parent Merger Surviving Company Section 2.6 Parent SEC Filings Section 5.3(i)(1) Pension Plan Section 5.3(r), Section 5.2(t)(2) Per Common Share Consideration Section 3.7(a)(i3.1(a)(1) Minimum Condition Phase II Survey Section 2.1(a)(i6.15(b) Multiemployer Plan Real Property Section 4.11(c5.2(u)(2) Registration Statement Section 6.5(a) Required Third Party Consents Section 6.3(a) Requisite Regulatory Approvals Section 6.3(a) Scheduled Intellectual Property Section 5.2(p)(1) Subsequent Mergers Recitals Supplemental Disclosure Schedule Section 6.1(c) Survey Section 6.14(a) Surviving Corporation Recitals Tail Coverage Period Section 6.11(a)(2) Tail Policy Section 6.11(a)(1) Takeover Laws Section 5.2(h) Title Commitment Section 6.14(a) Title Company Section 6.14(a) Title Notice Section 6.14(b) Title Review Period Section 6.14(b) Trust or Agency Accounts Section 5.2(y)(1) Trust or Agency Agreements Section 5.2(y)(1) Trust or Agency Records Section 5.2(y)(6) ▇▇▇▇▇▇ Section 7.3(c)
Appears in 2 contracts
Sources: Merger Agreement, Merger Agreement (Byline Bancorp, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.4(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Common Stock Recitals Company Compensation Committee 4.17(m) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gFinancial Advisors 4.25 Company IP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.10(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.8(a) Company Shares Recitals Competing Acquisition Transaction 9.3(b)(iii) Competing Party 9.3(b)(iii) Confidentiality Agreement Section 10.4 Consent 4.5 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(m) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGrant Date 4.6(e) Recitals Recitals Indemnified Persons Section 7.8(a7.9(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) LKQ Preamble Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.4(c) New Plans 7.10(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.10(c) Option Consideration 3.7(d) Outside Date 9.1(b) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Representatives 6.2(b) Restraint 8.1(b) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Stockholder List Date 2.2(c) Subsidiary Securities 4.7(c) Support Agreement Recitals Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Fee 9.3(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)
Appears in 2 contracts
Sources: Merger Agreement (LKQ Corp), Merger Agreement (Coast Distribution System Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(c)(ii) Antiboycott Rules Section 4.22(aAlternative Financing 6.5(b) Board Recommendation Section 2.2(bAnti-Corruption Laws 3.26(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.12 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.11(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gOption Consideration 2.9(a) Company License-Out Agreements Section 4.16(hPBRSU Consideration 2.9(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e) Company RSU Consideration 2.9(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Agreements 9.6 Consent 3.6 Copyrights 1.1(bbb) D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) Definitive Financing Agreements 6.5(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) ▇▇▇▇▇ 1.3(q) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.15 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFairness Opinions 3.3(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.11(a) Fee Letters 6.5(a) Financing 4.11(a) Guarantee Recitals Holdings Recitals Holdings Subsidiary Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(bbb) Maximum Annual Premium Section 7.8(c6.9(c) Maximum Company Liability Amount 8.3(e) Maximum Parent Liability Amount 8.3(a) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plan 6.10(c) Minimum Condition Section 2.1(a)(iNon-Recourse Party 9.18 Other Required Company Filing 6.3(b) Multiemployer Plan Section Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(ii) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter Article IV Parent Related Parties 8.3(a) Parties Preamble Party Preamble Patents 1.1(bbb) Payment Agent 2.10(a) Payoff Letters 6.19 Per Share Price 2.7(a)(iv) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Repaid Indebtedness 6.19 Required Amount 4.11(c) Requisite Stockholder Approval 3.4 Reverse Termination Fee 8.3(a) Rollover Agreements Recitals Rollover Shares 2.7(a)(ii) Rollover Stockholders Recitals SaaS 3.16(f) Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Subsidiary Owned Share 2.7(a)(iii) Support Agreement Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Written 1.3(r)
Appears in 2 contracts
Sources: Merger Agreement (R1 RCM Inc. /DE), Merger Agreement (R1 RCM Inc. /DE)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.8 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(4) Affiliate Master Agreement Agreement Preamble Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.5(a) Bankruptcy Code Section 8.8 Business Day Master Agreement CCB Program Master Agreement Celgene Preamble Celgene Independent Product Master Agreement Celgene Indemnified Parties Section 13.2(a) Celgene Manufacturing Responsibilities Section 4.1(a) Challenge Section 14.3(d) Challenging Party Section 14.3(d) Clinically Develop Section 8.6(a) Combination Product Section 1.34 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) DEFINITION SECTION Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Compound Master Agreement Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement Cure Period Section 14.3(b)(i) Deal Target Master Agreement Deal Target Program Master Agreement Develop/Development Master Agreement Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 Distinct Product Master Agreement Distinct Product Catch-Up Payments Section 9.1(a)(iv) Earlier Patent Section 10.8 Electronic Delivery Section 15.14 Enabling Manufacturing Section 8.6(a) Execution Date Preamble E3 Ligase Program Master Agreement FDA Master Agreement First Program Master Agreement force majeure event Section 15.5 Functional Phenotypic Assay Similarity Criteria Master Agreement Implementation Date Master Agreement IND Master Agreement Indication Master Agreement Indirect Taxes Section 9.6(a) Invalidity Claim Section 10.4(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.2(c) Licensed Product Data Section 14.4(c) Licensed Program Introduction Manufacture/Manufacturing Master Agreement Master Agreement Introduction Material Breach Section 14.3(b)(i) Opt-In Right Master Agreement Party/Parties Preamble Patent Master Agreement Payee Party Section 9.6(a) Paying Party Section 9.6(a) Person Master Agreement DEFINITION SECTION Permitted Indication Section 8.6(b)(vii) Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Product Trademarks Section 6.2(a) Program Assets Section 12.4 Program Compound Master Agreement Prosecution/Prosecute Master Agreement Publication Master Agreement Publication Purpose Section 11.4(a) Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.2 Requesting Party Section 11.3(b)(iii) Royalty Term Section Reference Acceptable Confidentiality 9.2(b) SEC Section 11.3(b)(i) Separate Program Master Agreement Separate Program Product Section 6.2(e)(iii8.6(b)(vii) Acquisition Proposal Selling Party Section 6.2(e)(i1.34 Target Master Agreement Term Section 14.1 Third Party Master Agreement Third Party Contractors Section 8.2(b) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4(a) Vividion Preamble Adverse Recommendation Change Vividion Cereblon Program Master Agreement Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseVividion Opt-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Notice Master Agreement
Appears in 2 contracts
Sources: Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.), Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts Section 2.8(d)(i) Alternative Acquisition Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iSection 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Vesting Period Section 2.7(c)(ii) Antiboycott Rules Section 4.22(aApproval Section 3.5 Assignee Section 10.3 Assumed Consideration Section 2.7(c)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date Section 3.6(a) Certificate of Merger Section 3.2 Section 2.3 Certificates Section 3.8(cSection 2.8(c) Change Section 1.1 Changes Section Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(dSection 2.2 Code Section 2.8(f) Collective Bargaining Agreement Section 3.18(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals Board Recommendation Section 5.3(a) Company Board Recommendation Change Section 5.3(b) Company Disclosure Letter Article IV Article III Company License-In Agreements Section 4.16(gProducts Section 3.15(b) Company License-Out Agreements Reports Section 3.8 Term Section 4.16(hReference Company Securities Section 3.6(d) Company Financial Advisor Section 4.10 Shareholder Approval Section 3.2 Company SEC Reports Section 4.7(aShareholders Meeting Section 7.3(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Section 7.8 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Due Diligence Review Section 4.13 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bSection 2.3 Employee Plans Section 3.17(a) Exchange Fund Section 2.8(b) FCPA Section 3.8(b3.20(b) Expiration Time Section 2.1(d)(iFDA Section 3.20(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSection 3.9(a) Recitals Funded International Employee Plan Section 3.17(i) Good Clinical Practices Section 3.20(e) Good Laboratory Practices Section 3.20(f) ICL Recitals Indemnified Persons Section 7.8(aSection 6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) Israeli Employees Section 3.18(d) ITA Section 2.8(f) Inventions Section Section 1.1 Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(aSection 3.12(a) Material Employee Plans Section 3.17(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cSection 6.1(c)
Appears in 2 contracts
Sources: Merger Agreement (Lumenis LTD), Merger Agreement (Lumenis LTD)
Additional Definitions. The In addition, each of the following capitalized terms shall have the respective meanings ascribed thereto meaning described in the respective sections corresponding section in the body of this Agreement set forth opposite each of or in the capitalized terms Financial Appendix referenced below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiIntroduction All Other Costs Exhibit 4.2E Asia-Pacific License 2.4(a) Acquisition Proposal Section 6.2(e)(iAsia-Pacific Licensee 2.4(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAuditing Party 7.17(a) BioMarin CF Improvements 11.1(c) BioMarin CF Indemnitees 16.2 Capitalized Asset Financial Appendix Co-Chair 3.3 Collaboration Agreement Preamble Alternative Acquisition Financial Appendix Completion Notice 7.7 Confidential Information 10.1 Contingent Right 2.4(f) Controlled Affiliate 1.2 Cost Effective Price 9.1(a) Data Monitoring Board 7.6(a) Definitive Agreement Section 6.2(c)(ii2.4(c) Antiboycott Rules Section 4.22(aDevelopment Costs Financial Appendix Development Transition Period 14.4(a)(i) Board Recommendation Section 2.2(bDispute 17.2 Distribution Costs Financial Appendix Effective Date Introduction Eliminated Party 14.4(a)(i) Cancelled Company Shares Section 3.7(a)(iiEnforcement Action 11.3(b)(i) Certificate Equity Election Notice 7.5 Fault of Merger Section 3.2 Certificates Section 3.8(cBioMarin CF 16.4(b)(ii) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dFault of La Jolla 16.4(b)(i) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseField-In Agreements Section 4.16(gBased FTEs 6.2(a)(i) Company LicenseFirst Commercial Sale Financial Appendix FTE Costs Financial Appendix Force Majeure Event 18.1 Forecast Exhibit 9.1A Futile Determination 7.6(b) GAAP Financial Appendix GMP 5.4 Gross Sales Financial Appendix IFRS Financial Appendix Indemnitee 16.3 Indemnitor 16.3 Infringement 11.3(a) Infringement Actions 11.4 Initial Operating Plan/Budget 4.2(b) Initial Product 4.3(a) Inspected Party 5.3 Interest Rate 7.14(b) IP Management Costs Financial Appendix JAMS 17.3(a) Joint Promotion Plan 6.2(c) Joint Steering Committee or JSC 3.1(a) JHU License Exhibit 1.15 La Jolla Improvements 11.1(c) La Jolla Indemnitees 16.1 Launch-1st Year Period Exhibit 4.2E Liabilities 16.1 Manufacturing Costs Financial Appendix Manufacturing Process Development 4.2(e)(ii) Marketing Costs Financial Appendix Maximum Regional Spend Exhibit 4.2E Multiple Product Sales Financial Appendix Negotiation Period 2.4(c) New Technology 11.6(c) Net Sales Financial Appendix Non-Out Agreements Section 4.16(hFutile Determination 7.6(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aObjecting Party 17.2 Ongoing Trials 14.4(a)(i) Company Securities Section Operating Forecast 4.2(a) Company Shares Recitals Confidentiality Operating Plan/Budget 4.2(a) Other Operating Expense Financial Appendix Other Operating Income Financial Appendix Out-of-Pocket Expenses Financial Appendix Paying Party Financial Appendix Phase IV Studies Exhibit 4.2E Prior Agreement Section 10.6 Producing Party 9.4(a) Product Liability Claim 16.5(a) Product Promotional Materials 12.1 Profit/Loss Financial Appendix Promotional/Sales/Marketing or PSM Exhibit 4.2E Proposed Territory 2.4(a) Prosecution and Maintenance or Prosecute and Maintain 11.2(c) Publication 10.4 Current Company D&O Insurance Section 7.8(cPurchased Interests 14.2.2(a) Customs Laws Section 4.22(aPurchase Notice 14.2.2(b) Debt Financing Dispute Section 10.9(aPurchase Price 14.2.2(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iPurchase Right 14.2.2(a) EAR Section 4.22(aP-Value Achievement 7.6(c) Effective Time Section Quarterly Measurement Exhibit 4.2E Q4, Q5 and Q6 Exhibit 9.1A Recall Costs 16.4(b) Region Exhibit 4.2E Remaining Party 14.4(a)(i) Renal Events Committee 7.6(d) Report Table Financial Appendix Responding Party 7.17(a) ROT Exhibit 4.2E Royalty Notice 6.3 R&D/LCM Exhibit 4.2E Sale Price 14.2.1 Sale Right 14.2.1 Sales Costs Financial Appendix Sales Force Deployment Option 6.2(a) Shared Costs Financial Appendix SEC Financial Appendix Secured Note 14.2.1 SLE Background Sold Interests 14.2.1 Third Party Claim 16.1 Wind-down Period 14.4(a)(ii) Working Group 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2nd Year of Sales Exhibit 4.2E 128 Flare Topline Data 7.6(e)
Appears in 2 contracts
Sources: Development and Commercialization Agreement (Biomarin Pharmaceutical Inc), Development and Commercialization Agreement (La Jolla Pharmaceutical Co)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approvals 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCARES Act 3.18(h) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.9(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Commitment Letters 4.10(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.3(u) Company License-Out Agreements Section 4.16(hIntellectual Property 3.17(b) Company Financial Advisor Section 4.10 Option 2.8(c)(i) Company Privacy Policy 3.17(m) Company PSU 2.8(b)(i) Company Recommendation 3.3(a) Company Recommendation Change 5.4(c)(i) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.8(d) Company Securities Section 4.2(a3.7(b) Company Shares Special Committee Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aContinuing Employees 6.11(b) Converted Cash Award 2.8(a)(ii) Copyrights 1.1(hhh) Covenant Exceptions 5.1(a) Debt Commitment Letter 4.10(a) Debt Fee Letter 6.6(b)(ii) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Elephant Recitals Enforcement Expenses 8.3(e) Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Arrangements 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Founder Recitals Guarantees Recitals Guarantors Recitals Indemnified Party Proceeding 6.10(b) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) IP Contracts 3.17(d) KKR Recitals Labor Agreements 3.20(a) Lease 3.15(b) Leased Real Property 3.15(b) Marks 1.1(hhh) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval 6.19 New Plans 6.11(a) Notice Period 5.4(d)(ii)(2) Old Plans 6.11(a) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Divesture Obligations 6.2(b) Party or Parties Preamble Patents 1.1(hhh) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Promissory Note 6.22 Proxy Statement 6.3(a) Reimbursement Obligations 6.6(h) Reinvestment Shareholders Recitals Required Amount 4.10(a) Required Permits 3.20(c) Restraint 7.1(b) Rollover Shares Recitals Statutory Stockholder Approval 3.4(a) Support Agreements Recitals Surviving Corporation Recitals Tail Policy 6.10(b) Technical Deficiencies 3.17(l) Termination Date 8.1(b) Trade Controls 3.22(b) Trade Secrets 1.1(hhh) Transaction Matters 9.12(a) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU 2.8(b)(i) Unvested Company RSU 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU 2.8(b)(i) Multiemployer Plan Section 4.11(c)Vested Company PSU Consideration 2.8(b)(i) Vested Company RSU 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Vista Recitals
Appears in 2 contracts
Sources: Merger Agreement (KnowBe4, Inc.), Merger Agreement (Vepf Vii SPV I, L.P.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Corruption Law 3.18(b) Antiboycott Rules Section 4.22(aAntitrust Laws 7.2(a) Board Recommendation Section 2.2(bAssumed Option 2.7(d) Assumed Unit 2.7(d)(ii) Barclays 3.26 Book-Entry Shares 2.8(b)(i) Cancelled Company Shares Section 3.7(a)(ii2.7(b)(iv) Cash Consideration 2.7(b)(i) Certificate 2.8(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock Recitals 2001 Plan 3.4(a) Company 2007 Director Plan 3.4(a) Company 2007 Plan 3.4(a) Company 2012 Inducement Plan 3.4(a) Company Board Recommendation 6.4(a) Company Board Recommendation Change 6.4(b) Company Capitalization Representations 8.2(a)(ii) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gExpense Reimbursement 9.3(c)(vi) Company License-Out Agreements Section 4.16(hFundamental Representations 8.2(a)(i) Company Financial Advisor Section 4.10 In Licenses 3.12(e) Company IP Licenses 3.12(f) Company Material Contract 3.13(a) Company Non-U.S. Employee Plans 3.15(i) Company Out Licenses 3.12(f) Company Permits 3.19 Company Qualified Plan 3.15(e) Company Real Property Leases 3.10 Company Registered Intellectual Property Rights 3.12(a) Company SEC Reports Section 4.7(a3.6 Company Stock Awards 3.4(c) Company Securities Section 4.2(aStock Option 2.7(d)(i) Company Shares Recitals Stock Plans 3.4(b) Company Stockholder Meeting 7.4(a) Company Subsidiary Documents 3.1(b) Company Terminating Plans 7.7(a) Company Voting Proposal 3.2(b) Confidentiality Agreement Section 10.4 Current Company 7.5(h) D&O Insurance Section 7.8(cPolicy 7.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) DLLCA Recitals ▇▇▇▇-▇▇▇▇▇ Act 3.6 EAR Section 4.22(a3.18(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cECCNs 3.18(c)(ii)
Appears in 2 contracts
Sources: Merger Agreement (Entropic Communications Inc), Merger Agreement (Maxlinear Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2023 Bonus Plan 7.9(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bAntitrust Clearance Condition Annex A Balance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Cash Amount Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section Date. 3.3 COBRA Section 4.11(dCollaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.23 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.2(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Covered Entity 4.20(j) CVR Recitals CVR Agreement Recitals D&O Insurance Section 7.8(cIndemnified Party 7.8(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData 1.1 Depository Agent 3.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Existing Payment Period 3.7(h) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDCA 4.20(a) Recitals Recitals Indemnified Persons Section 7.8(aForeign Antitrust Laws 4.6 French Tax Code 10.14 GDPR 1.1 Internet Properties 1.1 Inventions 1.1 Leased Real Property 4.18(b) Inventions Section 1.1 Material Contract Section 4.18(a4.19(a) Maximum Annual Premium Section 7.8(cMedical Device 4.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Milestone Option Amount 3.7(d)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) No Antitrust Proceedings Condition Annex A No Legal Restraint Condition Annex A Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Owned Real Property 4.18(a) Parent Preamble Paying Agent 3.8(a) Proprietary Information 1.1 PSU Consideration 3.7(f) Real Property 4.18(a) Real Property Leases 4.18(b) Regulatory Permits 4.20(i) Remedy Action 7.2(a) Rights Agent Recitals RSU Consideration 3.7(e) Schedule TO 2.1(f)(i) Schedule 14D-9 2.2(a) Social Security Act 4.20(e) Subsidiary Securities 4.2(e) Surviving Corporation. 3.1 Termination Condition Annex A Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c)(ii) Works of Authorship 1.1
Appears in 2 contracts
Sources: Merger Agreement (Johnson & Johnson), Merger Agreement (Johnson & Johnson)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Ancillary Scheme Documentation Section Reference Acceptable Confidentiality Agreement 4.1(a) Anti-Takeover Laws Section 6.2(e)(iii5.30 Bidco Preamble Burdensome Condition Section 8.2(a) Acquisition Proposal Closing Section 6.2(e)(i2.2 Closing Date Section 2.2 Company Preamble Company 401(k) Acquisition Sub Preamble Adverse Plan Section 8.8(c) Company Board Recitals Company Board Recommendation Section 5.5 Company Board Recommendation Change Section 6.2(c)(i7.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Equity Award Consideration Section 4.16(g3.2(a)(iii) Company License-Out Agreements Option Consideration Section 4.16(h3.2(a)(i) Company Financial Advisor Permits Section 5.24(e) Company PRSU Consideration Section 4.10 3.2(a)(iv) Company Related Parties Section 6.12 Company RSU Consideration Section 3.2(a)(iii) Company SEC Reports Section 4.7(a5.9(a) Company Securities Section 4.2(a5.2(d) Company Shares Recitals Confidentiality Agreement Section 10.4 11.6 Consideration Section 3.1(a) Court Documentation Section 4.1(g) Current Company Employee Section 8.8(a) D&O Insurance Section 7.8(c8.7(c) Customs Laws EBT Cash Amounts Section 4.22(a3.2(b) Debt Financing Dispute EBT Settled Company Equity Awards Section 10.9(a3.2(a)(i) DGCL Recitals Dissenting Company Shares EBT Trustee Section 3.7(c)(i) EAR Section 4.22(a3.2(a)(i) Effective Time Section 3.2 2.2 End Date Section 10.1(b)(i) Enforceability Exceptions Section 4.4 Environmental Permits 5.4 Equity Securities Section 4.15(b5.2(d) Exchange Fund Forms of Proxy Section 3.8(b4.1(a) Expiration Time In the Money Company Option Section 2.1(d)(i3.2(a)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a8.7(b) Inventions Indemnified Proceeding Section 1.1 8.7(b) Interim Time Section 3.2(a)(i) Leased Real Property Section 5.22(b) Match Right Notice Section 7.3(b) Material Contract Section 5.23(a) Other Required SEC Filing Section 4.18(a4.1(a) Maximum Annual Premium Parent Preamble Parent 401(k) Plan Section 7.8(c8.8(c) Merger Parent Board Recitals Merger Parent Related Parties Section 6.12 Parties Preamble Paying Agent Section 3.1(b) Payment Fund Section 3.1(b) Per ADS Consideration Section 3.7(a)(i3.1(a) Minimum Condition Proxy Statement Section 2.1(a)(i4.1(a) Multiemployer Plan Real Property Leases Section 5.22(b) Remedial Action Section 4.11(c)8.2(a) Scheme Document Annex Section 4.1(a) Transaction Recitals Transaction Documentation Section 4.1(d) Transfer Taxes Section 10.3(b) Voting and Support Agreement Recitals
Appears in 2 contracts
Sources: Transaction Agreement (Verona Pharma PLC), Transaction Agreement (Verona Pharma PLC)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAssumed Company Option 3.8(a) Antiboycott Rules Section 4.22(aAssumed Company Restricted Stock 3.8(c) Board Recommendation Section 2.2(bAssumed Company RSU 3.8(d) Cancelled Assumed Company Stock Awards 3.8(d) Amended Offer Documents 2.1(a)(i) Assets 4.14 Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Restricted Stock 3.8(c) Company Financial Advisor Section 4.10 Rights 4.16 Company SEC Reports Section 4.7(a4.6 Company Securities 4.4(c) Company Securities Section 4.2(aSeverance Arrangements 7.11(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.5(a) Continuing Directors 2.4(b) Continuing Employee 3.8(a) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(iv) EAR Section 4.22(aEffect 1.1(kk)
(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bExchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Indemnified Parties 7.12(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIndependent Directors 2.4(c) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.5(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A Non-Continuing Employee 3.8(b)
Appears in 2 contracts
Sources: Merger Agreement (Ramtron International Corp), Merger Agreement (Cypress Semiconductor Corp /De/)
Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Acquired Assets 2.3 Additional Withholding Taxes 5.9.2 Agreed Claims 9.5.6 Agreement Preamble Alternative Acquisition Assignment Consent 2.7.1 Assumed Liabilities 2.5 Buyer Preamble Buyer Change 5.9.2 Buyer Indemnified Parties 9.3 CDA Effective Date CDA definition [***] Merger Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 3.5.1 Claim Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 9.5.1 Claims 9.2 Clinical Trial Agreements 2.8.2 Closing Section 3.3 2.1 Closing Cash Consideration 5.1 Closing Date Section 3.3 COBRA Section 4.11(d) Company 2.1 Commercial Milestone Event 5.4 Commercial Milestone Payment 5.4 Confidential Information 7.2.1 Cooperation Period 2.7.1 Deductible 9.4.1 Excluded Assets 2.4 Excluded Liabilities 2.6 Factors Net Sales Definition FIRPTA Certificate 5.9.5 IFRS Net Sales Definition IND Transfer 2.9 Indemnifying Party 9.5.1 Indication 5.3 Licensed Patent 7.2.6 Losses 9.2 MHRA Regulatory Authority Definition Non-Assignable Asset 2.7.1 Ongoing Clinical Trials 2.8.1 Party/Parties Preamble Company Common Stock Recitals Company Purchase Price Allocation 5.9.7 Regulatory Milestone Event 5.3 Regulatory Milestone Payment 5.3 Report 3.3.1 Royalty Term 5.2.2 Seller Preamble Seller Disclosure Letter Article IV Company LicenseSchedule 6.1 Seller Indemnified Parties 9.2 Selling Party Net Sales Definition Term 8.1 Third-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Party Claim 9.5.1 Transfer Taxes 5.9.3 Transferred Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Reimbursement Amount 5.1
Appears in 2 contracts
Sources: Asset Purchase Agreement (Kronos Bio, Inc.), Asset Purchase Agreement (Kronos Bio, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti Bribery Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bArticles of Merger 2.2 Assets 3.14 Assumed Restricted Stock Unit Award 2.7(d)(ii) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Cash Consideration 2.7(a)(i) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letter 4.28 Company Preamble Company Annual Report Article III Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.17(a) Company License-Out Agreements Section 4.16(hERISA Affiliate 3.17(a) Company ESPP Rights 2.7(f) Company Financial Advisor Section 4.10 3.25 Company International Employee Plans 3.17(a) Company Material Contract 3.12(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Plans 6.12(a) Company Related Parties 8.3(b)(v) Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSource Code 3.15(o) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 3.3 Company Stockholder Meeting 6.4(a) Company Subsidiary Securities 3.7(c) Consent 3.5 Contaminants 3.15(n) Copyrights 1.1 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.11(b) DGCL Recitals 2.1 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aECCN 3.20(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iexport 3.20(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.27 Final Exercise Date 2.7(f) Recitals Recitals Financing 4.28(a) Financing Documents 4.28(a) Financing Failure Termination Fee 8.3(c)(iii) Form S-4 3.28 FSE List 3.20(i) Fractional Share Cash Amounts 2.11 FY2019 Plans 6.12(c) Government Officials 3.20(d) Grant Date 3.6(e) Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Termination Date 8.1(b)(i) Joint Proxy Statement/Prospectus 3.28 Leased Real Property 3.13(b) Leases 3.13(b) Lenders 4.28 Maximum Annual Premium Section 7.8(c6.11(b) MBCA Recitals Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.12(b) Multiemployer Old Plans 6.12(b) Owned Real Property 3.13(a) Parent Preamble Parent Annual Report Article IV Parent Board Recommendation Recitals Parent Board Recommendation Change 6.6(a) Parent Capitalization Date 4.6(a) Parent Common Stock Recitals Parent Common Stock Issuance Recitals Parent Disclosure Letter Article IV Parent Financial Advisor 4.24 Parent Grant Date 4.6(e) Parent Related Parties 8.3(c)(iii) Parent SEC Reports 4.8 Parent Securities 4.6(c) Parent Stockholder Approval 4.3 Parent Stockholder Meeting 6.4(c) Parent Subsidiary Securities 4.7(c) Patents 1.1 Permits 3.19 Regulatory Filings 6.2(a) Repatriation Notice 6.20 Replacement Bonus Plan Section 4.11(c6.12(c) Representatives 5.3(a) Restricted Stock Unit Consideration 2.7(d)(i) Reverse Termination Fee 8.3(c)(i) SDN List 3.20(i)
Appears in 2 contracts
Sources: Merger Agreement (Cohu Inc), Merger Agreement (Xcerra Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(n) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Change of Recommendation Notice 7.5(b) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Confidentiality Agreement Section 10.4 Consent 4.5 Continuing Directors 2.3(a) Copyright Rights 1.1 Covered Securityholders 4.17(n) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8(a) Effective Time Section 3.2 Employee Plan / Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Institutions 4.15(h) International Employee Plans 4.17(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c)
Appears in 2 contracts
Sources: Merger Agreement (Otsuka Holdings Co., Ltd.), Merger Agreement (Astex Pharmaceuticals, Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i409A Authorities 4.11(f) Action 4.9 Affiliate Transaction 4.24 Agents 4.20(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Appointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Arrangements 7.17 Book Entry Shares Section 3.7(a)(ii3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Bylaws 4.1(b) Company Charter 4.1(b) Company Compensation Committee 7.17 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEscrow Agreement 4.18(l) Company License-Out Agreements Section 4.16(hInsurance Policies 4.16 Company International Plan 4.11(g) Company Financial Advisor Section 4.10 Plans 4.11(a) Company Registered IP 4.18(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(aDocuments 4.6(a) Company Shares Recitals Company Stockholder Approval 4.4(a) Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidential Customer Information 4.18(m) Confidentiality Agreement Section 10.4 Current Company 7.9 Continuing Director 2.3(a) Covered Securityholders 7.17 D&O Insurance Section 7.8(c7.13(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployment Compensation Arrangement 7.17 ESPP 7.11(g) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(b) Recitals Recitals FAR 4.20(c) Final Exercise Date 7.11(g) Indebtedness 6.2(h) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Independent Directors 2.3(b) Initial Termination Date 9.1(b) Leased Real Property 4.17(a) Material Contract Section 4.18(a4.15(a) Maximum Annual Premium Section 7.8(c7.13(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 4.25 Nonqualified Deferred Compensation Plan Section 4.11(c4.11(f) Offer Recitals Offer Documents 2.1(f)
Appears in 2 contracts
Sources: Merger Agreement (Hewlett Packard Co), Merger Agreement (ArcSight Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDebt Financing 5.6(b)(ii) Antiboycott Rules Section 4.22(aBreach Cure Period 7.1(g) Board Recommendation Section 2.2(bBreach Termination Date 7.1(g) Cancelled Company Shares Section 3.7(a)(iiCertificate of Incorporation 1.5(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chancery Court 8.10 Closing Section 3.3 1.3 Closing Date Section 3.3 COBRA Section 4.11(d1.3 Collective Bargaining Agreement 2.18(a) Communications Act 2.6 Company Preamble Company Common Stock Recitals Board Recommendation 2.3 Company Board Recommendation Change 4.3(a) Company Disclosure Letter Schedule Article IV II Company License-In Agreements Section 4.16(gParties 7.3(e)(i) Company License-Out Agreements Section 4.16(hPermits 2.20 Company Restricted Share 1.7(d)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a2.9 Company Securities 2.7(c) Company Securities Section 4.2(aStockholder Meeting 5.4(a) Company Shares Recitals Systems 2.16(c) Confidentiality Agreement Section 10.4 Current Company 8.4 Consent 2.6 Continuation Period 5.11(b) Continuing Plans 5.11(a) D&O Insurance Section 7.8(c5.10(c) Customs Laws Section 4.22(aDebt Commitment Letter 3.10(b) Debt Financing Dispute Section 10.9(a3.10(b) Delaware Secretary of State 1.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b1.2 Employee Plans 2.18(a) Employment Laws 2.19(b) Equity Financing 3.10(b) Equity Financing Letter 3.10(b) Equity Financing Sources 3.10(b) ERISA Affiliate 2.18(b) Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iFCC 2.6 FCC Approvals 2.6 Federal Communications Laws 2.26(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 3.10(b) Financing 3.10(b) Financing Letters 3.10(b) Franchise 2.6 Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a5.10(a) Inventions Section 1.1 Leased Real Property 2.15(b) Leases 2.15(b) LFA 2.6 LFA Approvals 2.6 Material Contract Section 4.18(a2.13(a) Maximum Annual Premium Section 7.8(c5.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letter 5.6(b)(ii) New Plans 5.11(c) Notice Period 3.4(d)(i) Old Plans 5.11(c) Option Consideration Section 3.7(a)(i1.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c2.30 Owned Company Shares 1.7(a)(ii) Parent Preamble Parent Expenses 7.3(b)(ii) Parent Material Adverse Effect 3.1 Parent Parties 7.3(e)(ii) Payment Agent 1.8(a) Per Share Price 1.7(a)(i) Proxy Statement 2.30 Record Date 5.4(b) Required Information 5.6(b)(v)(A) Requisite Stockholder Approval 2.4 Rights 2.31 Rights Agreement 2.31 Rule 13a-15 2.10(b) Second Request 5.2(c) State Communications Laws 2.26(a) State PUC 2.6 State PUC Approvals 2.6 Subscribers 2.32 Subsidiary Securities 2.7(c) Surviving Corporation 1.1 Tax Returns 2.17(a) Termination Date 7.1(c) Transaction Committee Recitals Transaction Litigation 5.16 Uncertificated Shares 1.8(c) Warrant Consideration 1.7(d)(iii)
Appears in 2 contracts
Sources: Merger Agreement (Valley Telephone Co., LLC), Merger Agreement (Knology Inc)
Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this PD-1 License Agreement set forth opposite each of the capitalized terms indicated below: Additional Study 2.3.2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Additional Study Approval 2.3.2(c) Celgene Preamble Celgene Corp. Preamble Celgene PD-1 Patents 4.5.1 Celgene RIVOT Preamble Collaboration Combination Products 2.2.1 Combination Products 2.2.1 Competitive Infringement 4.5.1 Cure Period 6.3 [***] [***] Development Costs 2.3.5 Development Cost Report 2.3.5(b) Development Cost Share 2.3.5 Included Collaboration Candidates 2.1.3 Indemnification Claim 5.3 Indemnitee 5.3 Indemnitor 5.3 Indirect Taxes 3.2.3(b) Jounce Preamble Jounce Independent Product 4.5.2(b) Jounce License Material Transfer Agreement 2.7.1 Jounce License Material Transfer Agreement Effective Date Exhibit B Jounce Licensed Materials 2.7.1 Jounce Licensed Product Patents 4.5.2(a) Jounce Licensed Purpose 2.7.1 [***] [***] Jounce Reversion Products 6.7.1 JWG 2.3.1(a) Licensed Candidate 2.1.3; Exhibit A Licensed Diagnostic Products 2.2.1 Licensed Enforcement Proceeding 4.5.2(b) Licensed Materials Receiving Party 2.7.1 Licensed Products Recitals Licensed Program Assets 2.9 Licensed Step-In Proceeding 4.5.2(b) Licensed Target 2.1.2 License Transferring Party 2.7.1 Lump Sum 2.3.2(c) Master Collaboration Agreement Recitals Monotherapy Products 2.2.1 Non-Proposing Party 2.3.2 Party or Parties Preamble CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Payee Party 3.2.3 Paying Party 3.2.3 PD-1 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.1 PD-1 License Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiPD-1 Effective Date Preamble Proposing Party 2.3.2(b) Antiboycott Rules Section 4.22(aRegulatory Interactions 2.4.2 Revenue Split Product Exhibit E Third Party Agreements 3.2.1(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety and CMC Data 2.4.4 Safety Reason 6.2.2
Appears in 2 contracts
Sources: Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.), Master Research and Collaboration Agreement (Jounce Therapeutics, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.1(e) Acquisition Sub Preamble Adverse Recommendation Change Term Section 6.2(c)(i) Reference Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Arrangements 7.10 Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Catch-Up Opportunity 3.7(e) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section Change 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Commitment Letters 5.10(a) Company Preamble Company Common Stock Board Committee 2.2(a) Company Board Recommendation Recitals Company Board Recommendation Change 7.3(b) Company Compensation Committee 7.10(a) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(d) Company Shares Recitals Comparable Plans 7.9(b) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Insight Confidentiality Agreement Section Agreements 10.4 Current Company Consent 4.5 Copyright Rights 1.1 Covered Securityholders 7.10(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Expenses 9.4(a) ▇▇▇▇▇▇▇ Confidentiality Agreement 10.4 Employee Plans 4.17(a) Employment Compensation Arrangement 7.10(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 Equity Award 4.6(b) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Expenses 9.4(a) Financing 5.10(a) Fraud and Bribery Laws 4.20(c) Term Section 2.1(d)(iReference Grant Date 4.6(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGuarantors Recitals Inbound IP Contract 4.15(b) Recitals Recitals Indemnified Persons Section 7.8(a) Insight Confidentiality Agreement 10.4 International Employee Plans 4.17(a) Intervening Event Notice 7.3(c)(ii) Inventions Section 1.1 IT Systems 4.15(j) Leased Real Property 4.13(b) Leases 4.13(b) Limited Guaranty Recitals Major Stockholders Recitals Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)
Appears in 1 contract
Sources: Merger Agreement (E2open Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 6.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffected Employee 6.12(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAlternate Debt Financing 6.15(c) Antiboycott Rules Section 4.22(aAssumed Option 2.7(d)(iv) Board Recommendation Section 2.2(bAssumed RSU 2.7(d)(i) Assumed SAR 2.7(d)(iv) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Representations 7.2(a) Capitalization Time 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.7(a)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Date Indebtedness 6.15(e)(i)f) Collective Bargaining Agreements 3.20(a) Company Preamble Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In IP Agreements Section 4.16(g3.22(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRegistered IP 3.22(a) Company Securities Section 4.2(a3.4(d) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c6.10 Consent 3.5(b) Customs Laws Section 4.22(aDebt Commitment Letters 4.8(a) Debt Financing Dispute Section 10.9(a4.8(a) DGCL Recitals Debt Financing Conditions 4.8(b) Debt Financing Sources 4.8(a) Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.13(b) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Escrowed Compensatory Payments 2.8(c) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExport Controls 3.23(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.15(e)(i) Recitals Recitals Financing Sources 6.15(e)(i) Import Restrictions 3.23(a) Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 Intervening Event 6.2(c)(ii) Labor Organization 3.20(a) Leased Real Property 3.21(b) Leases 3.21(b) Loan Documents 6.17 Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals Merger Sub Preamble New Debt Commitment Letters 6.15(c) Minimum Condition Section 2.1(a)(iNoteholders 6.18(c) Multiemployer Plan Section 4.11(cNotes Consents 6.18(a) Notes Offer to Purchase 6.18(a) Notes Tender Offer 6.18(a) Notes Tender Offer Documents 6.18(c) Notice Period 6.2(c)(i) Optional Redemption 6.18(e) Optional Redemption Notice 6.18(e) Owned Real Property 3.21(a) Parent Preamble Parent Expenses 8.3(b)(iv) Parent Specified Representations 7.3(a) Payment Agent 2.8(a) Permits 3.14 Pre-Closing Director 6.15(e)(ii) Proxy Statement 3.8 PSU Consideration 2.7(d)(iii) Real Property 3.21(b) Required Financial Information 6.15(e) Requisite Stockholder Approval 3.3(c) Senior Notes 6.18(a) Significant Customer 3.16(a) Significant Supplier 3.16(b) Special Shares 2.7(e) Specified Representations 7.2(a) Subsidiary Securities 3.2(d) Supplemental Indenture 6.18(d) Surviving Corporation 2.1 Tail Policy 6.13(b) Tax Incentive 3.17(k) Termination Date 8.1(d) Termination Fee Amount 8.3(b)(i) TIA 6.18(b) Transition Period 6.12(b) Uncertificated Shares 2.7(a)(i) Unvested Restricted Stock 2.7(d)(v)
Appears in 1 contract
Sources: Merger Agreement (Microsemi Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2020 Bonus Plan 7.9(d) Acquisition Proposal Section 6.2(e)(i2020 Bonuses 7.9(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i401(k) Plan 7.9(e) 401(k) Plan Termination Date 7.9(e) Accepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bBalance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) CARES Act 1.1 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d4.12(d) Collaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 3.7(g) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 4.2(b) Company Financial Advisor Section 4.10 Advisors 4.11 Company Program Requirements 4.20(d) Company Programs 4.20(d) Company Regulatory Agency 4.20(b) Company Regulatory Permits 4.20(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section Tail Policy 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 Effects 1.1 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFFCRA 1.1 FFDCA 1.1 Final Exercise Date 3.7(g) Recitals Recitals Final Offering Period 3.7(g) Foreign Antitrust Laws 1.1 Indemnified Persons Section 7.8(a) Indemnified Proceeding 7.8(b) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.19(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Parent Preamble Parent 401(k) Plans 7.9(e) Participant 4.12(e) Paying Agent 3.8(a) Plans 4.12(a) Proprietary Information 1.1 Real Property Leases 4.18(b) Remedy Actions 7.2(a) Retention Agreements Recitals RSU Consideration 3.7(e) Schedule 14D-9 2.2(a) Schedule TO 2.1(f)(i) Subsidiary Securities 4.2(e) Surviving Corporation 3.1 Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvance Notice Period 5.2(d)(i)(1) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(a) Antiboycott Rules Section 4.22(aAlternative Financing 6.20(b) Board Recommendation Section 2.2(bBuyer Parties Preamble Bylaws 1.6(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 1.3 Certificates Section 3.8(c2.3(c) Changes Section 1.1 Charter 1.6(a) Closing Section 3.3 1.4 Closing Date Section 3.3 COBRA Section 4.11(d) 1.4 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(c) Company Board Recommendation Change 5.2(c)(i) Company Confidential Information 3.17(e) Company Data 3.17(l) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gFinancial Statements 3.5(c) Company License-Out Agreements Section 4.16(hMaterial Contracts 3.16(b) Company Financial Advisor Section 4.10 Preferred Stock 3.2(a) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.6 Continuation Period 6.19(a) Covered Employees 6.19(a) D&O Insurance Section 7.8(cTail Policies 6.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData Security Incident 3.17(l) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.1(c)(i) EAR Section 4.22(aDTC 2.3(d) DTC Payment 2.3(d) Effective Time Section 3.2 1.3 Electronic Delivery 9.15 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Exchange Fund Section 3.8(b2.3(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Guarantee 9.16 Guarantor Preamble Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 Material Contract Section 4.18(aInsurance Policies 3.20 Interim Period 5.1 Intervening Event 5.2(d)(i) Maximum Annual Premium Section 7.8(cLabor Agreement 3.12(a) Lease Agreement 3.16(a)(xi) Leased Real Property 3.14(b) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble Merger Transactions Recitals New Litigation Claim 6.12 Note Recitals Notice Period Expiration 5.2(d)(i)(2) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(c) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(d) Owned Company Share 2.1(a)(iii)
Appears in 1 contract
Sources: Agreement and Plan of Merger (Hall of Fame Resort & Entertainment Co)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.13(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppraisal Rights Provisions 2.12(a) Antiboycott Rules Section 4.22(aAssets 3.21 Cash Consideration 2.7(a)(1) Board Recommendation Section 2.2(bCertificates 2.8(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gIntellectual Property 3.22(a) Company License-Out Agreements Section 4.16(hProduct 3.22(a) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.22(b) Company Restricted Stock 2.7(d) Company Rights Plan Recitals Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Special Representations 7.3(a) Company Stockholder Approval 3.3(c) Company Stockholders' Meeting 6.3 Company Triggering Event 8.1(f)(ii) Confidentiality Agreement Section 10.4 Current Company 6.10 Copyrights 3.22(a)(2) D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(aDelaware Secretary of State 2.2 Dissenting Shares 2.12(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aStockholders 2.12(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Eligible Company Stock Option 2.7(a)(5) Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExclusivity Agreement 6.1(b) Financial Statements Incipio Incipio First Certificate of Merger Agreement Section 4.7(b2.2 First Merger 2.1(a) Recitals Recitals First Merger Surviving Entity 2.1(a) Form S-4 6.6(a) In-Licenses 3.22(k) Incentives 3.16(m) Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 Intellectual Property Rights 3.22(a) International Employee Plans 3.18(a) IP Licenses 3.22(l) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Communication 6.11(b) Merger Consideration Section 3.7(a)(i2.7(a) Minimum Condition Section 2.1(a)(iMerger Sub 1 Preamble Merger Sub 2 Preamble Modified Stock Option 6.12(a)(2) Multiemployer Plan Section 4.11(cModified RSU 6.12(a)(2) Open Source License 3.22(a)(4) Open Source Materials 3.22(a)(4) Option Exchange Ratio 2.7(a)(5) Out-Licenses 3.22(l) Parent Preamble Parent Disclosure Schedule Article IV Parent Intellectual Property 4.13(a) Parent Registered Intellectual Property 4.13(b) Parent SEC Reports 4.5 Parent Securities 4.3(c) Parent Special Representations 7.2(a) Patents 3.22(a)(2) Permits 3.13 Proxy Statement 3.8 Registered Intellectual Property 3.22(a)(6) Rollover RSU 6.12(b) Rollover Stock Option 6.12(b) Second Certificate of Merger 2.1(b) Second Merger 2.1(b) Second Merger Surviving Entity 2.1(b) Source Code 3.22(a)(7) Subsidiary Securities 3.2(c) Surviving Entity 2.1(b) Tax Opinions 6.19 Technology 3.22(a)(1) Termination Fee Amount 8.3(b)(1) Trade Secrets 3.22(a)(2) Trademarks 3.22(a)(2)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Condition Annex A Appointment Time 2.3(a) Antiboycott Rules Section 4.22(aArrangements 4.17(p) Board Recommendation Section 2.2(bAssets 4.14 Assumed Option 3.7(e)(ii) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date 3.3 Term Section 3.3 COBRA Section 4.11(dReference Collective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.17(p) Company Disclosure Letter Article IV Company License-In Intellectual Property Agreements Section 4.16(g4.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Company Stockholder Meeting 8.3(a) Comparable Plans 7.2(c) Confidentiality Agreement Section 10.4 Current Company 8.8 Consent 4.5 Continuing Directors 2.3(a) Covered Securityholders 4.17(p) D&O Insurance Section 7.8(c7.1(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.17(a) Employment Compensation Arrangement 4.17(p) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iFunded International Employee Plan 4.17(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Government Litigation Condition Annex A Illegality Condition Annex A Indemnified Persons Section 7.8(a7.1(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 4.17(a) Leased Real Property 4.13(b) Leases 4.13(b)
(a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cNew Plans 7.2(d)
Appears in 1 contract
Sources: Merger Agreement (Emc Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Anti-Corruption Laws Section 6.2(c)(ii3.19(b) Antiboycott Rules Assumed Option Section 4.22(a1.4(c)(i) Board Recommendation Assumed Unit Section 2.2(b1.4(c)(ii) Cancelled Company Book Entry Shares Section 3.7(a)(ii2.3(c) Certificate of Merger Section 3.2 1.1 Certificates Section 3.8(c2.3(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA 2.1 Cloudera Preamble Table of Contents Cloudera 2008 Stock Plan Section 4.11(d4.5(a) Company Preamble Company Common Cloudera 2017 Stock Recitals Company Plan Section 4.5(a) Cloudera Board Section 4.2(b) Cloudera Board Recommendation Section 7.4(e) Cloudera Board Recommendation Change Section 7.4(f) Cloudera Capitalization Representations Section 2.2(c)(ii)(B) Cloudera Designee Section 8.1(a) Cloudera Disclosure Letter Article IV Company License-Cloudera Fundamental Representations Section 2.2(c)(ii)(A) Cloudera In Agreements Licenses Section 4.16(g4.13(e) Company License-Cloudera IP Contracts Section 5.2(n) Cloudera IP Licenses Section 4.13(f) Cloudera Material Contract Section 4.14(a) Cloudera Material Real Property Lease Section 4.11 Cloudera Out Agreements Licenses Section 4.16(h4.13(f) Company Financial Advisor Cloudera Permits Section 4.10 Company 4.20 Cloudera Preferred Stock Section 4.5(a) Cloudera Qualified Plan Section 4.16(d) Cloudera Real Property Leases Section 4.11 Cloudera Registered Intellectual Property Section 4.13(a) Cloudera SEC Reports Section 4.7(a4.7 Cloudera Stock Awards Section 4.5(c) Company Securities Cloudera Stock Plans Section 4.2(a4.5(b) Company Shares Cloudera Stockholder Meeting Section 7.4(a) Cloudera Subsidiary Documents Section 4.4 Cloudera Support Agreement Recitals Cloudera Support Agreements Recitals Cloudera Tax Certificate Section 7.12(b) Cloudera Voting Proposal Section 4.2(b) Code Recitals Common Stock Consideration Section 1.4(b)(i) Confidentiality Agreement Section 10.4 Current Company 7.5(h) Continuing Employee Section 7.7(a) Continuing Employees Section 7.7(a) D&O Insurance Policy Section 7.8(c7.8(b) Customs Laws Delaware Secretary of State Section 4.22(a) Debt Financing Dispute Section 10.9(a) 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.19(c)(i) ECCNs Section 3.19(c)(ii) Effective Time Section 3.2 Enforceability Exceptions 1.1 ESPP Termination Date Section 4.4 Environmental Permits 7.7(b) Exchange Agent Section 4.15(b2.3(a) Exchange Fund Section 3.8(b2.3(b)(i) Expiration Time Exchange Ratio Section 2.1(d)(i1.4(b)(i) Financial Statements Incipio Incipio Merger Export Controls Section 3.19(c)(i) FCPA Section 3.19(b) Gazzang Plan Section 4.5(a) Hortonworks Preamble Hortonworks 2011 Plan Section 3.5(a) Hortonworks 2014 Plan Section 3.5(a) Hortonworks Board Section 3.2(b) Hortonworks Board Recommendation Section 7.4(e) Hortonworks Board Recommendation Change Section 7.4(f) Table of Contents Hortonworks Capitalization Representations Section 2.2(b)(ii)(B) Hortonworks Designee Section 8.1(a) Hortonworks Disclosure Letter Article III Hortonworks Fundamental Representations Section 2.2(b)(ii)(A) Hortonworks In Licenses Section 3.13(e) Hortonworks IP Contracts Section 5.2(n) Hortonworks IP Licenses Section 3.13(f) Hortonworks Material Contract Section 3.14(a) Hortonworks Material Real Property Lease Section 3.11 Hortonworks Out Licenses Section 3.13(f) Hortonworks Permits Section 3.20 Hortonworks Qualified Plan Section 3.16(d) Hortonworks Real Property Leases Section 3.11 Hortonworks Registered Intellectual Property Section 3.13(a) Hortonworks Restricted Stock Section 1.4(b)(iii) Hortonworks SEC Reports Section 3.7 Hortonworks Stock Awards Section 3.5(c) Hortonworks Stock Option Section 1.4(c)(i) Hortonworks Stock Plans Section 3.5(b) Hortonworks Stockholder Meeting Section 7.4(a) Hortonworks Subsidiary Documents Section 3.4 Hortonworks Support Agreement Recitals Hortonworks Tax Certificate Section 4.7(b7.12(b) Recitals Recitals Hortonworks Terminating Plans Section 7.7(d) Hortonworks Voting Proposal Section 3.2(b) Import Restrictions Section 3.19(c)(i) Indemnified Persons Parties Section 7.8(a) Inventions ITAR Section 1.1 Material Contract 3.19(c)(i) Joint Proxy Statement/Prospectus Section 4.18(a7.3(a) Malicious Code Section 3.13(n) Maximum Annual Premium Section 7.8(c7.8(b) Merger Recitals Merger Consideration Stockholder Meetings Section 3.7(a)(i7.4(a) Minimum Condition Merger Sub Preamble ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Section 2.1(a)(i4.2(b) Multiemployer Plan OFAC Section 4.11(c)3.19(c)(i) Qatalyst Partners Section 3.25 Registration Statement Section 7.3(a) Regulation M-A Filing Section 7.3(c) Representatives Section 6.1
Appears in 1 contract
Sources: Merger Agreement (Hortonworks, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aBylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(bCash Replacement Company RSU Amounts 2.8(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCash Replacement Option Amounts 2.8(b)(ii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a9.4 Consent 3.6 Copyrights 1.1(ii) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Effect 1.1(n) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.8(f) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(ii) Material Contract Section 4.18(aCustomers 1.1(mm)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(d)(ii)(3) Old Plans 6.11(d) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(ii) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Trade Control Laws 3.26(a)(i) Termination Date 8.1(c) Uncertificated Shares 2.9(c) Unvested Company Options 2.8(b)(ii) Unvested Company RSU 2.8(a)(ii)2.8(a)(i) Vested Option Consideration Section 3.7(a)(i2.8(b)(i) Minimum Condition Section 2.1(a)(iVested RSU Consideration 2.8(a)(i) Multiemployer Plan Section 4.11(c)Voting Agreements Recitals
Appears in 1 contract
Sources: Merger Agreement (Xactly Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bAntitrust Reimbursement Obligations 6.2(b) Cancelled Company Shares Section 3.7(a)(iiBenefits Period 6.11(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.9(c)(i) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hRelevant Persons 3.22(b) Company Financial Advisor Section 4.10 RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Converted Cash Award 2.8(a)(ii) Copyrights 1.1(iii) Covenant Exceptions 5.1(a) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(aPurchase Period 2.8(e) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(y) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(d) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Event Notice Period 5.4(d)(i)(2) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.6(a) Financing Reimbursement Obligations 6.6(e) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(iii) Material Contract Section 4.18(aCustomers 1.1(qqq)(x) Maximum Annual Premium Section 7.8(cMaterial Vendors 1.1(qqq)(x) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval 6.19 New Plans 6.11(c) Non-Cooperation Notice 6.6(b) Notice Period 5.4(d)(ii)(3) OFAC 1.1(gggg) Old Plans 6.11(c) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(e)(i) Party Preamble Patents 1.1(iii) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Processing 3.17(a) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(f) Required Permits 3.21 Requisite Stockholder Approval 3.4 Security Breach 3.17(b) Specified Foreign Direct Investment Law 6.2(a) Surviving Corporation 2.1 Tail Policy 6.10(c) Termination Date 8.1(c) Trade Controls 3.22(b) Trade Secrets 1.1(iii) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(b)(ii) Unvested Company RSU 2.8(a)(ii) UPE 6.2(a) Vested Company Option 2.8(b)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(b)(i) Minimum Condition Section 2.1(a)(iVested Company RSU 2.8(a)(i) Multiemployer Plan Section 4.11(cVested Company RSU Consideration 2.8(a)(i) Voting Agreements Recitals WARN Act 3.20(b)
Appears in 1 contract
Sources: Merger Agreement (ForgeRock, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto are defined elsewhere in this Agreement in the respective sections of this Agreement Section reference set forth opposite each of the capitalized such terms below: Term Section Reference Acceptable Accounts Payable 2.4.1 Accrued Employee Liabilities 2.3.4 Affiliate Obligations 2.4.12 Agreement Preamble Assigned Contracts 2.1.2 Assignment and Assumption 2.5 Assumed Liabilities 2.3 Basket 14.7.1 ▇▇▇▇ of Sale 2.5 Business Recital A Business Records 2.1.5 Buyer Preamble Buyer Indemnitees 14.2.1 Cap 14.6.2 Closing 10.1 Closing Date 10.1 Closing Date Valuation 3.3.1 COBRA 6.3.5 Communication Addresses 2.1.9 Competing Transaction 7.5 Computer Software and Databases 4.21 Confidentiality Agreement Section 6.2(e)(iii7.1 CPA 3.3.4 Damaged Inventory 3.3.2(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Damages 14.2.1 Employee 4.15.1 End User Software Licenses 13.8 Environmental Report 6.2 ERISA Definitions 4.17 Equitable Exceptions 4.2 Event of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Loss 2.7 Excluded Assets 2.2 Excluded Employees 6.3.2 Excluded Inventory 2.2.10 Excluded Liabilities 2.4 Facility Recital A Financial Statements Incipio Incipio Merger 4.4.1 Fixed Assets 2.1.1 Fixed Assets Purchase Price 3.3.2 Goodwill 2.1.7 Historical Annual Financial Statements 4.4.1 Holdback Amount 3.1.3 Holdback Disbursement Date 3.4.2 Huttig Receivables 2.2.2 Indemnified Party 14.4.1 Indemnifying Party 14.4.1 Intangible Property 2.1.8 Inventory 2.1.3 Lease 2.6 Outside Customer Receivablers 2.1.1 Negotiation Period 6.2 Net Holdback Amount 3.4.2 Permits and Licenses 2.1.7 Physical Count 3.3.1 Policy 4.22 Prepaid Expenses 2.1.2 Purchase Orders 2.3.1 Purchase Price 3.1.1 Purchased Assets 2.1 Related Agreements 6.1 Seller Preamble Seller Consents 4.3.2 Seller Indemnitees 14.3 Set-Off Notice 14.7 Stub Period Balance Sheet Date 4.4.1 Stub Period Financial Statements 4.4.1 Supplies 2.1.5 Supply Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)6.1 1060 Forms 3.2.3 Termination Date 7.5 Transferred Employees 6.3.2 Uncollected Outside Customer Receivables 6.5 Warranties 4.14 Warrantiy and Other Product Claims 2.4.14
Appears in 1 contract
Sources: Asset Purchase and Sale Agreement (Huttig Building Products Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.2(b) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.3(a) Capitalization Date 3.5(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.2(b) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Plan 3.5(b) Company License-Out Agreements Section 4.16(hIn License 3.13(e) Company Financial Advisor Section 4.10 IP Contract 5.2(n) Company IP License 3.13(f) Company Material Real Property Lease 3.11 Company Out Licenses 3.13(f) Company Real Property Lease 3.11 Company Related Parties 8.3(f)(i) Company SEC Reports Section 4.7(a3.7 Company Subsidiary Documents 3.4 Company Termination Fee 8.3(b)(i) Company Securities Section 4.2(aCopyrights 1.1(eee) Company Shares Recitals Confidentiality Covered Persons 6.10(a) COVID-19 1.1(t)(vi) COVID-19 Measures 1.1(t)(xi) Credit Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cTermination 6.20 Cut-Off Time 5.3(a) Customs Laws Section 4.22(aDebt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) Early ESPP Exercise Date 2.9 Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.13 Equity Commitment Letters 4.11(a) Equity Financing 4.11(a) ESPP 2.9 Event Notice Period 5.3(e)(i)(1) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(a) Financial Statements Incipio Incipio Merger Export Controls 3.19(c)(i) Financing 4.11(b) Financing Conditions 4.11(c) Financing Letters 4.11(b) Go-Shop Period 5.3(a) Guaranties Recitals Guarantor Recitals Import Restrictions 3.19(c)(i) Interim Period 5.1 Intervening Event 5.3(e)(i) IRS 1.1(eee) Labor Agreement Section 4.7(b3.14(a)(viii) Recitals Recitals Indemnified Persons Section 7.8(aLegal Restraint 7.1(c) Inventions Section 1.1 Malicious Code 3.13(n) Marks 1.1(eee) Material Contract Section 4.18(a3.14(a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble No-Shop Period Start Date 5.3(a) Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Disclosure Letter Article IV Parent Reimbursement Obligations 6.21 Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(eee) Pay-Off Letter 6.20 Payment Agent 2.10(a) Per Share Price 2.7(a)(ii) Permits 3.20 Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.3(e)(ii)(3) Proxy Statement 6.3(a) Qualified Plan Section 4.11(c)3.16(d) Reimbursement Obligations 6.6(a) Representatives 5.3(a) Required Amounts 4.11(f) Required Approvals 7.1(b) Required Investment Screening Laws 3.3(b) Requisite Stockholder Approval 3.2(c) RSU Consideration 2.8(b)(i) Sale Reimbursement Obligations 6.21 SEC Clearance Date 6.3(g) Surviving Corporation 2.1 Takeover Statute 3.23 Termination Date 8.1(c) Uncertificated Shares 2.10(c) Voting and Support Agreement Recitals
Appears in 1 contract
Sources: Merger Agreement (Cloudera, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bBenefits Period 6.11(b) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.10(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPSU 2.8(b)(i) Company Financial Advisor Section 4.10 Relevant Persons 3.22(b) Company Restricted Stock 2.7(b) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Copyrights 1.1(iii) Covenant Exceptions 5.1(a) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(aPurchase Period 2.8(f) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Disclosure Letters 1.4 Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDTC Payment 2.10(d) Effect 1.1(w) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(d) Equity Commitment Letter Recitals Equity Financing 4.9(a) Event Notice Period 5.4(d)(i)(2) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 6.6(a) Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) Maximum Annual Premium Section 7.8(cIP Contracts 3.16(d) Merger Recitals Merger Consideration Section 3.7(a)(iLabor Agreements 3.20(a) Minimum Condition Section 2.1(a)(iLabor Entities 3.20(a) Multiemployer Plan Section 4.11(cLease 3.14(b) Leased Real Property 3.14(b)
Appears in 1 contract
Sources: Merger Agreement (Sumo Logic, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiFinancing 5.6 Alternative Proposal 9.1(h) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBlue Sky 4.10 Cash Consideration 2.6(a) Certificate of Designation Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2(c) Changes Section 1.1 Closing Section 3.3 2.1 Closing Date Section 3.3 COBRA Section 4.11(d) 2.1 Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV ARTICLE III Company License-In Agreements Section 4.16(gRestricted Stock 2.6(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Rights Agreement Recitals Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Stockholder Meeting 5.4 Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c7.7 Consent 3.4 Continued Option 2.6(e) Customs Laws Section 4.22(aContinued RSU 2.6(f) Contracts 3.13(a) Damages 5.7 Debt Commitment Letters 3.28(a) Debt Financing Dispute Section 10.9(a3.28(a) Dissenting Shares 2.7 Divestiture 7.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bof the Merger 2.2(c) Exchange Fund Section 3.8(bElevation Preamble Indemnitees 5.7 Initial Expense Cap 9.3(c)(i) Expiration Time Section 2.1(d)(iInvestment Recitals Lenders 3.28(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.13(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.6(a) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Merger Sub Common Stock 2.6(d)
(a) Multiemployer Other Required Elevation Filing(s) 4.6(a) Permits 3.18 Plan Section 4.11(c)Amendments 2.6(e) Pre-Closing Period 5.1(a) Proxy Statement 3.30(a) Purchase Price 2.2(a) Purchased Shares Recitals Related Party 10.8 Requisite Stockholder Approval 3.2 Rights Agreement Amendment Recitals Solvent 3.26 Stockholder Litigation 5.7 Subsidiary Securities 3.6(b) Surviving Corporation in the Merger 2.2(c) Termination Date 9.1(b) Trade Secrets 3.16(c) Transaction Expenses 9.3(c)(i) Transactions Recitals
Appears in 1 contract
Sources: Preferred Stock Purchase Agreement and Agreement and Plan of Merger (Palm Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Acceptable Jurisdiction Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.21 Agreement Preamble Alternative Acquisition Agreement Anti-Bribery Laws Section 6.2(c)(ii3.25 Assumed Option Section 6.11(b) Antiboycott Rules Assumed RSU Section 4.22(a) Board Recommendation Section 2.2(b6.11(a) Cancelled Company Shares Option Section 3.7(a)(ii6.11(b)(ii) Capitalization Reference Date Section 3.04(a) Certificate of Merger Section 3.2 2.02(a) Certificates Section 3.8(c2.06(a) Changes Clarification Request Section 1.1 6.01(b) Closing Section 3.3 2.03 Closing Date Section 3.3 COBRA 2.03 Collective Bargaining Agreements Section 4.11(d3.19(a) Company Preamble Company Balance Sheet Section 3.09 Company Board Recitals Company Board Recommendation Section 6.02(a) Company Board Recommendation Change Section 6.02(b) Company Capitalization Representation Section 7.02(a)(iii) Company Common Stock Recitals Company Disclosure Letter Article IV ARTICLE III Company License-In Inbound License Section 3.21(c) Company IP Agreements Section 4.16(g3.21(c) Company License-Out Agreements Leased Real Property Section 4.16(h3.20(b) Company Financial Advisor Outbound License Section 4.10 3.21(c) Company Owned Real Property Section 3.20(a) Company Real Property Leases Section 3.20(b) Company Registered IP Section 3.21(a) Company Regulatory Agency Section 3.26(a) Company Regulatory Permits Section 3.26(a) Company SEC Reports Section 4.7(a3.06(a) Company Securities Section 4.2(a3.04(c) Company Shares Stockholders’ Meeting Section 6.03(a) Company Specified Representations Section 7.02(a)(ii) Company Support Agreement Recitals Company Termination Fee Amount Section 8.03(b) Confidentiality Agreement Section 10.4 Current Company 6.09 Consent Section 3.05(b) Copyrights Section 1.01 D&O Insurance Section 7.8(c6.13(b) Customs Laws Delaware Secretary of State Section 4.22(a2.02(a) Debt Financing Dispute DOJ Section 10.9(a6.05(a) DGCL Recitals Dissenting Company Shares Dollars or $ Section 3.7(c)(i1.03(d) EAR Domain Names Section 4.22(a) 1.01 Effect Section 1.01 Effective Time Section 3.2 2.02(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.03(a) EPA Section 4.15(b3.26(a) EU Section 1.01 Exchange Agent Section 2.06(a) Exchange Fund Section 3.8(b2.06(b) Expiration Time Excluded Shares Section 2.1(d)(i2.05(a)(i) Financial Statements Incipio Incipio Merger Agreement Export and Import Approvals Section 4.7(b3.22 Export Controls Section 3.22 FDA Section 3.26(a) Recitals Recitals FDCA Section 3.26(a) FIFRA Section 3.26(a) FQPA Section 3.26(a) FTC Section 6.05(a) Form F-4 Section 6.04(a) Fractional Share Cash Amount Section 2.05(c) Import Restrictions Section 3.22 Indemnified Persons Parties Section 7.8(a6.13(a) Inventions Issuance Section 1.1 6.04 Labor Organization Section 3.19(a) Linklaters Section 6.04(e) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Sub Preamble MoFo Section 6.04(e) Notice Period Section 6.02(d)(ii) Option Consideration Section 3.7(a)(i6.11(b)(ii) Minimum Condition Parent Preamble Parent Board Recitals Parent Capitalization Date Section 2.1(a)(i4.03(a) Multiemployer Plan Parent Capitalization Representation Section 4.11(c7.03(a)(iii) Parent Disclosure Letter ARTICLE IV Parent Regulatory Agency Section 4.16(a) Parent Regulatory Permits Section 4.16(a) Parent SEC Reports Section 4.05(a) Parent Securities Section 4.03(d) Parent Subsidiary Securities Section 4.01(e) Parent Specified Representations Section 7.03(a)(ii) Permits Section 3.13 Patents Section 1.01 Proxy Statement/Prospectus Section 6.04(a) Requisite Stockholder Approval Section 3.03(c) Restrictive Contracts Section 3.11(a)(vi) R&W Policy Section 6.14 Significant Customer Section 3.15(a) Significant Supplier Section 3.15(b) Specified Jurisdictions Section 7.01(b) Share Consideration Section 2.05(a)(i) Subsidiary Securities Section 3.02(d) Surviving Company Section 2.01 Tail Policy Section 6.13(b) Takeover Law Section 3.29(b) Targeted Amount Section 6.21 Tax Incentive Section 3.16(l) Termination Date Section 8.01(c) Trademarks Section 1.01 Trade Secrets Section 1.01 Triggering Event Section 8.01(e)(ii) Uncertificated Shares Section 2.06(a) USDA Section 3.26(a)
Appears in 1 contract
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article 1 shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) ---- ------- Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Assumed Awards 5.12(b) Antiboycott Rules Section 4.22(aBear Stearns 4.16 ▇▇▇▇▇▇icate of Amendment Recitals Certificates 2.7(c) Board Recommendation Section 2.2(bClaim 5.7(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Code Recitals Company Preamble Company Common Stock 401(k) Plans 5.12(e) Company Balance Sheet 3.4(b)
(a) Company SEC Documents 3.4
(a) Company Source Code 3.9(g) Company Stockholder Approval 3.3(c) Company Stockholders' Meeting 3.4(e) Company Voting Agreements Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gVoting Debt 3.2(d) Company License-Out Agreements Section 4.16(hWarrants 2.5(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c5.2(c)(1) Customs Laws Section 4.22(aContinuing Employees 5.12(d) Debt Financing Dispute Section 10.9(a) DGCL Delaware Law Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.9 Exchange Agent 2.7(a) Exchange Fund Section 3.8(b2.7(b) Expiration Time Section 2.1(d)(iExchange Multiple 2.4(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExchange Quotient 2.4(g) Recitals Recitals Indemnified Persons Section 7.8(aExchange Ratio 2.4(a) Inventions Section 1.1 Material Contract Section 4.18(aExpenses 5.7(a) Maximum Annual Premium Section 7.8(cJanney Montgomery ▇.▇▇ ▇▇▇▇▇▇▇▇▇▇▇ Parties 5.7(a) Initial Post-Closing Directors 5.13(a) L-1 2.2 Merger Recitals Merger Consideration 2.4
(a) Merger Sub Preamble Outside Date 7.1(b)(1) Parent Preamble Parent Balance Sheet 4.4(b) Parent Benefit Arrangements 4.10(d) Parent Benefit Plans 5.12(d) Parent Charter Amendment Recitals Parent Charter Documents 4.1(b) Parent Disclosure Letter 4 Parent Financial Statements 4.4(b) Parent IP Rights 4.9(a) Parent Material Contract 4.12(a) Parent-Owned IP Rights 4.9(a) Parent SEC Documents 4.4(a) Parent Source Code 4.9(g) Term Section 3.7(a)(i---- ------- Parent Stock Issuance Recitals Parent Stockholder Approval 4.3(c) Minimum Condition Section 2.1(a)(iParent Stockholders' Meeting 3.4(e) Multiemployer Plan Section 4.11(cParent Voting Agreements Recitals Parent Voting Debt 4.2(d) Parent Warrants 4.2(b) Restraints 6.1(c) Returns 3.8 Rule 145 Affiliates 5.14 Stock Consideration 2.4(a) Surviving Corporation 2.1 USBX 4.16 Use 3.9(a) and 4.9(a)
Appears in 1 contract
Sources: Agreement and Plan of Reorganization (Viisage Technology Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRegulatory Effects 8.2(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 8.8 Assets 4.15 Book-Entry Share 3.10(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.5(a) Certificate of Merger Section 3.2 Certificates 3.10(b) Term Section 3.8(c) Changes Section 1.1 Reference Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(e)(i) Company Preamble Company Acquisition Agreement 6.2(b) Company Adverse Recommendation Change 6.2(e) Company Board Recitals Company Board Recommendation 2.1 Company Common Stock Recitals Company Compensation Committee 8.8 Company Disclosure Letter Article IV Preamble Company License-In Agreements Section 4.16(gEquity Awards 4.5(b) Company License-Out Agreements Section 4.16(hReserve Reports 4.16(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.5(d) Company Shares Recitals Stockholder Meeting 8.3(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c8.7 Consent 4.4 Continuing Directors 2.3(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Covered Securityholders 8.8 Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.8(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEligible Shares 3.7(a)(ii) Employee Plan 4.19(a) Employment Compensation Arrangement 8.8 ERISA Affiliate 4.19(a) Exchange Fund Section 3.8(b3.10(a) Expiration Time Section 2.1(d)(iDate 2.1(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFairness Opinion 4.26 Grant Date 4.19(q) Recitals Recitals HSR Condition Annex A Indemnified Persons Section 7.8(aParty 7.1(a) Inventions Section 1.1 Indemnifying Parties 7.1(b) Leased Real Property 4.14(b) Leases 4.14(b) Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a)(ii) Merger Sub Preamble Minimum Condition 2.1(b) New Plans 7.2(e) Offer Recitals Offer Conditions 2.1(b) Term Section 2.1(a)(iReference Offer Documents 2.1(i) Multiemployer Plan Section 4.11(cOffer Price Recitals Old Plans 7.2(e) Option Consideration 3.9(a) Outside Date 10.1(b)(i) Parent Preamble Payment Agent 3.10(a) Permits 4.10 Proxy Statement 4.24(c) Representatives 6.2(a) Requisite Stockholder Approval 4.2(c) Schedule 14D-9 2.2(b) Schedule TO 2.1(h) Subsidiary Securities 4.6(c) Surviving Corporation 3.1 Termination Fee 10.3(a) Tender and Voting Agreements Recitals Top-Up Notice 2.4(c) Top-Up Option 2.4(a) Top-Up Option Shares 2.4(a) WARN 4.18(d)
Appears in 1 contract
Sources: Merger Agreement (Statoil Asa)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(e) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii7.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 8.3(c) Board Recommendation Section 2.2(bAlternative Debt Financing Agreements 8.3(c) Cancelled Alternative Debt Financing Commitment 8.3(c) Annual Bonus 8.9(b) Annual Bonus Payment Date 8.9(b) Buyer Parties Preamble Bylaws 5.1 Capitalization Date 5.6(a) Cash Replacement Amount 3.5(c)(ii) Cash Replacement Option Amount 3.5(c)(ii) Cash Replacement Company Shares Section 3.7(a)(iiRSA Amount 3.5(b)(ii) Cash Replacement Company RSU Amount 3.5(a)(ii) Centerview 5.3(b) Certificate of Merger Section 3.2 3.1(c) Certificates Section 3.8(c3.3(a) Changes Section 1.1 Charter 5.1 Chosen Courts 11.10(a) Closing Section 3.3 3.1(b) Closing Date Section 3.3 COBRA Section 4.11(d3.1(b) Collective Bargaining Agreement 5.18(a) Company Preamble Company 401(k) Plan 8.9(d) Company Board Recommendation 5.3(a) Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Section 4.16(gEquity Awards 5.6(b) Company License-Out Agreements Section 4.16(hOption Consideration 3.5(c)(i) Company Financial Advisor Section 4.10 PSA Consideration 3.5(d) Company PSU Consideration 3.5(e) Company Related Parties 10.3(f) Company RSA Consideration 3.3(b) Company RSU Consideration 3.5(a)(i) Company SEC Reports Section 4.7(a) 5.8 Company Securities Section 4.2(a5.6(c) Company Shares Recitals Compensation Continuation Period 8.9(a) Confidentiality Agreement Section 10.4 11.4 Consent 5.5 Consideration Fund 3.3(a) Continuation Period 8.9(a) Current Company D&O Insurance Section 7.8(c8.8(b) Customs Laws Section 4.22(aDebt Fee Letter 6.11(a) Debt Financing Dispute Section 10.9(a6.11(a) Debt Financing Commitment 6.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.4 Dollars 1.3(e) Effective Time Section 3.2 3.1(c) Electronic Delivery 11.13 Employee Plan 5.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 5.2 Equity Award Consideration 3.5(e) Exchange Fund Section 3.8(bEquity Commitment Letter Recitals Equity Financing 6.11(a) Excluded Shares 2.1(a) Expiration Time Section 2.1(d)(i2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Purchase Period 3.5(f) Financing 6.11(a) Financing Commitments 6.11(a) FDA 5.23(a) FDA Act 5.22(a) Guarantee Recitals Guarantor Recitals Indemnified Person 8.8(a) Insured Persons Section 7.8(a8.8(b) Inventions Section 1.1 Material Contract Section 4.18(aIntervening Event 7.3(d)(i) Investors Recitals Lease 5.13(b) Leased Real Property 5.13(b) Maximum Annual Premium Section 7.8(cAmount 8.8(b) Merger Recitals Merger Consideration Section 3.7(a)(i3.2(a) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Merger Sub Stockholder Approval Preamble New Plan 8.9(c) Multiemployer Notice Period 7.3(d)(ii)(2) Offer Recitals Offer Conditions 2.1(a) Offer Commencement Date 2.1(a) Offer Documents 2.1(f) Offer Price Recitals Original Merger 11.14 Original Merger Agreement Recitals Original Offer 11.14 Original Signing Date Recitals Original Transaction Documents 6.6 Original Waivers 11.14 Outside Date 10.1(c) Parent Preamble Parent 401(k) Plan Section 4.11(c8.9(d) Party Preamble Paying Agent 3.3(a) Payoff Letters 8.16 Permits 5.19 Pre-Amendment Claims 11.14 Prohibited Modifications 8.3(a) Recommendation Change 7.3(c)(i) Related Party Transaction 5.25 Repaid Indebtedness 8.16 Representatives 7.3(a) Required Amount 6.11(c) Retained Claims 11.14 Schedule 14D-9 2.1(f) Schedule TO 2.1(f) Share Recitals Surviving Corporation Recitals Takeover Statute 5.3(c) Tax Proceeding 5.16(c) Teoxane 11.14 Uncertificated Shares 3.3(a)
Appears in 1 contract
Sources: Agreement and Plan of Merger (Revance Therapeutics, Inc.)
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article I shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Adjustment Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 2.10 Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(d)(iii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Book Entry Shares Section 3.7(a)(ii2.7(a) Cash Consideration Section 2.6(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.6(b) Changes Section 1.1 Closing Section 3.3 2.4 Closing Date Section 3.3 COBRA Section 4.11(d) 2.4 Code Recitals Company Preamble Company Common Stock Recitals 401(k) Plan Section 5.12 Company Disclosure Letter Article IV Company License-In Agreements Adverse Recommendation Change Section 4.16(g5.2(d) Company License-Out Agreements Data Section 4.16(h3.14(b) Company Financial Advisor Statements Section 4.10 3.6(b) Company Intellectual Property Section 3.13(a) Company IT Systems Section 3.14(a) Company Material Contract Section 3.17(a) Company Multiemployer Plan Section 3.15(k) Company Plans Section 3.15(a) Company RSU Section 2.8(c) Company SEC Reports Documents Section 4.7(a3.6(a) Company Securities Stockholder Approval Section 4.2(a3.4(a) Company Shares Recitals Stockholders’ Meeting Section 3.19 Confidentiality Agreement Section 10.4 Current Company 5.2(b)(i) Copyrights Section 3.13(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a5.8(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.6(d) EAR Divestitures Section 4.22(a5.6(c) Effective Time Section 3.2 Enforceability Exceptions 2.3 ERISA Affiliate Section 4.4 Environmental Permits 3.15(a) Exchange Agent Section 4.15(b2.7(a) Exchange Fund Section 3.8(b2.7(a) Expiration Time Expenses Section 2.1(d)(i7.3(c) Financial Statements Incipio Incipio Merger Agreement Films in Progress Section 4.7(b3.22(a) ▇▇.▇▇▇ Common Stock Section 4.2(a) Indemnified Parties Section 5.8(a) Intellectual Property Section 3.13(a) Term Section IP Contracts Section 3.13(a) Leased Property Section 3.11(b) LLC Act Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.6(b) Minimum Condition Merger LLC Preamble Merger Sub Preamble Non-Owned Intellectual Property Section 2.1(a)(i3.13(a) Multiemployer Plan Outside Date Section 4.11(c7.1(b)(i) Owned Intellectual Property Section 3.13(a) Parent Preamble Parent SEC Documents Section 4.5(a) Real Property Leases Section 3.11(b) Reinstated Recommendation Section 5.3(b) Stock Consideration Section 2.6(b) Surviving Company Section 5.18 Surviving Corporation Section 2.1 Termination Fee Section 7.3(a) Trade Secrets Section 3.13(a)
Appears in 1 contract
Sources: Merger Agreement
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iActual PSU Consideration 2.8(a)(iv) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.9(c)(i) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV 1.4 Company LicenseEquity-In Agreements Section 4.16(gBased Award Consideration 2.8(a)(i) Company License-Out Agreements Section 4.16(hOption Consideration 2.8(b) Company Financial Advisor Section 4.10 Privacy Policy 3.17(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.3(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cCopyrights 1.1(iiii) Customs Laws Section 4.22(aDerivative Action 6.18(c) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(a3.22(b)(i) Effect 1.1(pp) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.2 Electronic Delivery 9.14 Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExport and Import Approvals 3.22(b)(iv) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFacility Security Clearances 3.28(a) Recitals Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(a) Labor Entities 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(iiii) Maximum Annual Premium Section 7.8(c6.9(b) Merger Recitals Merger Sub Preamble New Plans 6.10(c)(i) Nonqualified Deferred Compensation Plan 3.18(h) Notice Period 5.3(d)(ii)(3) OFAC 3.22(b)(i) Other Required Company Filing 6.2(e) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(iiii) Payment Agent 2.9(a) Payoff Letters 6.18(f) Pension Benefits 3.18(i) Per Share Price 2.7(a)(iv) Proxy Statement 6.2(a) Qualified Plans 3.18(c) Remedy Action 6.1(e)(i) Repurchase Transaction 6.18(a)(iii) Required Parent Filing 6.2(f) Requisite Stockholder Approval 3.4 Restraint 7.1(c) Section 16 Officer 6.10(f) Security Assessment 6.6(b)(i) Security Assessment Team 6.6(b)(i) Security Clearances 3.28(b) Source Code Scan 6.6(b)(ii) Surviving Corporation 2.1 Tail Policy 6.9(b) Tax Incentive 3.18(h) Termination Date 8.1(c) Top Channel Partners 3.32 Top Customers 3.31 Top Suppliers 3.30 Trade Compliance Laws 3.22(b)(i) Trade Secrets 1.1(iiii) Transactions Recitals Uncertificated Shares 2.9(c)(ii) Unvested Payment Plan Agreement 1.1(zzzzz) Unvested PSU Consideration Section 3.7(a)(i2.8(a)(v) Minimum Condition Section 2.1(a)(iUnvested RSU Consideration 2.8(a)(ii) Multiemployer Plan Section 4.11(cVoting Agreement Recitals WARN Act 3.20(a)
Appears in 1 contract
Sources: Merger Agreement (Mandiant, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Acquired Company Returns 3.15(a) Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAlternate Debt Financing 6.5(d) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(iiCertification 3.4(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.20 Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hOptions 2.8(b) Company Financial Advisor Section 4.10 Plans 6.11(b) Company SEC Reports Section 4.7(a3.4(a) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cComparable Plans 6.11(b) Customs Laws Section 4.22(aCovenant Exceptions 5.1(a) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Debt Financing Sources 4.10(a) Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(z) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Enforcement Expenses 8.3(e) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFee Letters 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 3.7(a) Leased Real Property 3.7(a) Major Customer 3.11(a) Major Supplier 3.11(b) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Misconduct Claim 3.16(f) New Debt Commitment Letters 6.5(d) New Plans 6.11(c) Non-Cooperation Notice 6.6(a)(vi) Notice Period 5.4(d)(ii)(3) Old Plans 6.11(c) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Party Preamble Patents 1.1(www) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) Qatalyst Partners 3.24 Reimbursement Obligations 6.6(f) Requisite Stockholder Approval 3.22 Restraint 7.1(c) Sanctioned Jurisdictions 3.13(d) Section 409A 3.16(l) Specified Foreign Direct Investment Laws 6.2(a) Standards Organization 3.8(c) Surviving Corporation 2.1 Tail Policy 6.10(b) Takeover Statute 3.21 Termination Date 8.1(c) Trade Secrets 1.1(www) Uncertificated Shares 2.9(c)(ii) Underwater Option 2.8(c)(i) Unfair Labor Practice 3.16(b) Unvested Company RSU 2.8(a) UPE 6.2(a) Vested Company Option 2.8(b) Vested Company Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iVested Company RSU 2.8(a) Multiemployer Plan Section 4.11(c)Vested Company RSU Consideration 2.8(a) Voting Agreements Recitals
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCertificates 2.10(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hOption 2.8(c)(i) Company Financial Advisor Section 4.10 PSU Award 2.8(b)(i) Company Relevant Persons 3.22(b) Company RSU Award 2.8(a)(i) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.5(a) Company Shares Voting Agreements Recitals Confidentiality Agreement Section 10.4 Company Warrant Consideration 2.9 Copyrights 1.1(jjj) Covenant Exceptions 5.1(a) Current Company D&O Insurance Section 7.8(cPurchase Period 2.8(f) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.10(d) Effect 1.1(w) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFinal Purchase 2.8(f) Financial Statements Incipio Incipio Merger Financing Reimbursement Obligations 6.7(f) Go-Shop Period 5.4(a) Guarantee Recitals Guarantors Recitals Haveli Voting Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 International Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(b) Labor Entities 3.20(b) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(jjj) Material Contract Section 4.18(aCustomers 1.1(qqq)(ix) Material Vendors 1.1(qqq)(ix) Maximum Annual Premium Section 7.8(c6.11(c) Merger Recitals Merger Sub Preamble New Plans 6.12(c) No-Shop Period Start Date 5.4(b) Non-Cooperation Notice 6.7(b) Notice Period 5.4(e)(ii)(3) OFAC 1.1(eeee) Old Plans 6.12(c) Other Required Company Filing 6.4(e) Other Required Parent Filing 6.4(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Party Preamble Patents 1.1(jjj)
(a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Processing 3.17 Proxy Statement 6.4(a) Required Amount 4.11(c) Required Permits 3.21 Requisite Stockholder Approval 3.4 Restraint 7.1(c) Security Breach 3.17(b) Solvent 4.11(d) Specified Date 8.1(c) Surviving Corporation 2.1 Tail Policy 6.11(c) Termination Date 8.1(c) Trade Secrets 1.1(jjj) Uncertificated Shares 2.10(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU Award 2.8(b)(ii) Unvested Company RSU Award 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU Award 2.8(b)(i) Multiemployer Plan Section 4.11(cVested Company PSU Consideration 2.8(b)(i) Vested Company RSU Award 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Voting Agreements Recitals WARN Act 3.21(e)
Appears in 1 contract
Sources: Merger Agreement (Couchbase, Inc.)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto meaning defined in the respective corresponding sections of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Effective Date Section 3.3 COBRA Section 4.11(d) Preamble BGI Preamble ▇▇▇▇▇ Netherlands Preamble Bunge Brazil Preamble Bunge Group Preamble Solazyme, Inc. Preamble Solazyme Brazil Preamble Solazyme Group Preamble Company Preamble Company Common Stock SB Oils Preamble JV Companies Preamble SBO Holdco Preamble Initial Plant Recitals Company Disclosure Letter Article IV Company License-Joint Venture Recitals Party 1.2 Dollar 1.2 Reais 1.2 * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. MT 1.2 Business 2.2(a) Percentage Interest 3.2 Capital Contributions 4.1 Initial Solazyme Equity Commitment 4.1(a)(i) Additional Solazyme Equity Commitment 4.1(a)(ii) Initial Bunge Equity Commitment 4.1(b)(i) Initial Equity Commitments 4.1(b)(i) Additional Bunge Equity Commitment 4.1(b)(ii) Additional Equity Commitments 4.1(b)(ii) Capital Call 4.5 Estimated Tax Distributions 4.8(e) Annual Tax Distribution 4.8(e) Tax Distributions 4.8(e) U.S. GAAP 4.9 Regulatory Allocations 5.4(d) SB Oils Officers 6.1 Board 6.1 Key Managers 6.11 Secondees 6.11 Administrative Services 7.1(b) R&D 7.2 Land Commitment for Purchase and Sale In Agreements Rem Right 7.6(a) 7.6(a) 7.6(b) Initial Business Plan 7.9(b) Initial Annual Budget 7.9(b) Section 4.16(g8.3(a) Company LicenseNotice 8.3(a) Section 8.3(a)(ii) Notice 8.3(a) Section 8.3(b) Notice 8.3(b) Section 8.3(c) Notice 8.3(c) Section 8.3(d) Notice 8.3(d) Expansion Notice 8.5(a) Election Period 8.5(b) Commence Construction 8.5(f) * Notice 9.1(a) Section 9.1(a) Notice 9.1(a) Section 9.1(a) Response 9.1(a) HSR Act 10.1 SBDC Approval 10.2 SOX Compliance 10.6(f)(ii) Form 1065 10.7 Tax Matters Partner 10.9 Fiscal Year 10.11 Tax Year 10.11 Lock-Out Period 12.1 * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Transferring Party 12.2 Remaining Party 12.2(a)(i) Section 12.2(a) Transfer Notice 12.2(a)(i) Qualifying Offer 12.2(a)(ii) Competitor Transfer Offer 12.2(b)(i) Offered Interest 12.2(b)(i) Section 12.2(b) Transfer Notice 12.2(b)(i) Election Notice 12.2(b)(ii) Target Party 12.3 Section 12.3(a) Notice 12.3(a) Section 12.3(b) Response Date 12.3(b) Confidential Information 14.1 Indemnifying Party 15.1 Indemnified Party 15.1 Term 16.1 Control Definition of Affiliate Acquired Party Definition of Change in Control Primary Field Definition of Field Secondary Field Definition of Field Solazyme Development Agreement Definition of JV Agreements Bunge Development Agreement Definition of JV Agreements Development Agreements Definition of JV Agreements Cross-License Agreement Definition of JV Agreements Feedstock Supply Agreement Definition of JV Agreements Brazilian Administrative Services Agreement Definition of JV Agreements Dutch Administrative Services Agreement Definition of JV Agreements Administrative Services Agreements Definition of JV Agreements Utility Supply Agreement Definition of JV Agreements Working Capital Agreement Definition of JV Agreements Lease Definition of JV Agreements Additional Definitions in the Solazyme Development Agreement. Capitalized terms used in this Agreement but not defined anywhere herein (including the Exhibits) shall have the meaning ascribed to them in the Solazyme Development Agreement. Such terms include the following: Term Section 4.16(hReference Background Technology 10.3 Solazyme Project Technology 10.3 Solazyme Technical Services Technology 10.3 Solazyme Platform Technology 10.3 Exhibit A – Page 8 EXHIBIT B PROJECT PLAN AND INITIAL BUDGET * Exhibit B – Page 1 * Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. EXHIBIT C CALCULATION EXAMPLES Percentage Interest Adjustment Pursuant to Section 4.5, 8.5(c)(iv) Company Financial Advisor or (v), or 8.5(d) Example of Funding of Deficiency by Other Party Aggregate Capital Funded – Party A 60 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 100 million Initial Percentage Interest – Party A 60%(60/100) Initial Percentage Interest – Party B 40%(40/100) Capital Call (each) 10 million Party A Funds 20 million Party B Funds -0- Aggregate Capital Funded – Party A 80 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 120 million Initial Percentage Interest – Party A 66.7%(80/120) Initial Percentage Interest – Party B 33.3%(40/120) Example of Funding Deficiency not Funded by Other Party Aggregate Capital Funded – Party A 60 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 100 million Initial Percentage Interest – Party A 60%(60/100) Initial Percentage Interest – Party B 40%(40/100) Capital Call (each) 10 million Party A Funds 10 million Party B Funds -0- Aggregate Capital Funded – Party A 70 million Aggregate Capital Funded – Party B 40 million Capital Committed to Date 110 million Initial Percentage Interest – Party A 63.6%(70/110) Initial Percentage Interest – Party B 36.4%(40/110) Exhibit C – Page 1 Cash Distribution Adjustment Pursuant to Section 4.10 Company SEC Reports 4.8(c) If the Percentage Interests of the Parties at the time of actual cash distributions has changed from the Percentage Interests of the Parties on the Effective Date, the * splt provided in Section 4.7(a4.8(b) Company shall be adjusted proportionately to the change in Percentage Interests as set forth in the following tables: * For Percentage Interests different than those set forth in the above table a comparable adjustment shall be made (assuming a straight line between the relevant numbers). * Certain information on this page has been omitted and filed separately with the Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) and Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Commission. Confidential treatment has been requested with respect to the omitted portions. EXHIBIT D PRELIMINARY ACTIVITIES
Appears in 1 contract
Sources: Joint Venture Agreement
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.20 Assumed Company Option 7.11(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCertificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.18(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gAcquisition Transaction 9.4(b)(i) Company License-Out Agreements Section 4.16(hBoard Recommendation 7.2(a) Company Financial Advisor Section 4.10 Board Recommendation Change 7.2(b) Company SEC Reports Section 4.7(aIP Agreements 4.21(e) Company Products 4.21(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.17(a) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIndemnified Parties 7.13(a) Recitals Recitals Indemnified Persons Section 7.8(aTermination Date 9.1(c) Inventions Section 1.1 International Employee Plans 4.17(b) Leased Real Property 4.19(b) Leases 4.19(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Sub Preamble Merger Consideration Section 3.7(a)(i3.7(a) Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cOffer Recitals Offer Documents 2.1(f) Offer Price Recitals Offer to Purchase 2.1(f) Parent Preamble Payment Agent 3.8(a) Permits 4.13 Proxy Statement 4.8(b) Requisite Stockholder Approval 4.24 Rights Agreement Recitals Rights Agreement Amendment Recitals SEC Reports 4.6 Schedule 14D-9 2.2(b) Schedule TO 2.1(f) Subsidiary Securities 4.2(c) Surviving Corporation 3.1 Tender and Voting Agreement Recitals Termination Date 9.1(c) Termination Fee Amount 9.4(b) Triggering Event 9.1(e)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii6.2(a) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Amended and Restated Stockholder Rights Agreement Section 6.2(c)(ii2.1(a)(v) Antiboycott Rules Section 4.22(aArrangements 7.18 Assets 4.14 Banks 7.19(c) Board Recommendation Section 2.2(b) Brookfield Recitals Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCOC EOD 7.19(a) Collective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Board Recommendation Notice 7.4(e) Company Common Stock Recitals Company Compensation Committee 7.18 Company Disclosure Letter Article ARTICLE IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Continuing Directors 2.3(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Financing Notice 7.19(b) Foreign Plans 4.17(l) Fund Guarantee Recitals Go-Shop Extension 6.2(a) Go-Shop Extension Expiration Time Section Date 2.1(d)(ii)(C) Go-Shop Period 6.2(a) Government Entity 4.20(b)(ii) Government Official 4.20(b)(i) Indemnified Persons 7.9(a) Initial Expiration Date 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIT Systems 4.15(h) Leased Real Property 4.13(b) Leases 4.13(b) Major Stockholders Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Condition 8.1(a)(iv) Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cNew Plans 7.10(b) No-Shop Period Start Date 6.2(a) Non-Cancelled Company Shares 3.7(a)(ii) Notice of Superior Proposal 7.4(e) Notice Period 7.4(e)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aTermination Fee 8.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c9.4 Consent 3.6 Covered Persons 6.10(a) Customs Laws Section 4.22(aCredit Agreement Termination 6.21 Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Event Notice Period 5.4(e)(i)(1) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFinancing 4.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Conditions 4.11(c) Financing Letters 4.11(b) Go-Shop Period 5.4(a) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(aInterim Period 5.1 Intervening Event 5.4(e)(i) Inventions Section 1.1 Material Contract Section 4.18(aLease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Money Transmitter License 3.27 Non-U.S. Plan 3.18(h) No-Shop Period Start Date 5.4(a) Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party. Preamble Payment Agent 2.9(a) Per Share Price 2.7(a)(ii) Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.4(e)(i)(3) Protected Information 3.16(h) Proxy Statement 6.3(a) Recent SEC Reports Article III Regulatory Agreement 3.22(c) Reimbursement Obligations 6.6(a) Representatives 5.4(a) Required Amounts 4.11(f) Requisite Stockholder Approval 3.4 RSA Consideration 2.8(b)(i) SEC Clearance Date 6.3(g) Specified Acquisition 5.3 Surviving Corporation. 2.1 Tax Proceeding 3.17(c) Termination Date 8.1(c) Trade Control Laws 3.26(a)(i) Uncertificated Shares 2.9(c)
Appears in 1 contract
Sources: Merger Agreement (RealPage, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i409A Correction 7.11(a) 409A Offer 7.11(a)
(a) 50% Top-Up Option 2.4(a) 50% Top-Up Option Shares 2.4(a) 90% Top-Up Option 2.5(a) 90% Top-Up Option Shares 2.5(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bAssets 4.21 Assumed Company Option 7.11(a) Cancelled Company Shares Section 3.7(a)(iiOption 7.11(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.19(a) Company Preamble Company Common Stock Recitals Acquisition Transaction 9.4(b) Company Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Preamble Company License-In IP Agreements Section 4.16(g4.22(e) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aProducts 4.22(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders' Meeting 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Director(s) 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(c) Recitals Recitals Foreign Employees 4.18(k) Funded International Employee Plan 4.18(b) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Initial Termination Date 9.1(c) International Employee Plans 4.18(a) Leased Real Property 4.20(b) Leases 4.20(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Sub Preamble Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c3.7(a)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAccounting Referee 1.5(c) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.6 Adjustment Amount 1.6(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Laws 5.3(b) Antiboycott Rules Section 4.22(aArbitrator 11.10(a) Board Recommendation Section 2.2(bBuyer Preamble Buyer Assignee 11.3 Buyer Filed Tax Return 6.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Financial Statements 4.8(b) Certificate of Merger Section 3.2 Certificates Section 3.8(cBuyer Fundamental Representations 8.1(c) Changes Section 1.1 Buyer Indemnified Parties 8.2(a) Buyer MAE Condition 9.1(f) Buyer Obligations 6.11(a) Buyer Parent Governing Documents 4.1 Buyer Permits 4.12(b) Buyer SEC Documents 4.8(a) Cap 8.2(c)(i) Closing Section 3.3 1.4(a) Closing Date Section 3.3 COBRA Section 4.11(d1.4(a) Closing Payment Certificate 1.1(a) Closing Statement 1.5(a) Company Preamble Preamble, 3.20 Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEntity 6.4(b) Company Financial Advisor Section 4.10 Statements 3.6 Company SEC Reports Section 4.7(aFundamental Representations 8.1(b) Company Securities Section 4.2(aMAE Condition 9.1(e) Company Shares Recitals Property 3.11(b) Company Subsidiary 3.4(a) Confidentiality Agreement Section 10.4 Current Company 6.4(a) Consulting Agreement 6.10 D&O Insurance Section 7.8(cTail Policy 6.3 Data Room 5.10 Deductible 8.2(c)(i) Customs Laws Section 4.22(aDispute Notice 11.10(a) Debt Financing Disputes 11.10 EGS 11.21(b) Employment Dispute Section 10.9(a3.17(g) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iEnd Date 9.1(c) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Escrow Account 1.3 Escrow Agent 1.3 Escrow Agreement 1.3 Escrow Amount 1.3 Escrow Property 1.3 Escrow Shares 1.3 Estimated Purchase Price 1.1(b) Exchange Fund Section 3.8(bException Claim 8.5(b) Expiration Time Section 2.1(d)(iExcess Recovery 8.8(f) Existing Company Debt 1.4(b)(iv) Final Escrow Release Date 1.3 Final Purchase Price 1.1(b) Final Resolution Date 1.5(c) Financial Statements Incipio Incipio Merger 3.6 Indemnified Party 8.5(b) Indemnifying Party 8.5(b) Initial Escrow Release Date 1.3 Interim Company Financial Statements 3.6 JAMS 11.10(b) Latest Balance Sheet 3.6 LCM Audited Financial Statements 3.6 LCM Financial Statements 3.6 LCM Interim Financial Statements 3.6 Lease 3.11(b) Leases 3.11(b) Lockup Agreement Section 4.7(b7.1(l) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a3.12(b) Maximum Annual Premium Section 7.8(cMaterial Customer 3.21(a) Merger Material Supplier 3.21(b) Objection Notice 1.5(b) Pending Claims 1.3 Registration Rights Agreement 7.1(m) Releasee 11.20(a) Releasees 11.20(a) SEC 3.7(b) Seller Fundamental Representations 8.1(a) Seller Indemnified Parties 8.3(a) Seller Representative Preamble Seller Representative Fund 11.22(c) Sellers Preamble Settlement Notice 8.5(d) Shares Recitals Merger Consideration Section 3.7(a)(iSigning Buyer SEC Documents Article IV ▇▇▇▇▇ Term Sheet 6.10 Special Claim 8.7(a) Minimum Condition Section 2.1(a)(iSubsidiary Equity Interests 3.4(d) Multiemployer Plan Section 4.11(cTangible Assets 3.9(a) Termination Fee 9.3 Third-Party Claim 8.5(b) Transfer Taxes 6.2(f)
Appears in 1 contract
Additional Definitions. The following Other capitalized terms defined elsewhere in this Agreement and not defined in this Article I shall have the respective meanings ascribed thereto assigned to such terms in this Agreement in the respective sections of this Agreement set forth opposite each of the capitalized terms below: . Term Section Reference Acceptable Confidentiality Agreement Acceptance Time Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.4(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.2(e)(iii) Antiboycott Rules Appraisal Shares Section 4.22(a3.9 Book-Entry Shares Section 3.6(b)(i) Bribery Act Section 4.10(d) Capitalization Time Section 4.2(a) Certificate Section 3.6(b)(i) Chosen Courts Section 9.14 Closing Section 3.4 Closing Date Section 3.4 Code Recitals Company Preamble Company 401(k) Plan Section 6.9(c) Company Adverse Recommendation Change Section 6.2(d) Company Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h2.3(a) Company Financial Advisor Statements Section 4.10 4.6(b) Company Joint Venture Agreement Section 4.3(c) Company Joint Venture Entity Section 4.3(c) Company Joint Venture Securities Section 4.3(c) Company Material Contract Section 4.17(a) Company Owned Real Property Section 4.11(a) Company Plans Section 4.15(a) Company SEC Reports Documents Section 4.7(a4.6(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 6.2(b)(i) Continuing Directors Section 2.4(a) Continuing Employees Section 6.9(a) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.7(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.6(a) EAR Divestitures Section 4.22(a6.5(c) Effective Time Equity Commitment Section 3.2 Enforceability Exceptions 5.4(b) Equity Interests Section 4.4 Environmental Permits 4.2(b) ERISA Affiliate Section 4.15(b4.15(a) Exchange Fund Excluded Shares Section 3.8(b3.6(a) Expenses Section 8.3(c) FCPA Section 4.10(d) Indemnified Parties Section 6.7(a) Independent Directors Section 2.4(b) Initial Expiration Time Date Section 2.1(d)(i2.1(d) Financial Statements Incipio Incipio Merger Agreement Leased Property Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.11(b) Merger Recitals Merger Consideration Section 3.7(a)(i3.6(a) Minimum Condition Merger Effective Time Section 2.1(a)(i3.3 Merger Fund Section 3.8(a) Multiemployer Plan Merger Sub Preamble Money Laundering Laws Section 4.11(c4.10(b) Offer Recitals Offer Commencement Date Section 2.1(a) Offer Conditions Section 2.1(b) Offer Documents Section 2.2(a) Offer Price Recitals Other Anticorruption Laws Section 4.10(d) Outside Date Section 8.1(b)(i) Parent Preamble Paying Agent Section 3.8(a)(i) Real Property Leases Section 4.11(b) Schedule 14D-9 Section 2.3(b) Stockholder List Date Section 2.3(c) Surviving Corporation Section 3.1 Tender and Support Agreement Recitals Termination Fee Section 8.3(a) Voting Company Debt Section 4.2(b)
Appears in 1 contract
Sources: Merger Agreement (Blyth Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iPlan 6.11(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdjusted Restricted Stock 2.8(a) Agreement Preamble Alternative Acquisition Agreement Term Section 6.2(c)(iiReference Antitrust Approval 7.1 Assumed Option 2.8(e) Antiboycott Rules Section 4.22(aAssumed Restricted Stock Unit 2.8(f) Board Recommendation Section 2.2(bBook-Entry Shares 2.9(b) Cancelled Company Shares Section 3.7(a)(ii2.7(b) Capitalization Date 3.4(a) Cash Consideration 2.7(b) Certificate 2.9(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreements 3.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.7(a) Company Board Recommendation Change 6.7(a) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gInsiders 6.14 Company Registered Intellectual Property 3.20(a) Company License-Out Agreements Section 4.16(hRestricted Stock 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholder Meeting 6.6(a) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.3(b) Continuing Employees 6.11(d) D&O Insurance Section 7.8(c6.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3(a) Employee Plans 3.15(a) ERISA Affiliate 3.15(a) Exchange Fund Agent 2.9(a)
(a) Final Surviving Corporation 2.1(b) First Step Merger Recitals Foreign Employees 3.15(j) In-Licenses 3.20(g) Incentives 3.14(o)
(a) Integrated Merger Recitals Interim Surviving Corporation 2.1(a) International Employee Plans 3.15(a) Term Section 3.8(bReference Intervening Event 6.7(b) Expiration Time Section 2.1(d)(iInvestment Company Act 3.11(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIP Licenses 3.20(h) Recitals Recitals Indemnified Persons Section 7.8(aLeased Real Property 3.17 Leases 3.17 Legal Proceeding Matters 6.8(d) Inventions Section 1.1 Material Contract Section 4.18(a3.13(a) Maximum Annual Premium Section 7.8(c6.12(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(b) Minimum Condition Section 2.1(a)(iMerger Proposal 6.6(a) Multiemployer Plan Section 4.11(cMerger Sub One Preamble Merger Sub Two Preamble Option Exchange Program 2.8(b) Option Exchange Proposal 2.8(c) Out-Licenses 3.20(h) Paragon 3.24 Parent Preamble Parent Disclosure Schedule Article IV Parent SEC Reports 4.5(a) Permits 3.11(a) Proxy Statement/Prospectus 6.5(a) Qualifying Amendment 6.5(c) Registration Statement 6.5(a) Regulation M-A Filing 6.5(d) Regulatory Filings 3.11(c) Requisite Merger Approval 3.2(c) Requisite Option Exchange Approval 3.2(c) Restricted Stock Units 2.8(b) Reviewable Transaction 8.1(b) RoHS Directive 1.1(y) Second Step Merger Recitals Specified Company Representations 7.2(a) Specified Parent Representations 7.3(a) Stock Consideration 2.7(b) Subsidiary Securities 3.5(d) Tax Opinions 6.18 Termination Date 8.1(b) Termination Fee Amount 8.3(b) Trade Secrets 1.1(hh) Trademarks 1.1(hh)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2009-2010 PARI R&D Grant 7.3 Accounting Firm 2.10(d) Acquisition Proposal Section 6.2(e)(iAccounting Report 2.10(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAgreed Adjustments 2.10(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppraiser 2.5(c) Antiboycott Rules Section 4.22(aAssumed Claims 2.3(b) Board Recommendation Section 2.2(bAssumed Liability 2.3 Assumed Liabilities 2.3 Business Financial Statements 3.5 Buyer Preamble Buying Entity 2.5(c) Cancelled Company Shares Section 3.7(a)(iiBuying Entities 2.5(c) Certificate of Merger Section 3.2 Certificates Section 3.8(cBuyer Indemnified Parties 11.1 Cash Portion 2.5(a) Changes Section 1.1 Closing Section 3.3 2.8(a) Closing Date Section 3.3 COBRA Section 4.11(d2.8(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Collective Bargaining Agreements Section 4.16(g3.14(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c6.4(a) Customs Laws Section 4.22(aConsent 3.3(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iNotice 2.10(b) EAR Section 4.22(a3.8(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.8(c) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iEscrow Agreement Recitals Excluded Asset 2.2 Excluded Assets 2.2 Excluded Liabilities 2.4 Excluded Liability 2.4 FAR 3.20(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSchedules Date 2.1(a) Recitals Recitals Incentives 3.12(n) Indemnified Persons Section 7.8(aParties 11.2 Indemnity Basket 11.3(b) Inventions Section 1.1 In-Licenses 3.18(h) IP-Licenses 3.18(i) ITAR 3.8(a) Leased Real Property 3.15(b) Leases 3.15(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(cMaterial In-Licenses 3.18(h) Merger Material IP-Licenses 3.18(i) Material Out-Licenses 3.18(i) Montreal Business 1.1(d) Montreal Business Financial Statements 3.5 Montreal Interim Financial Statements 3.5 Non-Assignable Asset 2.9(a) Out-Licenses 3.18(i) Potentially Insured Claims 11.5 Pre-Closing Taxes 8.1(a) Pre Closing Tax Period 8.1(a) Preliminary Purchase Price Allocation 2.5(c) Purchase Price 2.5(a) Related Agreements Recitals Merger Consideration Section 3.7(a)(iSalem Leased Property 6.8 Seller Preamble Seller Disclosure Schedule Article III Seller Inventory 3.24(a) Minimum Condition Section 2.1(a)(iSeller Licensee 3.18(b) Multiemployer Plan Section 4.11(c)Seller Registered Intellectual Property 3.18(a) Selling Entities 2.5(c) Selling Entity 2.5(c) Seller Indemnified Parties 11.2 SOF Business 1.1(d) SOF Business Financial Statements 3.5 SOF Interim Financial Statements 3.5 Straddle Period 8.1(a) Termination Date 10.1(b) Third Party Insurance 11.5 Transfer Taxes 2.6 Transferred Asset 2.1 Transferred Assets 2.1 Transferred Claims 2.1(e) Transferred Contracts 2.1(c) Transferred Intellectual Property 2.1(b) Transferred Permits 2.1(d) Transferred Tangible Property 2.1(a) Transition Services Agreement Recitals Visible Lasers 6.11
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisors 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAnti-Corruption Laws 3.26(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 9.4 Converted Cash Award 2.8(a)(ii) Consent 3.6 Continuation Period 6.11(b) Copyrights 1.1(vv) Current Company Offering Period 2.9 D&O Insurance Section 7.8(c6.10(c) Customs Data Protection Laws Section 4.22(a1.1(cc) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDPA 3.26(g) DTC 2.10(d) DTC Payment 2.10(d) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(cc) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iGDPR 1.1(cc)
(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(vv) Material Contract Section 4.18(aRelationships 1.1(zz)(iv) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(d)(ii)(2) Old Plans 6.11(c) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(vv) Payment Agent 2.10(a) Payoff Letters 6.22 Per Share Price 2.7(a)(ii) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Reimbursement Obligations 6.6(f) Reinvestment Stockholders Recitals Repaid Indebtedness 6.22 Representatives 5.3(a) Requisite Stockholder Approval 3.4 Rollover Shares Recitals Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Support Agreements Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Unvested Company Option 2.8(a)(ii) Unvested Company RSU 2.8(b)(ii) Vested Company Option 2.8(a)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Section 2.1(a)(iVested Company RSU 2.8(b)(i) Multiemployer Plan Section 4.11(cVested Company RSU Consideration 2.8(b)(i)
Appears in 1 contract
Sources: Merger Agreement (EngageSmart, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAssumed Company Option 2.8(c)(i) Board Recommendation Section 2.2(bAssumed Company Stock-Based Award 2.8(c)(ii) Base Indenture 1.1(ppp) Book-Entry Shares 2.9(b) Burdensome Condition 6.2(b) Bylaws 3.1 Cancelled Owned Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(b) Changes Section 1.1 Charter 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.4(a) Company License-Out Agreements Section 4.16(hEmployee 3.18(i) Company Financial Advisor Section 4.10 Plans 6.9(b) Company Recent SEC Reports Article III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.9(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Term Section Reference Dissenting Company Shares Section 3.7(c)(i2.7(b)(i) EAR Section 4.22(aEffect 1.1(o) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.12 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Fund Section 3.8(b2.9(a) Expiration Time Section 2.1(d)(iFinCEN 3.21(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFirst Supplemental Indenture 1.1(ooo) Recitals Recitals Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 Material Contract Section 4.18(aIndenture 1.1(ppp) Initial Termination Date 8.1(c) Injunction 8.1(b) International Employee Plan 3.18(a) Lease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.8(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plans 6.9(c) Minimum Condition Section 2.1(a)(iNotice Period 5.3(d)(ii)(3) Multiemployer OFAC 3.21(c) Old Plans 6.9(c) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter 1.4(b) Parent Qualified Plan Section 4.11(c6.9(d) Parent Recent SEC Reports Article IV Parent Termination Fee 8.3(c)(i) Party Preamble Paying Agent 2.9(a) Payoff Letter 6.16(d) Permits 3.20 Proxy Statement 6.3(a) Representatives 5.3(a) Repurchase Transaction 6.16(c) Repurchase Transaction Notice 6.16(c) Requisite Stockholder Approval 3.4 Revolving Credit Facility Termination 6.16(d) Sanctioned Countries 3.21(c) Sanctioned Person 3.21(c) Sanctions 3.21(c) Second Supplemental Indenture 1.1(ppp) ▇▇▇▇ ▇▇▇▇▇▇▇ Reference Sublease 3.14(c) Surrendered Company Stock-Based Award 2.8(a) Surviving Corporation 2.1 Tax Returns 3.17(a)(i) Termination Date 8.1(c)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Anti-Corruption Laws Section Reference Acceptable 3.19(b) Articles of Merger Section 1.1 ▇▇▇▇▇ Option Section 4.5(a)(iv) Book-Entry Shares Section 2.3(c) Canaccord Section 4.2(b) Certificates Section 2.3(c) Closing Date Section 2.1 Code Recitals Common Stock Consideration Section 1.4(b)(i) Confidentiality Agreement Section 6.2(e)(iii7.5(h) Acquisition Proposal Continuing Employee Section 6.2(e)(i7.7(a) Acquisition Sub Preamble Adverse Recommendation Change Continuing Employees Section 6.2(c)(i7.7(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Policy Section 7.8(c) Customs Laws DGCL Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) 3.23 EAR Section 4.22(a3.19(c)(i) ECCNs Section 3.19(c)(ii) Effective Time Section 3.2 Enforceability Exceptions 1.1 Employment Agreements Recitals Exchange Agent Section 4.4 Environmental Permits Section 4.15(b2.3(a) Exchange Fund Section 3.8(b2.3(b)(i) Expiration Time Exchange Ratio Section 2.1(d)(i1.4(b)(i) Financial Statements Incipio Incipio Merger Agreement Export Controls Section 4.7(b3.19(c)(i) Recitals Recitals FCPA Section 3.19(b) Import Restrictions Section 3.19(c)(i) Indemnified Persons Parties Section 7.8(a) Inventions ITAR Section 1.1 Material Contract 3.19(c)(i) Joint Proxy Statement/Prospectus Section 4.18(a7.3(a) Malicious Code Section 3.13(m) Maximum Annual Premium Section 7.8(c) MBCA Recitals Merger Recitals Merger Consideration Shareholder Meetings Section 3.7(a)(i7.4(a) Minimum Condition Merger Sub Preamble OFAC Section 2.1(a)(i3.19(c)(i) Multiemployer Plan Qumu Preamble Qumu Board Section 4.11(c3.2(b) Qumu Board Recommendation Section 7.4(e) Qumu Board Recommendation Change Section 7.4(f) Qumu Capitalization Representations Section 2.2(b)(ii)(B) Qumu Designee Section 8.1(a) Qumu Disclosure Letter Article III Qumu Fundamental Representations Section 2.2(b)(ii)(A)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Anti-Corruption Laws 2.17 Canceled Company Shares Section 3.7(a)(ii1.7(a)(ii) Capitalization Date 2.4(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chosen Courts 8.9 Closing Section 3.3 1.3 Closing Date Section 3.3 1.3 COBRA Section 4.11(d2.15(d) Company Preamble Company Common Stock Recitals Balance Sheet Date 2.6 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 5.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 5.1(b) Company Financial Advisor Section 4.10 Advisors 2.19 Company Financial Statements 2.5(b) Company Plans 5.9(c) Company SEC Reports Section 4.7(a2.5(a) Company Securities Section 4.2(a2.4(a) Company Share Recitals Company Shares Recitals Confidentiality Agreement Section 10.4 Company Stockholder Meeting 5.2(a) Competing Acquisition Transaction 7.3(b) Current Company D&O Insurance Section 7.8(c5.5(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a2.24(d) DGCL Recitals Disclosure Schedule Article II Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(b)(i) Effective Time Section 3.2 1.2 Enforceability Exceptions Section 4.4 2.2(a) Environmental Permits Section 4.15(b) Authorizations 2.11 Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iExon-▇▇▇▇▇▇ 2.3 Export Control Laws 2.24(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a5.5(a) Inventions Section 1.1 Interim Period 4.1 Joint Notice 2.3 Material Contract Section 4.18(a2.14(a) Maximum Annual Premium Section 7.8(c5.5(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble New Plans 5.9(c) NOLs 2.10(j) Notice of Intended Recommendation Change 5.1(c) Old Plans 5.10(c) Option Consideration 1.7(c) Parent Preamble Table of Contents Term Section 3.7(a)(iReference Parent 125 Plan 5.9(d) Minimum Condition Section 2.1(a)(iPayment Agent 1.8(a) Multiemployer Plan Section 4.11(c)Plans 2.15(a) Proxy Statement 5.2(a) Real Property Leases 2.12(b) Regulatory Filings 5.4(a) Representatives 4.3(a) Required Vote 2.21 Restraint 6.1(c) RSU Consideration 1.7(d) Surviving Corporation 1.1 Termination Date 7.1(b) Termination Fee 7.3(b) Trade Control Laws 2.24(b) Support Agreement Recitals Uncertificated Shares 1.8(c) Willful and Material Breach 7.2
Appears in 1 contract
Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Adjournment Proposal Section 6.2(e)(i5.2(e) Acquisition Sub Preamble Adverse Recommendation Change Advance Section 6.2(c)(i) 5.15 Agreement Preamble Alternative Acquisition Agreement Antitrust Laws Section 6.2(c)(ii5.5(a) Antiboycott Rules Antitrust Matters Section 4.22(a5.5(b) Board Recommendation Assets Section 2.2(b3.18 Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consideration Fund Section 2.10(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Debt Financing Dispute Current Restricted Share Section 10.9(a2.11(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) Equity Commitment Section 4.15(b4.6 Equity Funding Section 4.6 Equity Investor Recitals ERISA Affiliate Section 3.15(a) Exchange Fund ESPP Section 3.8(b3.4(c) Expiration Time Expense Cap Section 2.1(d)(i7.3(c) Financial Statements Incipio Incipio Merger Agreement Identified Company Representations Section 4.7(b6.2(a)(i) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b) Leases Section 3.17(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Permits Section 3.11(a) Paying Agent Section 2.10(a) Prior Agreement Recitals Proxy Statement Section 5.2(a) Qualifying Amendment Section 5.2(c) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22 ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act Section 3.6 Surviving Corporation Recitals Transferred Employees Section 5.7(a)
Appears in 1 contract
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Acquiror Definition of ‘Change of Control’ in ARTICLE I Act Section Reference Acceptable 5.6.1 Agreement Preamble Auditor Section 4.7.2 Bankruptcy Code Section 3.3.1 BPCIA Section 5.6.2 Change of Control ARTICLE I Claims Section 8.1 Competing Infringing Activities Section 5.5 [*] Section [*] Confidential Information Section 6.1 Development and Regulatory Milestone Payment Section 4.2 Development and Regulatory Milestone Payments Section 4.2 Disclosing Party Section 6.1 [*] Section [*] Effective Date Preamble Existing Confidentiality Agreement Section 6.2(e)(iii6.1(e) Acquisition Proposal Future IP Section 6.2(e)(i5.1.2 Indemnified Party Section 8.3.1 Indemnifying Party Section 8.3.1 Inventory Section 7.2(m) Acquisition Sub Losses Section 8.1 Novartis Preamble Adverse Recommendation Change Novartis Indemnitees Section 6.2(c)(i8.2 Novartis Patents Section 5.1.2 Novartis Product Section 9.4.4(b) Parties Preamble Party Preamble Payment Breach Section 9.2 Phase I/II Definition of ‘Phase II Clinical Trial’ in ARTICLE I Phase II Definition of ‘Phase II Clinical Trial’ in ARTICLE I [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Phase III Definition of ‘Phase III Clinical Trial’ in ARTICLE I pivotal Definition of ‘Phase III Clinical Trial’ in ARTICLE I Process Section 2.5.2 Product Marks Section 5.8 [*] Section [*] Receiving party Section 6.1 [*] Section [*] Rights Definition of ‘Control’ in ARTICLE I Royalty Term Section 4.3.2(a) Sales & Royalty Report Section 4.4.2 Selling Party Definition of ‘Net Sales’ in ARTICLE I Servier Definition of ‘Servier Loan’ in ARTICLE I Servier Liens Section 4.1.1(a) Servier Loan Agreement Preamble Alternative Acquisition Agreement Definition of ‘Servier Loan’ in ARTICLE I Servier Loan Repayment Section 6.2(c)(ii4.1.1(a) Antiboycott Rules Servier Payoff Estimated Amount Section 4.22(a4.1.1(a) Board Recommendation [*] Section 2.2(b) Cancelled Company Shares [*] Term Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs 9.1 Trade Control Laws Section 4.22(a) Debt Financing Dispute 11.7 XOMA Preamble XOMA Indemnitees Section 10.9(a) DGCL Recitals Dissenting Company Shares 8.1 [*] Section 3.7(c)(i) EAR [*] [*] Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)[*]
Appears in 1 contract
Sources: License Agreement (XOMA Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(e) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii7.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 8.3(c) Board Recommendation Section 2.2(bAlternative Debt Financing Agreements 8.3(c) Cancelled Alternative Debt Financing Commitment 8.3(c) Annual Bonus 8.9(b) Annual Bonus Payment Date 8.9(b) Buyer Parties Preamble Bylaws 5.1 Capitalization Date 5.6(a) Cash Replacement Amount 3.5(c)(ii) Cash Replacement Option Amount 3.5(c)(ii) Cash Replacement Company Shares Section 3.7(a)(iiRSA Amount 3.5(b)(ii) Cash Replacement Company RSU Amount 3.5(a)(ii) Centerview 5.3(b) Certificate of Merger Section 3.2 3.1(c) Certificates Section 3.8(c3.3(a) Changes Section 1.1 Charter 5.1 Chosen Courts 11.10(a) Closing Section 3.3 3.1(b) Closing Date Section 3.3 COBRA Section 4.11(d3.1(b) Collective Bargaining Agreement 5.18(a) Company Preamble Company 401(k) Plan 8.9(d) Company Board Recommendation 5.3(a) Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Section 4.16(gEquity Awards 5.6(b) Company License-Out Agreements Section 4.16(hOption Consideration 3.5(c)(i) Company Financial Advisor Section 4.10 PSA Consideration 3.5(d) Company PSU Consideration 3.5(e) Company Related Parties 10.3(f) Company RSA Consideration 3.3(b) Company RSU Consideration 3.5(a)(i) Company SEC Reports Section 4.7(a) 5.8 Company Securities Section 4.2(a5.6(c) Company Shares Recitals Compensation Continuation Period 8.9(a) Confidentiality Agreement Section 10.4 11.4 Consent 5.5 Consideration Fund 3.3(a) Continuation Period 8.9(a) Current Company D&O Insurance Section 7.8(c8.8(b) Customs Laws Section 4.22(aDebt Fee Letter 6.11(a) Debt Financing Dispute Section 10.9(a6.11(a) Debt Financing Commitment 6.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.4 Dollars 1.3(e) Effective Time Section 3.2 3.1(c) Electronic Delivery 11.13 Employee Plan 5.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 5.2 Equity Award Consideration 3.5(e) Exchange Fund Section 3.8(bEquity Commitment Letter Recitals Equity Financing 6.11(a) Excluded Shares 2.1(a) Expiration Time Section 2.1(d)(i2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Purchase Period 3.5(f) Financing 6.11(a) Financing Commitments 6.11(a) FDA 5.23(a) FDA Act 5.22(a) Guarantee Recitals Guarantor Recitals Indemnified Person Insured Persons Section 7.8(a8.8(a) Inventions Section 1.1 Material Contract Section 4.18(a8.8(b) Inside Date 3.1(b) Intervening Event 7.3(d)(i) Investors Recitals Lease 5.13(b) Leased Real Property 5.13(b) Maximum Annual Premium Section 7.8(cAmount 8.8(b) Merger Recitals Merger Consideration Section 3.7(a)(i3.2(a) Minimum Condition Section 2.1(a)(iMerger Sub Merger Sub Stockholder Approval Preamble Preamble New Plan 8.9(c) Multiemployer Notice Period 7.3(d)(ii)(2) Offer Recitals Offer Conditions 2.1(a) Offer Commencement Date 2.1(a) Offer Documents 2.1(f) Offer Price Recitals Outside Date 10.1(c) Parent Preamble Parent 401(k) Plan Section 4.11(c8.9(d) Party Preamble Paying Agent 3.3(a) Payoff Letters 8.16 Permits 5.19 Prohibited Modifications 8.3(a) Recommendation Change 7.3(c)(i) Reimbursement Obligations 8.4(f) Related Party Transaction 5.25 Repaid Indebtedness 8.16 Representatives 7.3(a) Required Amount 6.11(c) Schedule 14D-9 2.1(f) Schedule TO 2.1(f) Share Recitals Stockholder List Date 2.2(a) Surviving Corporation Recitals Takeover Statute 5.3(c) Tax Proceeding 5.16(c)
Appears in 1 contract
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: [***] Section 1.1 ([***] definition) [***] Section 6.5.4(a) [***] Section 6.5.4(b) Act Section 1.1 (Change of Control definition) Alliance Manager Section 3.6.8 Agreement Preamble Audited Party Section 6.13(e) Auditing Party Section 6.13(e) Baseline Net Sales Section 6.5.4(a) Breaching Party Section 12.3 CF Background Co-Development Election Section 3.2.6(f) Co-Development Percentage Section 3.2.6(g) Confidential Information Section 8.1 COPD Background COPD Co-Development Election Section 3.2.6(c) COPD Pre-Option Costs Section 3.2.6(d) Development Plan Section 3.2.1 Development Reconciliation Payment Section 6.13(d) Development Reconciliation Report Section 6.13(d) Development Report Section 6.13(b) Dollars Section 6.8 Effective Date Preamble Enforcement Action Section 7.4 Event Notice Section 12.4 Exercise Notice Section 5.1.1 Existing Patents Section 9.2.2 HS Exhibit E Indemnify Section 10.1 Infringing Product Section 7.4 Inventor Personnel Section 9.2.11 Joint Commercialization Agreement Section 5.2.2 Joint Inventions Section 7.1.2 JSC Section 3.6.1 Losses Section 10.1 ActiveUS 144208420v.18 NCFB Background NCFB Co-Development Election Section 3.2.6(b) NCFB Development Termination Notice Section 3.2.6(d) Non-Breaching Party Section 12.3 Northern Trial Section 3.2.3(a) Option Section 2.8.2 Option Compound Section 2.8.2 Option Fee Section 6.2 Option Notice Section 2.8.2 Option Period Section 2.8.2 Option Compound Licensed Product Section 6.4.1(d) Orange Book and Equivalents Section 7.8 Outside Scope Claims Section 7.2.3 P-1055 Development Notice Section 3.2.6(a) P-1055 Lead Compound Section 3.2.6(a) P-1055 Lead Compound Licensed Product Section 3.2.6(a) Parion Preamble Parion COPD Opt-in Section 3.2.6(e) Parion Indemnitees Section 10.2 Parion Inventions Section 7.1.1 Party Preamble Patent Term Extensions Section 7.2.5 PCD Background Product Trademarks Section 7.9 Profit/Loss-Sharing Option Section 5.1.1 Prosecution and Maintenance Section 7.2.4 Safety Data Exchange Agreement Section 4.5 Second Compound Licensed Product Section 6.4.1(c) Selection Period Section 2.7.1 Shared Development Cost Section 3.2.6(g) Shared Product Section 5.2.1 Southern Trial Section 3.2.3(b) Subcommittee Section 3.6.9 Supplemental Royalty Rate Section 6.5.1(b) Term Section Reference Acceptable Confidentiality Agreement 12.1 Third-Party Claim Section 6.2(e)(iii) Acquisition Proposal 10.1 Third-Party Infringement Claim Section 6.2(e)(i) Acquisition Sub 7.3.1 Vertex Preamble Adverse Recommendation Change Vertex Indemnitees Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) 10.1 Vertex Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)7.1.3 Vertex UK Preamble
Appears in 1 contract
Sources: Strategic Collaboration and License Agreement (Vertex Pharmaceuticals Inc / Ma)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference 2.8(d)(i) Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Approval Section 4.22(a3.5 Assignee Section 10.3 Capitalization Date Section 3.6(a) Board Recommendation Cash Bonus Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii2.7(c)(i) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.18(b) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Shares Section 2.8(b) Company 102 Options Section 2.8(d)(i) Company Board Recommendation Section 5.3(a) Company Disclosure Letter Article IV III Company License-In Agreements Products Section 4.16(g3.15(b) Company License-Out Agreements Registered Intellectual Property Section 4.16(h3.15(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shares Recitals Section 2.7(a)(i) Company Shareholders Meeting Section 7.3(a) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 7.8 Contractors Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.18(g) Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.17(a) ERISA Affiliate Section 4.15(b3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.22(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Recitals Recitals Indemnified Persons Funded Employee Plan Section 7.8(a3.17(i) ICL Preamble IPL Section 3.15(g) Information Agent Section 2.8(a) Inventions Section 1.1 Israeli Employees Section 3.18(i) Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Preamble Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notice Section 2.1(a)(i2.3 Merger Proposal Section 7.4(a) Multiemployer Plan Merger Sub Preamble OECD Convention Section 4.11(c3.22(a) Option Consideration Section 2.7(c) Outside Date Section 9.1(c) Panoptes Section 3.7(g) Parent Preamble Paying Agent Section 2.8(a) Paying Agent Agreement Section 2.8(a) Payor Section 2.8(f) Permits Section 3.19 Principal Company Shareholders Preamble Prohibited Payment Section 3.22(a) Proxy Statement Section 7.3(a) R&D Sponsor Section 3.15(i) Related Party Section 3.26 Representatives Section 1.1 Requisite Shareholder Approval Section 3.3(b) Section ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ 3.16(ee) Section 14 Arrangement Section 3.18(a) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Tax Returns Section 3.16(a) Termination Fee Section 9.3(b) Trademarks Section 1.1 Uncertificated Shares Section 2.8(c) Underwater Option Section 2.7(c)(i) Valid Certificate Section 2.8(f) Voting Agreement Preamble WARN Section 3.18(c) Works of Authorship Section 1.1 Withholding Drop Date Section 2.8(f) Withholding Tax Ruling Section 7.9(a)(i)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aArrangements 4.17(n) Board Recommendation Section 2.2(bAssets 4.14(a) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gPlan 7.11(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Continuing Directors 2.3(a) Covered Securityholders 4.17(n) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iFunded International Employee Plan 4.17(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Inventions Section 1.1 International Employee Plans 4.17(a) Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i2.1(b)(i) Multiemployer Plan Section 4.11(cNew Plans 7.11(d)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdvisors 3.3(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Consideration 3.7(e) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Articles of Merger 2.2 Audited Financial Statements 3.10(a) Audited Financials Date 3.10(a) Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company Shares Section Restricted Stock Amount 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) OTC Reports 3.9 Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRelated Parties 8.3(f)(i) Company Securities Section 4.2(a3.7(c) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cAgreements 9.4 Consent 3.6 Copyrights 1.1(vv) Customs Laws Section 4.22(aCovered Persons 6.9(a) COVID-19 1.1(x)(xi) COVID-19 Measures 1.1(x)(xi) Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(x) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Event Notice Period 5.4(d)(i)(B)(2)(I) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) FCC 3.6 FCC Consent 3.6 FCC Filings 3.6 Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Financing 4.11(b) Financing Conditions 4.11(c) Financing Letters 4.11(b) Guarantor(s) Recitals Guaranty(ies) Recitals Indemnified Persons Section 7.8(aInjunction 8.1(b) Inventions Section 1.1 Material Contract Section 4.18(aInterim Period 5.1 Intervening Event 5.4(d)(i) KBCA Recitals Kentucky PSC Notification 3.6 Latest Financial Statements 3.10(a) Latest Financials Date 3.10(a) Lease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.9(c) Marks 1.1(vv) Material Customers 1.1(bbb)(ii)(A) Material Vendors 1.1(bbb)(ii)(B) Merger Recitals Merger Sub Preamble Open Source Software 1.1(ccc) Organizational Documents 3.1 OTCQX Disclosure Guidelines 3.9 OTC Market 6.18 OTC Rules 3.9 Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party(ies) Preamble Patents 1.1(vv) Payment Agent 2.9(a) Per Share Price 2.7(a)(ii) Permits 3.20 Privacy Requirements 3.16(h) Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.4(d)(ii)(3) Protected Information 3.16(h) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(b) Relinquishment Applications 3.6 Representatives 5.4(a) Required Amounts 4.11(f) Requisite Shareholder Approval 3.4 RSA Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Section 2.1(a)(iSecurity Incident 3.16(h) Multiemployer Plan Section 4.11(cSpecified Acquisition 5.3 Support Agreements Recitals Surviving Corporation. 2.1 Tax Proceeding 3.17(c) Termination Date 8.1(c) Trade Control Laws 3.26(a)(i) Uncertificated Shares 2.9(c) Vested Shares 2.8(a)(i)
Appears in 1 contract
Sources: Merger Agreement
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a) Company Shares Recitals Stockholder Meeting 6.4(a) Company Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a9.4 Consent 3.6 Copyrights 1.1(hh) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Equity Commitment Letters 4.11(a) Equity Financing 4.11(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExport Control Laws 3.26(a)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranties Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(hh) Material Contract Section 4.18(aCustomers 1.1(mm)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(d)(ii)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(hh) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Termination Date 8.1(c)
Appears in 1 contract
Sources: Merger Agreement (Cvent Inc)
Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION [***] Loss of Market Exclusivity Section 1.1 –Loss of Market Exclusivity definition [***] or More Loss of Market Exclusivity Section 1.1 – Loss of Market Exclusivity definition 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Acquirer Program Section 8.6(b)(v)(C) Additional Amounts Section 1.1 – Control definition Adjusted Deferred Loss Exhibit E Agreement Preamble Alliance Manager Section 2.1(d) Allocable Overhead Exhibit E Audit Rights Holder Section 9.8(e) Audit Team Section 9.8(a) Auditee Section 9.8(e) Bankruptcy Code Section 8.8 BeiGene Preamble BeiGene Cayman Preamble BeiGene Switzerland Preamble BeiGene Indemnified Parties Section 13.2 BioAtla Preamble BioAtla Indemnified Parties Section 13.1 BeiGene Territory Royalty Rate Section 9.5(b) Capital Account Exhibit F CFIUS 12.2 CFIUS Clearance 12.4 DEFINITION SECTION Challenge Section 14.3(e) Challenging Party Section 14.3(e) Claim Section 13.1 Clinical Combination Activities 8.6(c) Co-Development Opt-Out Section 3.6(a) Co-Development Opt-Out Date 3.6(a) Co-Development Opt-Out Notice Section 3.6(a) Co-Development Opt-Out Notice Period Section 3.6(a) Co-Development Percentage Section 9.2(a) Combination Product Section 1.1—Net Sales Definition Combination Trial 8.1(c) Combination Regimen Section 1.1- Net Sales definition Commercialization Budget Section 6.2(c) Commercialization Costs Exhibit E Commercialization Plan Section 6.2(a) Committee Section 2.1(a) Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit E CPI Section 1.1—FTE Rate definition Cure Period Section 14.3(c)(i) Deferred Loss Exhibit E Deferred Loss Notice Exhibit E Development Budget Section 3.1(a)(i) Disclosing Party Section 11.1 Dispute Section 15.1 Distribution Costs Exhibit E Earlier Patent Section 10.7 Effective Date Preamble Electronic Delivery Section 15.17 Exclusivity Period Section 8.6(a) Existing Regulatory Materials Section 12.2(p) Ex-US ROW Agreement 15.19(a) Ex-US ROW Partnership 15.19(b) force majeure event Section 15.8 Global Safety Database Section 5.3 ICC Section 15.2 Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.9(b)(iii) DEFINITION SECTION Interest Rate Exhibit E Initial Enforcement Party Section 10.3(b) JCC Section 2.1(a) JDC Section 2.1(f) JRC Section 2.1(a) JSC Section 2.1(a) K-1 Exhibit F Licensed Branding Section 6.5(c) Licensing Party Section 8.5(c) Manufacturing Costs Exhibit E Manufacturing Plan Section 4.2 Marketing Costs Exhibit E Material Breach Section 14.3(c)(i) Negotiating Party Section 8.6(b)(v)(A) Negotiation Period Section 8.6(b)(v)(A) Non-Paying Party 9.9(b)(i) Offering Party Section 8.6(b)(v)(A) Operating Profits or Losses Exhibit E Other Operating Income/Expense Exhibit E Other Product Section 1.1—Net Sales definition Parent Entity Section 1.1—Change of Control definition Partners Exhibit F Partnership Exhibit F Partnership Representative Exhibit F Party or Parties Preamble Patent Coordinator Section 2.1(a) Patent Prosecution Expenses Section 10.2(c) Paying Party Section 9.9(b)(i) Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit E Product Recall Expenses Exhibit E Product Trademarks Section 6.5(a) Prosecuting Party Section 10.2(d)(ii) Pursuing Party Section 14.3(e) Recipient Party 9.9(b)(i) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Expenses Exhibit E Regulatory Interactions Section 5.1(b) Replacement Agreement 15.19(b) Report Exhibit E Requesting Party Section 11.3(b)(iii) DEFINITION SECTION ROFN Candidate Section 8.6(b)(v)(A) ROFN Notice Section 8.6(b)(v)(A) ROW Product Revenue Exhibit E ROW Profit & Loss Share Exhibit E Royalty Rate Section 9.5(a) Royalty Term Section Reference Acceptable Confidentiality 9.5(b) Rules Section 15.2 Sales Costs Exhibit E Sales Milestone Events Section 9.3(b) SEC Section 11.3(b)(i) Segregation Activities Section 8.6(b)(v)(C)
1.1 Net Sales definition Single Price Combination Regimen Section 1.1—Net Sales definition Step-In Enforcement Party Section 10.3(c) Sublicense Revenues Exhibit E Term Section 14.1 Third Party Agreement Section 6.2(e)(iii9.6(b) Acquisition Proposal Third Party Contractors Section 6.2(e)(i8.2(a)(ii) Acquisition Sub Preamble Adverse Recommendation Change Third Party Infringement Section 6.2(c)(i10.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Third Party Infringement Action Section 10.4 Current Company D&O Insurance Third Party Products Liability Action Section 7.8(c13.5(a) Customs Laws Working Group Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.1(c)
Appears in 1 contract
Sources: Global Co Development and Collaboration Agreement (BioAtla, Inc.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAML 6.2(a) Antiboycott Rules Section 4.22(aAssets 3.14 Assumed Options 2.7(d)(i) Board Recommendation Section 2.2(bBalance Sheet Date 3.10(a) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Company Preamble Company Common Stock Recitals Acquisition Agreement 5.2(a) Company Board Recommendation 3.1(b) Company Disclosure Letter Article IV Art. III Company License-In Agreements Section 4.16(gFinancial Statements 3.9(a) Company License-Out Intellectual Property Agreements Section 4.16(h3.15(b) Company Financial Advisor Section 4.10 Rights Plan Recitals Company SEC Reports Section 4.7(a3.8 Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 5.4 Consent 3.4 D&O Insurance Section 7.8(c6.7(c) Customs Laws Section 4.22(aDeferred Compensation Plan 2.7(e)(v) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.2 Designated Open Source 3.15(k) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 2.7(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(i)(ii) Recitals Recitals ▇▇▇▇▇▇▇▇ ▇▇▇ 3.5 Hangzhou Queenhive 3.5 Incentives 3.16(n) Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 International Employee Plans 3.17(a) Intervening Event 5.3(a)(ii) Leased Real Property 3.13(b) Leases 3.13(b) Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Section 7.8(c6.7(c) Merger Recitals 2.1 Merger Sub Preamble Option Consideration Section 3.7(a)(i2.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filings 3.29 Out of the Money Options 2.7(d)(i) Multiemployer Owned Company Common Stock 2.7(a)(ii) Owned Real Property 3.13(a) Parent Preamble Parent Stock 2.7(d)(i) Parent’s 401(k) Plan Section 4.11(c2.7(e)(iv)
(a) Per Share Price 2.7(a)(i) Permits 3.19 Proxy Statement 3.29 Public Grants 3.30 Recommendation Change 5.3(a) Representatives 5.2(a) Requisite Stockholder Approval 3.2
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality 2.8(d)(i) Alternative Transaction Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement Approval Section 6.2(c)(ii3.4 Capitalization Date Section 3.5(a) Antiboycott Rules Cash Award Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii2.7(c)(ii) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.2 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Closing Option Consideration Section 4.11(d2.7(c)(i) Closing RSUs Consideration Section 2.7(c)(i) Closing Warrant Consideration Section 2.7(c)(i) Code Section 2.13(a) Collective Bargaining Agreement Section 3.16(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company ▇▇▇ ▇▇▇▇ Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(a) Company Cure Period Section 9.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Nominee Section 4.16(g7.3(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.5(b) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current 2.7(a)(i) Company Subsidiaries Section 3.6(a) Continuing Employees Section 6.2(a) control Section 1.1 controlled by Section 1.1 under common control with Section 1.1 D&O Insurance Section 7.8(c6.1(c) Customs Laws Divestiture Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a7.2(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Exchange Fund Section 3.8(b2.8(b) Expiration Time Excluded Employee Plan Section 2.1(d)(i6.2(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.7(c) Recitals ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Inventions Information Agent Section 1.1 2.8(a) Interim Option Tax Ruling Section 7.7(a) Investments Law Section 3.14(p) ITA Section 2.13(a) Lease Section 3.11(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.10(a) Material Contracts Section 3.10(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notification Section 2.1(a)(i7.2(a) Multiemployer Merger Proposal Section 7.4(a) Merger Sub Preamble Options Tax Ruling Section 7.7(a) Outside Date Section 9.1(c) Parent Preamble Parent Cure Period Section 9.1(g) Parent Retention Plan Section 4.11(c6.4 Payor Section 2.13(a) Permits Section 3.17(a) Proxy Statement Section 7.3(a) R&D Sponsor Section 3.13(g) Recommendation Change Notice Section 5.3(b) Restricted Actions Section 7.3(b) Rothschild Section 3.22 Subsequent Option Consideration Section 2.7(c)(ii) Subsequent RSU Consideration Section 2.7(c)(ii) Surviving Company Section 2.1 Tax Returns Section 3.14(a) Termination Fee Section 9.3(b) Transaction Expenses Amount Section 3.26 Uncertificated Shares Section 2.8(c) VAT Section 3.14(q) Vesting Date Section 2.7(c)(ii) willful breach Section 9.2 Withholding Drop Date Section 2.13(b) Withholding Tax Ruling Section 7.7(b)
Appears in 1 contract
Sources: Merger Agreement (Frutarom LTD)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRegulatory Effects 8.2 (c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 8.8 Assets 4.15 Book-Entry Share 3.10 (b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.5 (a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.10 (b) Changes Section 1.1 ▇▇▇▇ ▇▇▇▇▇▇▇ Reference Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18 (e)(i) Company Preamble Company Acquisition Agreement 6.2 (b) Company Adverse Recommendation Change 6.2 (e) Company Board Recitals Company Board Recommendation 2.1 Company Common Stock Recitals Company Compensation Committee 8.8 Company Disclosure Letter Article IV Preamble Company License-In Agreements Section 4.16(gEquity Awards 4.5 (b) Company License-Out Agreements Section 4.16(hReserve Reports 4.16 (a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.7 (a) Company Securities Section 4.2(a4.5 (d) Company Shares Recitals Stockholder Meeting 8.3 (c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c8.7 Consent 4.4 Continuing Directors 2.3 (a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Covered Securityholders 8.8 Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.8 (a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEligible Shares 3.7(a)(ii) Employee Plan 4.19 (a) Employment Compensation Arrangement 8.8 ERISA Affiliate 4.19 (a) Exchange Fund Section 3.8(b3.10 (a) Expiration Time Section 2.1(d)(iDate 2.1 (e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFairness Opinion 4.26 Grant Date 4.19 (q) Recitals Recitals HSR Condition Annex A Indemnified Persons Section 7.8(aParty 7.1 (a) Inventions Section 1.1 Indemnifying Parties 7.1 (b) Leased Real Property 4.14 (b) Leases 4.14 (b) Material Contract Section 4.18(a4.13 (a) Maximum Annual Premium Section 7.8(c7.1 (c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a)(ii) Merger Sub Preamble Minimum Condition 2.1 (b) New Plans 7.2 (e) Offer Recitals Offer Conditions 2.1 (b) Term Section 2.1(a)(iReference Offer Documents 2.1 (i) Multiemployer Plan Section 4.11(cOffer Price Recitals Old Plans 7.2 (e) Option Consideration 3.9 (a) Outside Date 10.1 (b)(i) Parent Preamble Payment Agent 3.10 (a) Permits 4.10 Proxy Statement 4.24 (c) Representatives 6.2 (a) Requisite Stockholder Approval 4.2 (c) Schedule 14D-9 2.2 (b) Schedule TO 2.1 (h) Subsidiary Securities 4.6 (c) Surviving Corporation 3.1 Termination Fee 10.3 (a) Tender and Voting Agreements Recitals Top-Up Notice 2.4 (c) Top-Up Option 2.4 (a) Top-Up Option Shares 2.4 (a) WARN 4.18 (d)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Agreement Date Preamble Alternate Debt Financing 6.5(c) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Payments 4.12(a) Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 1.1 Company Liability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 0 Consent 3.6 Copyrights 1.1 D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letter Recitals Debt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a4.12(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1 Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter Recitals Equity Financing 4.12(a) ERISA Affiliate 3.18(a) ESPP 2.8(e) Event Notice Period 5.3(e)(i)(1) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFee Letter Recitals Financing 4.12(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Letters Recitals Go-Shop Period 5.3(a) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section Interim Period 5.1 International Employee Plans 3.18(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1 Material Contract Section 4.18(aRevision 5.3(e)(ii)(3) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i4.12(a) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Debt Commitment Letters 6.5(c) Multiemployer Plan Section 4.11(cNew Plans 6.11(d) No-Shop Period Start Date 5.3(a) Old Plans 6.11(d) Option Consideration 2.8(b)(i) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Reimbursement Obligations 6.6(f) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)
Appears in 1 contract
Sources: Merger Agreement (STAMPS.COM Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii“Aggregate Consideration” 4.10(b) Acquisition Proposal Section 6.2(e)(i“Agreement” Preamble “Alternative Financing Commitment Letter” 6.12(b) Acquisition Sub Preamble Adverse “Alternative Financing” 6.12(b) “Ancillary Documents” 9.13 “Antitrust Consents” 7.1(c) “Book-Entry Shares” 2.7(h)(iii) “Canceled Company Shares” 2.7(a)(ii) “Capitalization Date” 3.2(a) “Cautionary Note Regarding Forward-Looking Statements” Article III “Certificate of Merger” 2.2 “Certificates” 2.7(h)(ii) “Change of Recommendation Change Section 6.2(c)(iNotice” 5.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii“Closing Date” 2.3 “Closing” 2.3 “COBRA” 3.11(d) Antiboycott Rules Section 4.22(a) “Company Board Recommendation Section 2.2(bChange” 5.3(b) Cancelled “Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Board Recommendation” Recitals “Company Preamble Company Common Stock Board” Recitals “Company Disclosure Letter Letter” Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) III “Company Financial Advisor Section 4.10 Advisors” 3.10 “Company SEC Reports Section 4.7(aReports” 3.7(a) “Company Securities Section 4.2(aSecurities” 3.2(c) “Company Shares Source Code” 3.16(f) “Company Stockholder Damages” 8.2 “Company Stockholder Meeting” 5.4(c) “Company Termination Fee” 8.3(b) “Company” Preamble “Confidentiality Agreement” 9.4 “D&O Insurance” 6.7(c) “Debt Financing” 4.10(a) “Definitive Financing Agreements” 6.12(a) “DGCL” Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals “Dissenting Company Shares Section 3.7(c)(iShares” 2.7(c)(i) EAR Section 4.22(a“Effective Time” 2.2 “Enforceability Exceptions” 3.4 “Equity Commitment Letter” Recitals “Equity Financing” 4.10(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b“Exchange Fund” 2.7(g) Exchange Fund Section 3.8(b“Financing Letters” 4.10(a) Expiration Time Section 2.1(d)(i“Financing” 4.10(a) Financial Statements Incipio Incipio “Foreign Antitrust Laws” 3.6 “Indemnified Persons” 6.7(a) “Indemnified Proceeding” 6.7(b) “Investors” Recitals “Company IT Systems” 3.16(h) “Letter of Transmittal” 2.7(h)(ii) “Limited Guarantee” 4.10(f) “Material Contract” 3.18(a)(xi) “Merger Agreement Section 4.7(bConsideration” 2.7(a)(i) “Merger Sub” Preamble “Merger” Recitals Recitals Indemnified Persons Section 7.8(a“Multiemployer Plan” 3.11(c) Inventions Section 1.1 Material Contract Section 4.18(a“Option Consideration” 2.7(d) Maximum Annual Premium Section 7.8(c“Owned Real Property” 3.17(a) Merger Recitals Merger Consideration Section 3.7(a)(i“Parent 401(k) Minimum Condition Section 2.1(a)(iPlan” 6.8(c) Multiemployer Plan Section 4.11(c“Parent Termination Fee” 8.3(c) “Parent” Preamble “Paying Agent” 2.7(f) “Payoff Letter” 6.11(d) “Plans” 3.11(a) “Proxy Date” 5.4(c) “Proxy Statement” 5.4(a) “Real Property Leases” 3.17(b) “Remedy Actions” 6.2(a) “Required Amount” 4.10(b) “Risk Factors” Article III “Service Provider” 3.11(e) “Solvent” 4.8 “Surviving Corporation” 2.1 “Termination Date” 8.1(b)(i)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(f) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnnual Incentive Award 3.6(d)(vii) Antiboycott Rules Section 4.22(aAssumed Option 3.6(d)(ii) Board Recommendation Section 2.2(bAssumed Unit 3.6(d)(iv) Book-Entry Shares 3.7(b)(i) Cancelled Company Shares Section 3.7(a)(ii3.6(b)(ii) Capitalization Date 4.4(a) Certificate 3.7(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing 3.2 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Balance Sheet Date 1.1(j) Company Board Recommendation 2.2(b) Company Board Recommendation Change 7.4(a) Company Disclosure Letter Article IV Company License-Facilities 4.10 Company In Agreements Section 4.16(gLicenses 4.12(e) Company License-Out Agreements Section 4.16(hIP Licenses 4.12(f) Company Financial Advisor Section Material Contract 4.13(a) Company Non-U.S. Employee Plans 4.15(i) Company Out Licenses 4.12(f) Company Permits 4.19 Company Qualified Plan 4.15(e) Company Real Property Leases 4.10 Company Registered Intellectual Property Rights 4.12(a) Company Related Party 11.8 Company SEC Reports Section 4.7(a4.6 Company Shares 1.1(o) Company Securities Section 4.2(aStock Awards 4.4(d) Company Shares Recitals Stock Option 3.6(d)(i) Company Stock Plans 4.4(b) Company Subsidiary Documents 4.1(c) Company Terminating Plans 8.7(a) Compensation Committee 8.7(d) Confidentiality Agreement Section 10.4 Current Company 8.5(i) Converted Incentive Award 3.6(d)(vii) Converted Performance Option 3.6(d)(v) Converted Performance Unit 3.6(d)(vi) Copyrights 1.1(pp) D&O Insurance Section 7.8(cPolicy 8.9(b) Customs Laws Section 4.22(aDebt Commitment Letter 5.6(b) Debt Financing Dispute Section 10.9(a5.6(b) Delaware Secretary of State 3.3 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.6(c) EAR Section 4.22(a▇▇▇▇-▇▇▇▇▇ Act 4.6 Effect 1.1(s) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 3.3 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b4.17(c) Expiration Time Section 2.1(d)(iDate 2.1(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExport Controls 4.18(c)(i) Recitals Recitals Financing Sources 8.3(b) Import Restrictions 4.18(c)(i) Indemnified Persons Section 7.8(aParties 8.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInventory 4.12(k) Maximum Annual Premium Section 7.8(c8.9(b) Merger Recitals Merger Consideration Section 3.6(b)(i) Merger Sub Preamble Offer Recitals Offer Conditions 2.1(b) Offer Documents 2.1(g) Offer Price Recitals Option Award Amount 3.6(d)(i) Parent Preamble Patent 1.1(pp) Payment Agent 3.7(a)(i) Minimum Condition Section 2.1(a)(iPayment Fund 3.7(a)(ii) Multiemployer Plan Section 4.11(cPre-Recommendation Change Notice 7.4(a)(i) Representatives 7.1 Schedule 14D-9 2.2(a) Schedule TO 2.1(g) SIG 4.12(i) Significant Company Customer 4.23(a) Significant Company Supplier 4.23(b) Substitute Financing 8.3(b) Support Agreement(s) Recitals Surviving Corporation 3.1 Takeover Statute 4.24(a) Termination Date 10.1(c) Termination Fee Amount 10.3(b)(i) Trademarks 1.1(pp) Trade Secrets 1.1(pp) Unit Award Amount 3.6(d)(iii) Unvested Company Performance Option 3.6(d)(v) Unvested Company Performance Unit 3.6(d)(vi) Vested Company Option 3.6(d)(i) Vested Company Unit 3.6(d)(iii) WARN Act 4.16(e)
Appears in 1 contract
Sources: Merger Agreement (Maxlinear Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality 2.8(d)(i) Alternative Transaction Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.3(a) Agreement Preamble Alternative Acquisition Agreement Anti-Kickback Statute Section 6.2(c)(ii3.20(h) Antiboycott Rules Approval Section 4.22(a3.4 BLA Section 3.20(b) Board Recommendation Capitalization Date Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii3.5(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Change Section 1.1 Changes Section 1.1 Charter Documents Section 3.2 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.13(a) Collective Bargaining Agreement Section 3.16(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(a) Company Cure Period Section 9.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current 2.7(a)(i) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Subsidiary Section 3.6(a) Continuing Employees Section 6.2(a) D&O Insurance Section 7.8(c6.1(c) Customs Laws Divestiture Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a7.2(e)(i) Effective Time Section 3.2 Enforceability Exceptions 2.3 Electronic Data Room Section 4.4 Environmental Permits Section 4.15(b) 3.26 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i2.8(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.7(c) IAA Section 7.2(a) ICL Recitals Recitals IND Section 3.20(b) Indemnified Persons Section 7.8(a6.1(a) Inventions Information Agent Section 1.1 2.8(a) Interim Option Tax Ruling Section 7.9(a) ITA Section 2.13(a) Lease Section 3.11(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.10(a) Maximum Annual Premium Section 7.8(c6.1(c) Medicine Section 3.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Notification Section 2.1(a)(i7.2(a) Multiemployer Plan Merger Proposal Section 4.11(c7.4(a) Merger Sub Preamble NDA Section 3.20(b) Option Consideration Section 2.7(c) Option Tax Ruling Section 7.9(a) Outside Date Section 9.1(c) Parent Preamble Parent Cure Period Section 9.1(h) Paying Agent Agreement Section 2.8(a) Payor Section 2.13(a) Permits Section 3.17(a) Proxy Statement Section 7.3(a) R&D Sponsor Section 3.13(g) Recommendation Change Notice Section 5.3(b) Surviving Company Section 2.1 Tax Returns Section 3.14(a) Termination Fee Section 9.3(b) Uncertificated Shares Section 2.8(c) Voting Agreements Recitals Withholding Drop Date Section 2.13(b) Withholding Tax Ruling Section 7.9(b)
Appears in 1 contract
Sources: Merger Agreement (NeuroDerm Ltd.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.13(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.21 Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Closing 2.3 Closing Average 1.1(bb) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Common Affiliate 6.20 Company Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Intellectual Property 3.22(a) Company Product 3.22(a) Company Registered Intellectual Property 3.22(b) Company Restricted Stock 2.7(d) Company Rights Plan Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gSecurities 3.4(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Stockholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.10 Consent 3.5(b) D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Delaware Secretary of State 2.2 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExtended Termination Date 8.1(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 3.18(m) Recitals Recitals Funded International Employee Plan 3.18(c) In-Licenses 3.22(n) Incentives 3.16(p) Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 Initial Termination Date 8.1(b) Intellectual Property Rights 3.22(a) International Employee Plans 3.18(a) IP Licenses 3.22(o) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger 2.1 Merger Sub Preamble Object Code 3.22(a) Open Source Materials 3.22(a) Out-Licenses 3.22(o) Parent Preamble Parent Restricted Stock 4.3(b) Parent SEC Reports 4.5 Proxy Statement 3.8 Registered Intellectual Property 3.22(a) Requisite Stockholder Approval 3.3(b) Rights Plan Amendment Recitals Merger Consideration Section 3.7(a)(iRoHS Directive 1.1(y) Minimum Condition Section 2.1(a)(iSEC Reports 3.6 Source Code 3.22(a) Multiemployer Plan Section 4.11(cSpecial Representations 7.3(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Technology 3.22(a) Termination Fee Amount 8.3(b)(i) Triggering Event 8.1(f)(iii) Voting Agreement Recitals WEEE Directive 1.1(y)
Appears in 1 contract
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiCapitalization Date 3.7(a) Antiboycott Rules Section 4.22(aCertificates 2.8(c) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aShareholders Meeting 7.3(d) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 7.7 Consent 3.6 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(aDissenting Shareholder 2.7(c) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c) Effective Time 2.3 Equity Commitment Letter Section 3.2 Enforceability Exceptions 4.10(a) Equity Financing Section 4.4 Environmental Permits Section 4.15(b4.10(a) Exchange Fund 2.8(b) Guarantee Recitals HKIAC Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals 10.9 Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a6.1(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Sub Preamble Option Consideration 2.7(d) Outside Date 9.1(b) Parent Preamble Paying Agent Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iPer ADS Merger Consideration 2.7(a)(ii) Multiemployer Per Share Merger Consideration 2.7(a)(ii) Permits 3.14 Plan Section 4.11(c)of Merger Recitals Preliminary Proxy Statement 7.3(a) Proxy Statement 7.3(a) Recommendation Change Notice 5.3(b) Registrar of Companies 2.3 Requisite Shareholder Approval 3.4 Schedule 13E-3 3.6 Special Committee Recitals Subsidiary Securities 3.8(c) Surviving Corporation 2.1 Tax Returns 3.13(a) Uncertificated Shares 2.8(c) Voting Agreement Recitals
Appears in 1 contract
Sources: Merger Agreement (WSP Holdings LTD)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble 90% Top-Up Option 1.4 90% Top-Up Option Shares 1.4 90% Top-Up Exercise Notice 1.4 90% Top-Up Notice Date 1.4 90% Top-Up Closing 1.4 90% Top-Up Notice Receipt 1.4 Adverse Recommendation Change Section 6.2(c)(i) Regulatory Condition Annex A Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 1.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.20 Capitalization Representation Annex A Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Change in Control Agreement 6.13(d) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Company Preamble Company Common Stock Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Schedule Article III Preamble Company IP Agreements 3.21(f) Company Representative 6.1(b) Company Rights Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Rights Plan Recitals Company Securities Section 4.2(a3.4(c) Company Shares Recitals Company Stockholders 1.1(f) Term Section Reference Company Stockholders’ Meeting 6.3(a) Compensation Committee 3.3(d) Computershare Recitals Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Continuing Directors 1.3(a) Covered Securityholders 4.9 D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aDistribution Date 3.3(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExclusivity Agreement 6.10 Export Controls 3.22 FIN 48 3.15(o) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(b) Recitals Recitals Import Restrictions 3.22 Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.19(b) Leases 3.19(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Consideration Section 3.7(a)(i2.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c1.1(a)(i)
Appears in 1 contract
Sources: Merger Agreement (Moldflow Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAmended Offer Documents 2.1(a)(i) Antiboycott Rules Section 4.22(aAntitrust Approval 8.1(c) Board Recommendation Section 2.2(bAnnual Meeting 7.6(b) Cancelled Company Assets 4.19 Assumed Option 3.8(a) Assumed Restricted Stock Unit 3.8(b) Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d3.2 Collective Bargaining Agreements 4.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Products 4.20(a) Company Financial Advisor Section 4.10 Restricted Stock 3.8(c) Company SEC Reports Section 4.7(a4.6(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.6(a) Confidential Materials 7.9(a) Continuing Directors 2.4(b) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(vi) EAR Section 4.22(aEffect 1.1(pp) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b3.3(a)
(a) Exchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Foreign Employees 4.15(j) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 4.20(d) Recitals Recitals Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 Independent Directors 2.4(c) Leased Real Property 4.17 Leases 4.17 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.6(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A Notes 7.9(a)
Appears in 1 contract
Sources: Merger Agreement (Emc Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdvisor 3.3(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Consideration 3.7(e) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aBylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(bCash Replacement Company RSU Award Amounts 2.8(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCash Replacement Option Amounts 2.8(b)(ii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 1.1(o) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(f)(ii) Company Financial Advisor Section 4.10 Plans 6.11(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(oo) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Exchange Fund Section 3.8(bEquity Commitment Letter Recitals Equity Financing 4.11(a) Expiration Time Section 2.1(d)(iERISA Affiliate 3.18(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bESPP 2.8(e) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cEvent Notice Period 5.3(e)(i)(1)
Appears in 1 contract
Sources: Merger Agreement (Instructure Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAAA 9.10(a)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.18(f) Commercial Rules 9.10(a)(i) Commitment Letters 4.11(a)(ii) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV Article III Company License-In Agreements Section 4.16(gRestricted Stock Consideration 2.8(a) Company License-Out Agreements Section 4.16(hRestricted Stock Unit Consideration 2.8(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c9.4 Consent 3.6 Copyrights 1.1 Cut-Off Date 5.3(a) Customs Laws Section 4.22(aData Protection Requirements 3.16(j)(ii) Debt Commitment Letter 4.11(a)(i) Debt Financing Dispute Section 10.9(a4.11(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Early ESPP Exercise Date 2.8(f) Effect 1.1 Effective Time Section 3.2 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2 Enforcement Costs 8.3(e) Equity Commitment Letter 4.11(a)(ii) Equity Financing 4.11(a)(ii) ESPP 2.8(f) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFair Value 4.13(e)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.11(a)(i) Recitals Financing 4.11(a)(ii) Financing Source Provisions 8.4 Go-Shop Period End Date 5.3(a) Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(j) Intervening Event 5.3(e)(i) IP Contracts 3.16(e) IT Systems 3.16(j)(i) KYC Deliverables 6.6(a)(viii) Lease 3.14(b) Leased Real Property 3.14(b) Limited Guaranty Recitals Malicious Code 3.16(l) Marks 1.1 Material Contract Section 4.18(a) Suppliers 1.1 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Non-Employee Holders 2.9(b) New Plans 6.11(d) Notice Period 5.3(e)(ii)(3) Offering Period 2.8(f) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(c) Minimum Condition Section 2.1(a)(iOutside Date 8.1(c) Multiemployer Plan Section 4.11(cOwned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Account 8.3(b)(ii) Parent Disclosure Letter Article IV Party Preamble Parent Termination Fee 8.3(c) Patents 1.1 Payment Agent 2.9(a) Payoff Letters 6.6(a)(v) Permits 3.20 Per Share Price 2.7(a)(ii) PHI 3.27(e) Present Fair Salable Value 4.13(e)(ii) Process Agent 9.10(a)(xiii) Proxy Statement 6.3(a) Purchase Period 2.8(f) Recent SEC Reports Article III Representatives 5.3(a) Required Financing Amount 4.11(c) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tax Incentive 3.17(i) Tax Returns 3.17(a) Trade Control Laws 3.26(a) Uncertificated Shares 2.9(c)
Appears in 1 contract
Sources: Merger Agreement (Natus Medical Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiFinancing 6.4(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.14 B▇▇▇ Capital Recitals Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.1(b) Company Disclosure Letter Article IV Art. III Company License-In Intellectual Property Agreements Section 4.16(g3.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Rights Plan Recitals Company SEC Reports 3.8 Term Section 4.7(aReference Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 5.4 Consent 3.4 D&O Insurance Section 7.8(c6.8(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) Delaware Secretary of State 2.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitment Letters 4.10(a) Funded International Employee Plan 3.17(h)(ii) Guarantors Recitals Huawei Recitals Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.13(b) Leases 3.13(b) Limited Guarantees Recitals Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Section 7.8(c6.8(c) Merger 2.1 Merger Sub Preamble Newco Preamble Other Required Company Filings 3.29(a) Other Required Newco Filings 4.6(a) Payment Agent 2.8(a) Per Share Price 2.7(a)(i) Permits 3.19 Proxy Statement 3.29(a) Recommendation Change 5.3(a) Required Information 6.4(a) Requisite Stockholder Approval 3.2 Rights Plan Amendment Recitals Merger Consideration Section 3.7(a)(iSpecified Person 8.3(g) Minimum Condition Section 2.1(a)(iSubsidiary Securities 3.6(b) Multiemployer Plan Section 4.11(cSurviving Corporation 2.1 Tax Returns 3.16(a) Termination Date 8.1(b)
Appears in 1 contract
Sources: Merger Agreement (3com Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAcquisition Preamble Acquisition Proposal 6.5(a) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTransaction 6.5(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Financing 5.6 Balance Sheet 4.8(a) Antiboycott Rules Section 4.22(aBalance Sheet Date 4.8(b) Board Recommendation Section 2.2(bof Directors Recitals
(a) Cancelled Company Shares Section 3.7(a)(iiCEO Recitals CEO Term Sheet Recitals Certificate 3.1(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.3 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Commitment Letters 5.6 Company Preamble Company Common Stock Recitals Board Recommendation 4.2(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gFinancial Advisor 4.21 Company Intellectual Property Rights 4.19(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Organizational Documents 4.1 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.3(b) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cContinuing Employees 6.14(a) Customs Laws Section 4.22(aCustomer Information 4.19(d) Debt Financing Dispute Section 10.9(a5.6 Definitive Financing Agreements 6.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.4(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 2.3 Environmental Permits Section 4.15(bLaws 4.18 Exchange Act 4.3(e) Exchange Fund Section 3.8(bExisting Bylaws 2.5(b) Expiration Time Section 2.1(d)(iExisting Charter 2.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitment 5.6 Hazardous Materials 4.18 HSR Act 4.5 Indemnified Parties 6.9(a) Recitals Recitals Indemnified Persons Section 7.8(aInventory 4.13(b) Inventions Section 1.1 IRS 4.15(a) JWC 5.6 LC Satisfaction 6.8(d) Leased Real Property 4.12(a) Material Contract Section 4.18(aContracts 4.14(a) Maximum Annual Aggregate Premium Section 7.8(c6.9(c) Merger Recitals NASDAQ 4.5 New Plans 6.14(b) Option Consideration 3.2(a) OSIM 5.6 Owned Real Property 4.12(b) Parent Preamble Parent Disclosure Letter Article V Parent Expenses 8.3(a)(ii) Paying Agent 3.5(a) Payoff Amount 6.8(d) Payoff Letter 6.8(d) Per Share Merger Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPermits 4.10(b) Multiemployer Plan Section 4.11(cPost-Signing Returns 6.13(a) Preferred Stock 4.3(a) Privacy Policy 4.19(d) Proxy Statement 6.3(b) Real Property 4.12(b) Real Property Leases 4.12(a) Real Property Subleases 4.12(d) Required Stockholder Approval 4.2(a) Revised Offer 6.5(d) Schedule 13E-3 6.3(b) Securities Act 4.3(d) SOX 4.7(a) Special Committee Recitals Stock Award Consideration 3.2(b) Stockholders Agreement 4.3(d) Stockholders Meeting 6.4 Subject Property 4.18 Superior Proposal 6.5(b) Surviving Corporation 2.1 Takeover Statute 4.2(b) Temasek 5.6 Third Party 6.5(a) Transaction Related Legal Proceeding 6.12 2004 Draft 10-K 4.7(a) 2005 Budget 6.2(p) WARN Act 4.16(e)
Appears in 1 contract
Sources: Merger Agreement (Brookstone Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2.8(d)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.2(b)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(b)(ii) Antiboycott Rules Approval Section 4.22(a3.5 Benchmark Section 3.26 Capitalization Date Section 3.6(a) Board Recommendation CERCLA Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 1.1 Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Closing Net Cash Section 4.11(d6.2(f) Code Section 2.12(a) Collective Bargaining Agreement Section 3.18(b) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recitals Company Disclosure Letter Article IV III Company License-In Agreements Ground Stations Section 4.16(g3.24 Company Reports Section 3.8(a) Company License-Out Agreements Shareholder Approval Section 4.16(h) 3.2 Company Financial Advisor Shareholders Meeting Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a5.9(a) Company Shares Recitals Section 2.7(a)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 5.3 control Section 7.8(c) Customs Laws 1.1 Copyrights Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.17(a) Encouragement Law Section 4.15(b3.16(s) Estimated Closing Certificate Section 5.17(a) Excess Earnout Certificate Section 5.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Expense Reimbursement Section 2.1(d)(i7.3(b) FCC Section 3.5 FCPA Section 3.20(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Recitals Funded International Employee Plan Section 3.17(e) Guarantor Preamble ICL Recitals Indemnified Persons Person Section 7.8(a5.6(a) Independent Accountant Section 5.17(b) Interim Option Tax Ruling Section 5.14(a) Inventions Section 1.1 Israeli Employees Section 3.18(e) IT Systems Section 3.15(i) ITA Section 2.12(a) Joint Venture Interests Section 3.7(b) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Major Stations Section 3.24 Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Material Customer Section 7.8(c3.12(a) Material Employee Plans Section 3.17(a) Material Permits Section 3.19(a) Material Supplier Section 3.12(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Proposal Section 2.1(a)(i5.10(a) Multiemployer Plan Merger Sub Preamble MOC Section 4.11(c)3.5 Objection Notice Section 5.17(b) OECD Convention Section 3.20(b) Option Consideration Section 2.7(c)(i) Option Tax Ruling Section 5.14(a) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.13(a) Parent Preamble Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.19(a) Prohibited Payment Section 3.20(b) Proxy Statement Section 5.9(a) Registered Intellectual Property Section 3.15(a) RSUs Consideration Section 2.7(d)(i) Section 14 Arrangement Section 3.18(a) Special Enterprise Section 3.16(s) Surviving Company Section 2.1 Tax Returns Section 3.16(a) Temporary Order Section 3.16(t) Termination Fee Section 7.3(c) Trade Secrets Section 1.1
Appears in 1 contract
Sources: Merger Agreement (RR Media Ltd.)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(f) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnnual Incentive Award 3.6(d)(vii) Antiboycott Rules Section 4.22(aAssumed Option 3.6(d)(ii) Board Recommendation Section 2.2(bAssumed Unit 3.6(d)(iv) Book-Entry Shares 3.7(b)(i) Cancelled Company Shares Section 3.7(a)(ii3.6(b)(ii) Capitalization Date 4.4(a) Certificate 3.7(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing 3.2 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Balance Sheet Date 1.1(j) Company Board Recommendation 2.2(b) Company Board Recommendation Change 7.4(a) Company Disclosure Letter Article IV Company License-Facilities 4.10 Company In Agreements Section 4.16(gLicenses 4.12(e) Company License-Out Agreements Section 4.16(hIP Licenses 4.12(f) Company Financial Advisor Section Material Contract 4.13(a) Company Non-U.S. Employee Plans 4.15(i) Company Out Licenses 4.12(f) Company Permits 4.19 Company Qualified Plan 4.15(e) Company Real Property Leases 4.10 Company Registered Intellectual Property Rights 4.12(a) Company Related Party 11.8 Company SEC Reports Section 4.7(a4.6 Company Shares 1.1(o) Company Securities Section 4.2(aStock Awards 4.4(d) Company Shares Recitals Stock Option 3.6(d)(i) Company Stock Plans 4.4(b) Company Subsidiary Documents 4.1(c) Company Terminating Plans 8.7(a) Compensation Committee 8.7(e) Confidentiality Agreement Section 10.4 Current Company 8.5(i) Converted Incentive Award 3.6(d)(vii) Converted Performance Option 3.6(d)(v) Converted Performance Unit 3.6(d)(vi) Copyrights 1.1(qq) D&O Insurance Section 7.8(cPolicy 8.9(b) Customs Laws Section 4.22(aDebt Commitment Letter 5.6(b) Debt Financing Dispute Section 10.9(a5.6(b) Delaware Secretary of State 3.3 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.6(c) EAR Section 4.22(a▇▇▇▇-▇▇▇▇▇ Act 4.6 Effect 1.1(s) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 3.3 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b4.17(c) Expiration Time Section 2.1(d)(iDate 2.1(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExport Controls 4.18(c)(i) Recitals Recitals Financing Sources 8.3(b) Import Restrictions 4.18(c)(i) Indemnified Persons Section 7.8(aParties 8.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInventory 4.12(k) Maximum Annual Premium Section 7.8(c8.9(b) Merger Recitals Merger Consideration Section 3.6(b)(i) Merger Sub Preamble Offer Recitals Offer Conditions 2.1(b) Offer Documents 2.1(g) Offer Price Recitals Option Award Amount 3.6(d)(i) Parent Preamble Patent 1.1(qq) Payment Agent 3.7(a)(i) Minimum Condition Section 2.1(a)(iPayment Fund 3.7(a)(ii) Multiemployer Plan Section 4.11(cPre-Recommendation Change Notice 7.4(a)(i) Representatives 7.1 Schedule 14D-9 2.2(a) Schedule TO 2.1(g) SIG 4.12(i) Significant Company Customer 4.23(a) Significant Company Supplier 4.23(b) Substitute Financing 8.3(b) Support Agreement(s) Recitals Surviving Corporation 3.1 Takeover Statute 4.24(a) Termination Date 10.1(c) Termination Fee Amount 10.3(b)(i) Trademarks 1.1(qq) Trade Secrets 1.1(qq) Unit Award Amount 3.6(d)(iii) Unvested Company Performance Option 3.6(d)(v) Unvested Company Performance Unit 3.6(d)(vi) Vested Company Option 3.6(d)(i) Vested Company Unit 3.6(d)(iii) WARN Act 4.16(e)
Appears in 1 contract
Sources: Merger Agreement (Exar Corp)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2016 Warrant 2.7(f)(ii) Acquisition Proposal Section 6.2(e)(i2016 Warrant Consideration 2.7(f)(ii) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Chosen Courts 9.9(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.16(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 3.2(b) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company Financial Advisor Section 4.10 Advisors 3.21 Company Plans 6.9(c) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a3.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Competing Acquisition Transaction 8.3(b) Covered Securityholders 3.24 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.4(c) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Employment Compensation Arrangement 3.24 Enforceability Exceptions Section 4.4 3.2 Environmental Permits Section 4.15(b3.12(b) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 3.19 FDA Permits 3.17(b) Recitals Recitals Healthcare Laws 3.17(a) Indemnified Persons Section 7.8(a6.4(b) Indemnified Proceeding 6.4(b) Inventions Section 1.1 10.1 Know-How 10.1 Leased Real Property 3.13(b) Material Contract 3.15(a) Term Section 4.18(a) Reference Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Parent Preamble Parent Common Stock 2.7(c) Payment Agent 2.8(a) Plans 3.16(a) Real Property Leases 3.13(b) Representatives 5.3(a) Restraint 7.1(b) Restricted Share Wage Consideration 2.7(g) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software 10.1 Solvent 4.10 Stock Award Exchange Ratio 2.7(c) Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.3(b) Trademarks 10.1 Uncertificated Shares 2.8(c) Works of Authorship 10.1
Appears in 1 contract
Sources: Merger Agreement (Relypsa Inc)
Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEffect on Financing 7.18 Advisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a)(i) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8 Effect 1.1(t) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c)6.3(e)(i) Event Notice Period 6.3(e)(i) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Go-Shop Period 6.3(a) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz)
(a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) No-Shop Period Start Date 6.3(a) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)
Appears in 1 contract
Sources: Agreement and Plan of Merger (H&E Equipment Services, Inc.)